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The derivation of embryonic stem cells (ESCs), first from mice blastocysts in 
1981 then eventually from human blastocysts in 1998 has created an invaluable resource 
for scientific study and discovery.   ESC models allow for in vitro study of normal and 
pathological mammalian embryological development and have created a platform on 
which therapies can be tested on human cells before trial in the clinic.  Directed 
differentiation of ESCs towards functional, adult-cell types holds the promise of cell-
based regenerative medicine with goals of curing diseases and restoration of function, 
rather than pharmacological treatment of symptoms or mitigation of side-effects.  
Already two clinical trials using human ESC derived adult cell types have begun in the 
United States to determine the safety and efficacy of ESC-derived cell therapies. 
 Even with successful derivation of adult cell types including cardiomyocytes, 
oligodendrocytes, retinal epithelial cells and others, further improvement in 
differentiation protocols is necessary to generate the large number of cells needed for 
clinical relevance.  Additionally, directed differentiation of ESCs towards heterogeneous 
cell types, organized in 3D for construction of neo-tissues would be of great value for 
both research diagnostics, including limiting the need for animal studies, and for 
regenerative therapies.  Differentiation of ESCs is commonly initiated through the 
formation of aggregates grown in suspension culture, termed embryoid bodies (EBs).  
Differentiation within EBs can be directed by the addition of soluble growth factors to the 
surrounding medium; however, barriers to free diffusion within the aggregates limit the 
effectiveness of this method.  Recently, engineered biomaterials incorporated within 
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aggregates of ESCs have been utilized to gain access to the interior microenvironment.  
The goal of this work was to develop a method to incorporate biomaterial microparticles 
(MPs) within stem cell aggregates and to evaluate their use for local control of the 
cellular microenvironment for directed differentiation.  The central hypothesis was that 
incorporation of biomaterials within EBs would induce efficient differentiation by 
controlled presentation of morphogens. 
 The effects of unloaded MPs on ESC differentiation were first determined by 
controlled incorporation of poly(lactic-co-glycolic acid) (PLGA), agarose and gelatin 
MPs.  Previously reported methods of material incorporation within EBs were not 
adequate for incorporation of the three materials, therefore, a forced aggregation culture 
technique was modified to allow for robust and controlled incorporation of the MPs 
within EBs.  Forced aggregation allowed for controlled study of EBs containing roughly 
the same number of MPs fabricated from the different material types.  EB formation, cell 
viability, and gross morphology were not affected by the presence of the MPs.  Further 
analysis of gene expression and patterns of phenotypic marker expression revealed 
alterations in the differentiation profile in response to material incorporation.  
Specifically, endoderm genes, including α-fetoprotein (AFP), and mesoderm genes, 
including myosin light chain-2V (MLC-2V), were increased in presence of gelatin MPs.  
Patterns of phenotypic marker expression of AFP and α-sarcomeric actin, analyzed by 
whole-mount immunostaining, were also altered in MP treated groups. 
It was hypothesized that the materials could be interacting with endogenously 
produced growth factors, thereby altering the microenvironment and modulating EB 
differentiation.  In order to test this hypothesis, gelatin MPs were modified with heparin, 
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a sulfated glycosaminoglycan known to regulate growth factor interactions in vivo.  
Incorporation of heparin-modified gelatin MPs altered the secretion of growth factors by 
the EBs into the surrounding medium and gene expression was altered at days 7 and 11.  
The spatial expression pattern of vascular endothelial cadherin, a marker expressed by 
endothelial cells, was found to co-localize with the heparin-gelatin MPs, but not with 
unmodified gelatin MPs, further suggesting the MPs can influence the local 
microenvironment with EBs. 
The ability of MPs to direct ESC differentiation was investigated by incorporation 
of growth factor loaded MPs within EBs.  MPs were loaded with bone morphogenetic 
protein-4 (BMP-4), a protein which promotes mesoderm differentiation of ESCs, or with 
Noggin, a BMP-4 inhibitor.  BMP-4 loaded MPs were capable of inducing mesoderm 
gene expression (Brachyury-T and fetal liver kinase-1) while at the same time inhibiting 
expression of an ectoderm marker (Pax-6) compared to untreated EBs.  Noggin loaded 
MPs did not reduce mesoderm gene expression compared to untreated EBs but did 
increase the expression of Pax-6.  Further analysis was performed on EBs formed from 
ESCs genetically engineered to express green fluorescent protein when Brachyury-T is 
expressed.  EBs with BMP-4 loaded gelatin MPs contained a higher percentage of cells 
differentiated towards a mesoderm lineage (~50%) compared to soluble BMP-4 treatment 
(~40%) and untreated EBs (~25%).  In this study, the amount of BMP-4 used for soluble 
delivery was over 10 fold greater than that used via MPs, indicating the potential 




Finally, magnetic MPs (magMPs) were incorporated within EBs for controlled 
heterogeneity within cell constructs.  The number of incorporated magMPs was 
controlled by the seed ratio (cells:magMPs) used prior to EB formation.  Similar to 
PLGA, agarose and gelatin MPs tested previously, magMP incorporation did not affect 
EB formation, viability or gross morphology.  After formation, EBs containing magMPs 
could be manipulated using magnets placed outside the culture dish.  The sensitivity of 
EBs to applied magnetic fields was controlled by the number of magMPs incorporated 
within the aggregates.  Magnets placed on the outside of culture vessels were used to 
pattern populations of EBs both in static and in hydrodynamic culture systems.  Cell 
construct heterogeneity could be controlled by taking advantage of E-cadherin based 
agglomeration of ESC aggregates placed in contact under static conditions.  By using 
magnetic guidance to control the precise spatial location of EBs, a single construct could 
be created from 4 EBs formed from fluorescently labeled ESC populations.  Interestingly, 
the fluorescently labeled cells remained in the approximate location of their original EB, 
thereby creating distinct quadrants, visualized by fluorescent microscopy, in the resulting 
construct.  This same principle was used to create larger constructs from heterogeneous 
populations of hundreds of EBs demonstrating the flexibility of magnetic manipulation 
across broad length scales. 
Overall, the results indicated that PSC differentiation within spheroids is sensitive 
to various types of biomaterials.  Incorporation of MPs within EBs can be used to direct 
ESC differentiation by control of the cellular environment from microscale interactions, 
by delivery of soluble factors, to macroscale interactions, by control of EB position in 







Embryonic stem cells (ESCs) are pluripotent cells with the potential to serve as a 
limitless source for a range of cellular therapies.  Limitations in current approaches to 
controlling ESC differentiation have prevented wide-scale application of ESC derived 
cells in clinical trials.  Complex, multi-step protocols exist to increase the efficiency of 
directed differentiation in monolayer culture; however, such methods have only been 
successfully applied only to select cell types.  Recently, interest has grown in 
manipulation and engineering of the three-dimensional microenvironment of ESC 
spheroids, termed embryoid bodies (EBs), in order to develop scalable differentiation 
methods more broadly applicable to the production of a wide range of mature cell types.  
Current approaches to directing EB behavior focus on “outside-in” methods including: 
manipulation of media components and control of EB size.  Both these methods act 
directly on cells of only the exterior of the spheroids leading to non-uniform treatment of 
cells and gradients in signaling.  Conversely, our lab has developed methods to 
incorporate biomaterial morphogen delivery vehicles within EBs as an “inside-out” 
approach to more efficiently control the local microenvironment of cells in the EB 
interior for directed differentiation.  The objective of this work was to efficiently direct 
ESC differentiation within EBs through incorporation of biomaterial 
microparticles.  The central hypothesis was that incorporation of biomaterial 
microparticles within EBs would induce efficient differentiation by spatially and 
temporally controlled presentation of morphogenic factors.  The objective was 
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accomplished and the central hypothesis was tested through completion of the following 
specific aims: 
 
Specific Aim 1.  Determine the effects of unloaded biomaterial MPs on EB 
differentiation.  The working hypothesis was that the presence of unloaded biomaterial 
microparticles within EBs can influence ESC differentiation.  The number of MPs 
incorporated per EB was determined for PLGA, agarose and gelatin MPs as a function of 
loading conditions.  The effects of incorporation on EB differentiation were tested using 
equal incorporation amounts of comparably sized particles allowing for comparisons 
between materials.  Material effects were further analyzed by incorporation of heparin-
modified gelatin MPs.  The material effects on differentiation were assessed using gross 
morphological analysis as well as qtPCR and immunofluorescent staining of early germ 
lineage markers for endoderm, mesoderm and ectoderm. 
 
Specific Aim 2.  Investigate the efficacy of MP delivery of single morphogens for 
directed differentiation within EBs.  The working hypothesis was that morphogens 
delivered locally within EBs via incorporated MPs would result in more efficient 
differentiation, requiring less growth factor compared to soluble delivery.  BMP-4 was 
delivered via gelatin MPs for directed mesodermal differentiation.  In parallel, Noggin, a 
naturally secreted agonist of BMP4, loaded particles were also examined for their ability 
to inhibit mesoderm differentiation and promote ectoderm differentiation.  Differentiation 
was assessed through gene and protein expression analysis of mesodermal and neural 
markers as well as morphological hallmarks of differentiation including neurite 
outgrowth.  Cells genetically engineered to express green fluorescent protein upon 
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Brachyury-T expression, a marker of early mesoderm differentiation, were utilized to 
examine spatial patterns of differentiation in all conditions. 
 
Specific Aim 3.  Examine the ability of microparticle incorporation to manipulate 
EBs on micro and macro scales.  The working hypothesis was that controlled 
incorporation of magnetic MPs within EBs can modulate EB sensitivity to magnetic 
fields, allowing subsequent magnetic manipulation of spheroid location and merging.  
The application of magnetic fields was examined as a method to control spatial 
positioning of single spheroids as well as populations of spheroids in dynamic and static 
suspension culture.  Magnetic fields were used to control the aggregation of 
heterogeneous EBs to form a single construct for complex, multi-signal control of the 
microenvironment.  The effects of magnetic MP incorporation were determined by gene 
expression analysis, analysis of EB morphology and cell viability. 
 
The work is significant because it is the first study to utilize and analyze the 
effects of multiple materials incorporated within stem cell aggregates.  Material specific 
effects on ESC differentiation led to development of heparin-modified particles for 
directed interaction between endogenously secreted factors and the microparticles within 
3D constructs.  Efficient capture or presentation of endogenously secreted factors could 
enable large-scale differentiation of ESCs in suspension with minimal growth factor 
supplementation.  In addition, the use of MPs to control growth factor presentation in 
combination with magnetic manipulation of spheroids is an enabling technology expected 
to yield insights for the transformation of ESCs into neo-tissues with applications to stem 








Embryonic stem cells 
 Embryonic stem cells (ESCs) are capable of extensive self-renewal in vitro and 
differentiate into cells constituting all three primitive germ layers– mesoderm, ectoderm 
and endoderm, as well as germ cells (sperm and ova).  ESCs, isolated from the inner cell 
mass of blastocyst stage embryos, were first derived from mouse embryos[1-3], followed 
by the derivation of primate[4, 5] and human[6, 7] ESC lines.  Recently, an alternative 
method for deriving pluripotent cells by retroviral transduction of a combination of 
embryonic genes into somatic cells was reported, first by Yamanaka‟s group, followed 
shortly thereafter by several other groups independently[8-12].  The “induced” 
pluripotent stem (iPS) cells created from both mouse and human somatic cells appear 
similar to ESCs in terms of both self-renewal and differentiation capacity. 
 A functional test of pluripotency is whether introduction of the cells into a 
blastocyst stage embryo results in a chimera with ESCs (or iPS cells) contributing to all 
tissues of the organism[13, 14].  Similarly, ESCs injected into various tissue sites of adult 
organisms spontaneously form teratomas, benign tumors composed of a disorganized mix 
of cells from all three germ layers.  Blastocyst injection and teratoma studies demonstrate 
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that the environment into which pluripotent cells are introduced can influence 
differentiation, however, in vivo studies are limited in their ability to attain mechanistic 
insights into the effects of environmental factors on stem cell differentiation.  In contrast, 
differentiation of ESCs in vitro, affords more controlled methods to present morphogenic 
cues in the stem cell microenvironment and directly assess differentiated cell phenotypes.  
Common formats to induce ESC differentiation in vitro include monolayer culture on 
defined matrices[15], co-culture with heterotypic cell types[16] and the formation of cell 
aggregates grown in suspension termed embryoid bodies (EBs)[3].  Culture of ESCs in 
planar formats (i.e. monolayer, co-culture) attempt to provide a more defined substrate 
for ESC attachment and uniform exposure to soluble media components, while the 3D 
aggregates of ESCs formed by EB culture techniques more accurately recapitulate the 
complex assembly of cell adhesions and intercellular signaling of early embryogenesis. 
 
Culture in two or three dimensions 
Traditionally, two-dimensional culture (2-D) is used to maintain cells in an 
undifferentiated state whereas three-dimensional (3-D) culture techniques are more 
commonly implemented in differentiation protocols. For example, ESCs are commonly 
differentiated through the formation of 3-D multicellular aggregates, referred to as 
embryoid bodies (EBs)[3]. Spheroid culture provides a platform for scalable culture of 
cells because they can be grown in suspension and require a lower tissue culture surface 
area-to-volume ratio compared to cells in monolayer. The 3D spheroid microenvironment 
is complex and becomes more so as differentiation progresses. Differentiating cells 
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deposit extracellular matrix and are subjected to homo- and heterotypic cell-cell 
interactions, as well as autocrine and paracrine factors.  
Soluble factors added to the culture media are more accessible to cells grown in 
monolayer and the temporal resolution of these factors can be fairly well controlled by 
simply exchanging the culture media at specific times[17]. In contrast, 3-D culture 
provides more physiological cues such as increased cell-cell interactions and the potential 
for increased cell-extracellular matrix interaction; however, diffusion limitations 
complicate 3-D cultures of cells. Concentration gradients of soluble factors added to the 
media, which result from the diffusion properties of 3-D cellular aggregates or constructs, 
can result in differences in the microenvironment depending on the spatial positioning of 
cells. Stem cells can be very sensitive to small perturbations in the biochemical 
composition of their surroundings and the effects of soluble factors often vary in a dose-
dependent manner. This limited control of the 3D environment has necessitated the 
development of biomaterial technologies to engineer the microenvironment of 3D culture 
systems in order to further develop stem cell differentiation protocols.  
 
Embryoid body development 
The in vitro culture of ESCs as EBs affords opportunities to mechanistically study 
early differentiation events of 3D assemblies of pluripotent cells.  One advantage of in 
vitro differentiation studies is that genetic manipulation of ES cells can be studied for 
gene mutations or knockouts that prove to be lethal during normal embryonic 
development in vivo[18-20].  Although several phenotypic and functional differences 
between mouse and human ESCs have been determined[21-24], few studies have directly 
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examined differences between mouse and human EB differentiation.  One such study, 
however, identified shared signaling pathways active during mouse and human EB 
differentiation, suggesting that mechanisms regulating differentiation may be conserved 
between the species[25].  EB differentiation begins with the formation of an aggregate of 
ESCs, the size of which is dependent on the number of cells which initially self-assemble 
via cell-cell adhesion receptors[26-28].  Following cell aggregation, the first indication of 
differentiation is the spontaneous formation of a layer of primitive endoderm (PE) on the 
exterior surface of the EBs (23).  While the specific cues responsible for stimulating PE 
differentiation remain unknown, the formation of a PE layer on the exterior of EBs 
appears to be dependent on fibroblast growth factor (FGF) signaling mediated by the PI 
3-kinase pathway [29, 30]. The PE cells exhibit an epithelial morphology on the EB 
surface, further differentiate into visceral and parietal endoderm, and deposit a basement 
membrane rich in laminin and collagen IV[18].  The basement membrane which 
separates the PE cell layer from the remaining mass of undifferentiated cells within the 
EB is generally thought to promote the survival of adjacent cells, whereas cells not in 
direct contact with the basement membrane undergo apoptosis, contributing to the 
formation of cystic cavities in most EBs[31-33].   
 As EB development progresses, differentiated cell phenotypes of all three germ 
lineages begin to arise[34].  For example, evidence of hematopoietic differentiation of 
EBs is supported by the appearance of yolk sac-like blood islands and spontaneously 
contractile foci of cells within EBs, indicative of cardiomyogenic differentiation, are 
readily apparent under low magnification[3, 35].  Upon plating onto an adherent 
substrate, elongated cell projections resembling neurite extensions emanate out from EBs 
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and morphological evidence of endothelial cells, fibroblasts and other cell types can be 
readily observed.  Global DNA microarray analysis indicates that EBs temporally express 
genes in a manner that recapitulates the sequence of normal development from primitive 
ectoderm formation, to gastrulation, and eventual early cell specification prior to 
organogenesis[36].  Expression of phenotypic markers of endoderm (such as Foxa2, 
Sox17, GATA 4/6, α-fetoprotein, and albumin), mesoderm (such as Brachyury-T, 
Msp1/2, Isl-1, α-actin, ζ-globin, and Runx2), and ectoderm (such as Sox1, Nestin, Pax6, 
GFAP, Olig2, neurofilament, and βIII tubulin) definitively demonstrate the ability of EBs 
to generate cells from all three germ layers[37].  However, the typical heterogeneous 
differentiation of EBs is a significant challenge for the efficient production of defined cell 
types and can be influenced by EB formation and culture methods. 
 
Embryoid body culture methods 
The term „embryoid body‟ has been broadly applied to describe pluripotent cell 
aggregates induced to differentiate using a variety of different formation and culture 
methods.  Generally speaking, an aggregate of pluripotent stem cells, cultured in 
suspension, and capable of forming derivatives of all three germ lineages is regarded as 
an EB.  Although no universally accepted benchmarks currently exist for EB formation, 
characteristics such as EB size, shape and homogeneity are typically used as points of 
reference for comparison.  Common EB culture practices, such as hanging drop and static 
suspension culture were adopted from in vitro differentiation methods originally used for 
embryonic carcinoma (EC) cells, pluripotent precursors to the ESCs themselves[38].  A 
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comprehensive review describing several of the most common EB culture methods has 
recently been published[39]. 
 The hanging drop method of EB formation produces homogeneous cell 
aggregates by dispensing a defined number of ESCs in physically separated droplets of 
media suspended from the lid of a Petri dish[40, 41].  Individual EBs form within each 
drop via gravity-induced aggregation of the cells and although EBs created by the 
hanging drop method can be subsequently introduced to suspension batch culture, the 
technique is not easily amenable to scale up for production of large numbers of EBs.  An 
additional limitation of hanging drop culture is the difficulty in exchanging or 
manipulating the small volume of medium (typically 10-20 µl) without disturbing the 
EBs, thus the composition of the media cannot be easily controlled or assayed during the 
period of hanging drop suspension.  
 In contrast to hanging drop methods, static suspension culture is performed by 
simply adding a suspension of ESCs to a bacteriological grade Petri dish or similar vessel 
that inhibits cell adhesion (i.e. agar- or other hydrophilic polymer-coated substrate), 
thereby allowing the cells to spontaneously aggregate via cell-cell adhesions[3, 42, 43].  
Static suspension cultures produce a large number of EBs rather simply, but the size and 
shape of the resulting EBs are highly variable due to the tendency of EBs in static 
suspension to agglomerate after initial formation, often producing large, irregularly 
shaped masses of cells.  Often times, depending on the surface chemistry of the culture 
vessel, EBs may prematurely attach to the substrate, leading to greater heterogeneity and 
loss of EBs from suspension culture. 
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 Entrapment of a single cell suspension or small clusters of ESCs in hydrogels, 
such as methylcellulose[35, 44, 45], fibrin[46] or hyaluronic acid[47], represents a 
compromise between hanging drop and static suspension approaches to attain physically 
separated EBs in a bulk semi-solid suspension media.  Entrapment in methylcellulose, a 
temperature sensitive hydrogel, yields EBs of clonal origin, thereby improving the overall 
synchrony and reproducibility of EB differentiation; however, the efficiency of EB 
formation from individual ESCs can be rather low and soluble factor treatments and 
retrieval of differentiated cells may be complicated by the presence of the hydrogel 
material[44]. 
Alternative techniques for EB formation and culture have also been recently 
developed using multi-well and microfabrication technologies, as well as stirred and 
mixed suspension culture systems.  Centrifugation of ESCs within round-bottomed 96-
well plates induces aggregation more rapidly than hanging drops, but still requires 
individual processing and manipulation of the resulting EBs[48].  Microwells fabricated 
by lithographic techniques yield EBs in parallel at a much higher density than other 
physical separation methods and the ability to form EBs within microwells in a 
continuous volume of medium permits batch processing, therefore significantly 
improving the throughput of EB formation[49-51].  Likewise, batches of EBs can be 
formed in microfluidic chambers, separated from the flowing culture medium by a semi-
permeable membrane, which allows for temporal control of the molecular makeup of the 
medium[52].  
Formation of EBs in hydrodynamic conditions created by rotary orbital culture, 
stirred/ rotating culture vessels, or spinner flasks generally enhances ESC aggregation, 
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forming EBs faster and more uniformly than static bulk cultures[26, 53-58].  Hence, 
hydrodynamic conditions can generate large populations of EBs at a relatively high 
density, while at the same time, controlling the extent of EB agglomeration and 
subsequent differentiation of the cells[54, 56, 58, 59].  The mixing environment also 
distributes media components more homogenously throughout the culture volume so that 
the population of EBs is continuously exposed to a more uniform concentration of 
soluble factors and environmental conditions (i.e. pH, oxygen, etc.).  
An inherent trade-off in most of the current systems available for EB formation is 
that batch-based suspension methods produce large numbers of EBs rather simply, but 
generally lack the fidelity of physical separation methods (hanging drop, microwell), thus 
yielding more heterogeneous populations of EBs.  On the other hand, physical separation 
methods capable of generating homogeneous EB populations are often not capable of 
being directly scaled up to produce the yields of ESC derivatives thought to be necessary 
for therapeutic or diagnostic applications. 
 
Engineering embryoid body cues 
Differentiation of cells within EBs is directed by morphogenic cues comprising 
the intercellular and surrounding extracellular microenvironment, including exogenously 
administered molecules and endogenous factors produced by the ESCs.  Individual 
aspects of the microenvironment can be studied rather simply in planar culture formats, 
but similar to a developing embryo, the 3D organization of an EB is inherently comprised 
of a complex milieu of integrated signals that synergistically affect cell differentiation.  
Although the 3D assembly of cells to form EBs presents unique challenges for regulating 
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the homogeneity of stem cell differentiation, attempts to control EB size, soluble factor 
delivery, extracellular matrix (ECM) interactions and cell-cell adhesions within EBs may 




Figure 2.1. Environmental factors influencing EB differentiation. Embryoid body 
differentiation is influenced by a variety of factors comprising the intercellular 
microenvironment. The size of the EB, soluble factor signaling, ECM interactions and 
cell-cell interactions can all influence ESC commitment. General strategies to control the 
different elements of the EB microenvironment are listed for each.  
 
Size control 
The size of EBs, typically in the range of 100-400 μm, is thought to be a simple, 
yet important physical parameter capable of influencing the proportion of cells 
differentiating toward different lineages.  EB size, which is primarily a function of the 
number of ESCs constituting each cell aggregate, impacts other environmental 
parameters affecting differentiation, such as the diffusion of soluble molecules and the 
extent of ECM-cell and cell-cell adhesive interactions.  Recent developments in EB 
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formation techniques have enabled more controlled systems capable of modulating EB 
size in order to begin to determine the effects on subsequent differentiation of the cells.   
As described above, forced aggregation of ESCs using multi-well round-bottomed 
plates or microtechnologies provides a very direct manner to precisely control the number 
of cells in individual cell aggregates.  For example, the number of cells used to form 
hanging drops can influence the chondrogenic differentiation potential of EBs[60].  
Likewise, forced centrifugation studies examining hematopoietic differentiation of 
human ESCs of varying sizes indicated that a minimum EB starting size (500 cells/EB) 
was required for myeloid differentiation to occur in over 90% of EBs and that an 
intermediate size range (1000 cells/EB) promoted erythroid cell differentiation[48].  The 
initial size of EBs can also be controlled through the geometric size of microwell or 
micropattern features in order to spatially define the number of ESCs within individual 
aggregates[50, 51, 61].  Micropatterned control of ESC colonies can dictate both the size 
of EBs and the phenotype(s) of the starting cell population used to form EBs, which can 
affect the differentiation of the cells to particular germ lineages[61].  Recently, 
microfabricated cell culture inserts compatible with standard multi-well culture plates 
were reported which significantly enhance the yield of EBs formed using forced 
aggregation[49].  The size of the resulting EBs can be controlled by the concentration of 
the cells inoculated into the well and after 24 hours, EBs can be extracted from the 
microwells with gentle pipetting and transferred to suspension culture.  Depending on the 





 microwells per 100 cm
2
 of surface area - a dramatic increase over the capabilities of 
round-bottomed 96-well plates[49]. 
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In addition to forced aggregation methods, hydrodynamic culture conditions can 
be used not only to prevent EB agglomeration, but also regulate the size of EBs formed 
from single cell suspensions[53-55].  For EBs in horizontal rotary culture and stirred 
bioreactor culture, an inverse relationship exists between mixing speed and EB size, with 
decreasing EB size achieved by faster mixing conditions; thus EB size in bulk suspension 
can be modulated by hydrodynamic mixing conditions [54, 58].  EB size can also be 
controlled by encapsulating suspensions of individual ESCs or primitive EBs into 
hydrogel microbeads of controlled volumes.  For example, agarose[26], alginate[62-64], 
and dextran[65] have all been used successfully to encapsulate ESCs, either as single 
cells or small clumps of cells, to form EBs within microgels.  The diameter of the 
microgels laden with ESCs can vary greatly from 100 µm agarose beads[26] to 2.3 mm 
diameter alginate beads[64].  One problem with increasing microgel size, however, is that 
encapsulated ESCs may have a tendency to form multiple EBs within individual beads, 
limiting the ability to accurately control EB size. 
Depending on the different culture methods used, the kinetics of EB formation 
vary dramatically from minutes (forced aggregation) to hours (hydrodynamic mixing) to 
days (cell encapsulation),. Despite such differences, the consequences of the time scale 
for EB formation on cell fate and lineage determination has not been directly examined 
independently of EB size. In addition, although different methods to control initial EB 
size have been developed, the mechanisms regulating the causal relationship between the 
size of individual EBs and their propensity to differentiate into different cell phenotypes 





 Controlling the molecular composition of culture media to direct ESC 
differentiation has been studied extensively in a variety of systems and the effects of 
specific soluble factors and signaling pathways on ESC differentiation have been 
thoroughly discussed previously[66-68].  Small molecules such as ascorbic acid[69], 
retinoic acid[70] and dexamethasone[71], as well as larger growth factors such as 
fibroblast growth factors, bone morphogenic proteins and transforming growth 
factors[67, 72], are examples of soluble factors which have been shown to affect ESC 
differentiation.  Presentation of soluble signaling molecules to ESCs in monolayer culture 
has been the primary method to screen the ability of libraries of chemical compounds and 
biomolecules to induce ESC differentiation into specific cell types[15, 69, 73]. In lieu of 
direct co-culture, complex, yet poorly defined media conditioned by secondary cell types 
has been applied to stem cells in order to direct differentiation[74, 75]. On the other hand, 
defined soluble media comprised of known amounts of different factors has also been 
used successfully to generate relatively homogeneous populations of cells, particularly 
for neural progenitors or neurogenic cell fates[15, 76, 77].  
In stark contrast to 2D planar culture formats, only the cells on the exterior of 3D 
EBs are in direct contact with soluble factors present in the culture medium.  Soluble 
factors must diffuse through this multi-layered cell environment and barriers to transport, 
which likely vary as a function of stages of EB differentiation, contribute to the formation 
of concentration gradients which comprise the cell microenvironment.  Even the diffusion 
of small molecules (<1000 Da), may have a limited ability to pass through  the peripheral 
cells of EBs[78].  High-powered SEM microscopy analysis of EBs indicates that the 
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surface layer of epithelial-like cells (Figure 2.2A) exhibit tight cell-cell junctions (Figure 
2.2B) and cross-sectional analysis of EBs (Figure 2.2C) indicates that EBs tend to form a 
relatively dense layer of ECM and cells at the periphery of EBs (Fig. 2.2D), compared to 
the rest of the interior cellular morphology.  Therefore, steric barriers to diffusion posed 
by EB structure make it unlikely that homogenous concentrations of molecules can be 
attained uniformly throughout the interior of EBs and limit the efficacy of differentiation 





Figure 2.2. Embryoid body ultrastructure. Scanning electron microscopy analysis of 
EBs differentiated for 10 days in suspension culture.  A) Endoderm layer on the EB 
exterior and B) tight junctions between cells on the surface (arrows), C) cross-sectional 
view of an EB showing the differences between the outer layer and the porous interior, 
D) the thick outer layer of cells and ECM that is formed on the exterior (arrows). Cell 





Members of the TGF-β superfamily have been shown to influence cell fate 
decisions during embryonic development, especially for cardiac and phenotypes.  BMPs 
are large, dimeric secreted proteins shown to play important roles in embryonic 
development as well as adult physiology.  BMPs interact with type I and type II 
serine/threonine protein kinase receptor subunits.  The type II subunit contains a 
constitutively active kinase which phosphorylates the type I subunit upon ligand binding.  
Activated type I receptors then phosphorylate SMAD 1, 5, or 8, which heterodimerize 
with SMAD4, translocate to the nucleus and regulate gene expression.  BMP-4 is 
expressed in the extraembryonic ectoderm in the post-implantation mouse embryo, and 
plays a role in regulating primitive streak formation[79].  BMP-4 is expressed in the 
visceral endoderm starting at E6.0, and appears to function in production of 
extraembryonic mesoderm as well as primordial germ cells.  Mice deficient in BMP-4 
exhibited defects in cardiac development, suggesting that BMP-4 secreted by the 
extraembryonic mesoderm plays a role in cardiogenesis[80].  Additionally, BMP-4 has 
been implicated in various roles of cardiac development and patterning[81-83].  In vitro 
and in vivo studies using embryonic stem cells (both mouse and human) have 
demonstrated that BMP-4 plays an inductive role in mesoderm formation, and 
specifically, cardiomyogenesis[84-87].  However, the role of BMPs in differentiation is 
context dependant, as BMP-4/4 has been implicated in maintaining the pluripotency of 
epiblast cells, and inhibition of BMP signaling results in neural induction [88].  Similarly, 





Extracellular matrix interactions 
 The ECM can be a potent mitigator of cell fate decisions by providing a complex 
assembly of morphogenic cues to stem cells. The ECM is a structural framework of 
secreted macromolecules consisting primarily of glycosaminoglycans and fibrous 
proteins which provide mechanical support, adhesive interactions and sequestration of 
growth factors. Native ECM components direct cell differentiation through integrin-
mediated signaling events with adhesive proteins, as well as proteolytic release of 
affinity-bound growth factors during matrix remodeling[68, 93]. Integrin ligation and 
growth factor binding to receptors initiate intracellular signaling cascades that ultimately 
culminate in gene expression changes that modulate cell phenotype[94].   
 The effects of ECM molecules on EB differentiation have largely been examined 
by seeding ESCs or pre-formed EBs directly within natural ECM hydrogel materials[46, 
47, 72, 95].  EBs differentiated in collagen scaffolds consisting of variable amounts of 
fibronectin and laminin demonstrated that varying the composition of the ECM could 
differentially direct EB differentiation.  EBs in collagen scaffolds with high laminin 
content adopted a cardiomyocyte phenotype more frequently, whereas EBs were directed 
towards more epithelial and vascular cell fates in hydrogels with high fibronectin content, 
and EB cavitation and differentiation appeared to be inhibited in hydrogels with 
increasing collagen content[95].  ECM signaling peptides can also be incorporated into 
non-bioactive hydrogels used to encapsulate EBs, such as RGD modified dextran[65], to 
examine the effects of ECM on ESC differentiation. In addition to changes in the specific 
biochemical constituents of the ECM, differences in the elasticity of the ECM may also 
provide mechanotransductive cues capable of affecting stem cell differentiation[96]. 
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 Encapsulation of EBs within ECM matrices limits the interactions between ESCs 
and the ECM to the exterior surface of the ESC aggregates.  Therefore, in an attempt to 
directly manipulate the composition of the ECM within the EB microenvironment, 
individual matrix molecules like collagen and laminin have been added solubly to 
suspensions of ESCs during EB formation[18, 97, 98].  Similarly, the addition of soluble 
complex, tissue-derived matrices, such as Matrigel or Cartigel, to EB culture media has 
been used to promote the formation of glandular and tubular-like structures or cartilage 
development, respectively[97].  Although soluble addition of ECM molecules to ESC 
suspensions may favor incorporation within EBs, soluble ECM molecules alone do not 
necessarily assemble to form a functional matrix. Self-assembling peptide-based 
matrices, on the other hand, can rapidly form within developing cell aggregates to form a 
hydrogel network of nanofibers presenting different signaling epitopes[99, 100].  
Utilizing this strategy, neural progenitor cells encapsulated as neurospheres in a self-
assembling IKVAV (laminin epitope) amphiphile solution differentiated rapidly into 
neurons, while astrocyte differentiation was attenuated[100].  Interestingly, the density of 
the peptide epitope within the cell microenvironment, a material characteristic which can 
be controlled by matrix formulation conditions, could modulate the differentiation of the 
cells.  Applying a similar principle to EBs, self-assembling matrices could provide a 
novel route to control the composition and spatial distribution of extracellular signaling 





 EBs are initially formed via cell-cell adhesive interactions, but intercellular 
adhesions can also serve an important role in cell signaling throughout EB differentiation.  
Cell-cell interactions are mediated primarily by cadherins, a family of Ca
2+ 
dependent 
transmembrane adhesion receptors that play important roles in cell differentiation during 
embryogenesis[101].  Homophilic cadherin receptor binding triggers intracellular 
signaling pathways mediated by cytoplasmic catenin proteins, such as β-catenin, which is 
linked to the Wnt pathway, a potent regulator of cell morphogenesis and 
differentiation[101].  Undifferentiated ESCs express epithelial-cadherin (E-cadherin), 
which is the primary molecular mediator of EB formation, but sustained E-cadherin 
expression can also be responsible for the agglomeration of EBs at later stages of 
differentiation[26].  Inhibition of E-cadherin mediated adhesion, either by the use of E-
cadherin binding antibodies or E-cadherin null ESCs, prevents normal EB formation and 
subsequent differentiation[26, 27, 55].  Differential cadherin expression, associated with 
different cell phenotypes, is temporally regulated during the course of EB differentiation 
and can directly influence cell fate specification.  For example, ESCs constitutively 
expressing E-cadherin are prone to more epithelial differentiation, while ESCs 
constitutively expressing N-cadherin differentiate more readily into cartilage and 
neuroepithelium[28].  Although it has not been systematically investigated, the use of 
cadherin signaling to control EB differentiation either through integration of a genetically 
modified cell line over-expressing a particular cadherin or through the presentation of 
cadherins on biomaterial surfaces integrated within EBs to mimic cell-cell interactions is 
a promising area for control of EB differentiation. 
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Strategies to control other types of cell-cell interactions, including transmembrane 
receptors and ligands not anchored to the cytoskeleton, have also been explored in stem 
cells.  For example, the Notch pathway is involved in a variety of cell fate decision 
processes through development and adult tissue morphogenesis[102, 103].  ESCs can 
express multiple Notch receptors and Notch signaling has been implicated both in stem 
cell self-renewal and differentiation towards different phenotypes, such as neuronal 
cells[104-106].  In general, Notch signaling requires immobilized ligand presentation 
from a surface or cell membrane in order to achieve optimal bioactivity[107]. Jagged-1, a 
Notch ligand, immobilized to polystyrene or polyHEMA surfaces promoted early and late 
stage differentiation of cultured epithelial stem cells[108].  Comparable methods of 
presenting Notch ligands to cells uniformly within EBs would require that engineered 
biomaterials be integrated directly within the interior of the ESC aggregate. 
 
Strategies for biomaterial control of the 3D microenvironment 
As introduced above, adhesive protein biomaterials (i.e. Matrigel and gelatin) 
have been used as culture substrates for stem cell maintenance culture in 2-D.  
Biomaterials can also be integrated within 3D stem cell environments in order to control 
the increased complexity of the microenvironment. Strategies to control stem cell 
behavior using biomaterials have largely aimed to deconstruct elements of native 
biological complexity and integrate defined components into controlled systems to 
present molecular cues to stem cells.  
Parameters such as hydrophobicity, porosity, degradation kinetics and surface 
coating can be engineered to create the desired material properties. The ability to 
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engineer biomaterial surface properties can be utilized to present insoluble factors to 
mimic cell-cell or extracellular matrix interactions. Stem cells and biomaterials can be 
combined as scaffolds in the classic tissue engineering paradigm, wherein a spongy or 
fibrous scaffold provides mechanical support for attachment and migration guidance 
initially and then degrades as the cells produce their own natural scaffolding. In addition 
to scaffolds, which have been used extensively with other cell types, single cell 
suspensions or EBs are often completely encapsulated in either a natural ECM matrix or 
in a polymer designed to provide differentiation cues. Encapsulation typically occurs in 
the form of small spherical beads (hundreds of microns in diameter) grown in suspension 
culture whereas scaffolds are much larger and are grown in static or perfused cultures. 
Another approach is to integrate biomaterials within stem cell spheroids, either using 
microcarriers or microparticles, to control the microenvironment from the „inside-out.‟  
Strategies utilizing scaffolds, encapsulation and microcarrier/microparticles for control of 




The application of polymeric scaffolds to support somatic cells was one of the 
original tenets of tissue engineering strategies[109].  Polymer scaffolds were originally 
designed primarily as carriers for cell transplantation which provided temporary 
structural support until cells could adequately synthesize their own matrix to replace the 
biodegradable synthetic material.  However, advancements in the field of biomaterials 
have led to the development of more sophisticated scaffolds in various forms (e.g. 
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porous, fibrous), capable of responding to environmental changes (e.g. temperature, pH, 
electrical stimulation, proteases) and directly incorporating biomolecular cues to mediate 
cell attachment, proliferation and differentiation.  Recently, pluripotent and multipotent 
stem cells have been seeded onto polymer scaffolds as a means to examine self-renewal 
and differentiation properties in 3D. 
Scaffolds have been studied in combination with mesenchymal stem cells (MSCs) 
for a wide variety of applications including bone and cartilage regeneration. The ability 
of MSCs, derived from bone marrow or other tissues (e.g. adipose tissue), to differentiate 
into a variety of cell types, including osteo-, chondro-, and adipogenic lineages, has made 
MSCs the most common cell source for musculoskeletal tissue engineering strategies.  A 
variety of synthetic and natural polymers have been utilized for both osteogenesis and 
chondrogenesis of MSCs, including nanofibrous electrospun poly(caprolactone) 
(PCL)[110-112], PLGA[113-117], and silk[118-121]. The ability of multiple scaffold 
types with a wide range of chemical and physical properties to support MSC proliferation 
and differentiation makes this a promising and active area of stem cell research. 
Pluripotent stem cells can likewise be cultured on or within scaffolds, and much 
of the knowledge gained from previous studies with MSCs can be applied to ESC culture. 
As discussed above, culture of undifferentiated ESCs is typically performed in 
monolayer, with cells grown on either an inactivated MEF feeder layer or Matrigel. 
However, the use of synthetic scaffolds for self-renewal culture may circumvent the 
issues of xenogenic contact and scale-up feasibility associated with MEF and Matrigel 
substrates. The culture of hESCs on an artificial matrix composed of semi-
interpenetrating polymer networks (sIPN) supported short-term maintenance of 
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pluripotency[122]. The sIPN hydrogels were functionalized with the arginine-glycine-
aspartic acid (RGD) peptide sequence, and RGD concentration, as well as the mechanical 
properties of the hydrogel, were varied independently to identify conditions which 
promoted self-renewal of hESCs. Artificial extracellular matrices for stem cell renewal 
can be used as a xeno-free alternative to defined media.  
Additionally, ESCs have been cultured on nanofibrillar polyamide matrices 
known as Ultra-Web under self-renewal conditions[123]. ESCs grown on Ultra-Web 
displayed higher alkaline phosphatase activity, indicative of pluripotency, as well as 
enhanced proliferation, relative to gelatin-coated glass coverslips. Activation of Rac, a 
small GTPase, was also enhanced in cells cultured on Ultra-Web, as was activation of the 
PI3K pathway and Nanog expression. These data indicate that the 3D architecture on 
which cells are cultured may play an important role in cell fate determination and must be 
taken into account in future design of cell culture systems for ESC self-renewal. 
 Synthetic scaffolds have also been applied to differentiation approaches for ESCs. 
Porous scaffolds composed of PLGA/PLLA have been investigated as substrates for 
hESC adhesion and differentiation, with the intent of forming complex tissue 
architectures to be used in transplantation therapies[124]. The combination of seeding 
human ESCs on porous scaffolds and media supplementation with growth factors was 
found to induce differentiation into various cell types that expressed markers of neural, 
chondrogenic and hepatic lineages. Cells remained viable on the scaffolds following 
implantation in severely immune compromised mice, and continued differentiation and 
reorganization was observed. Studies focusing specifically on neural differentiation of 
hESCs seeded onto PLGA scaffolds were performed, with the effect of various media 
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supplements reported[125]. The addition of nerve growth factor and neurotrophin 3 to the 
scaffold cultures enhanced differentiation to nestin and βIII tubulin positive cells, 
indicative of neural progenitors and neurons, respectively. However, formation of 
functional, higher-ordered tissues will likely require greater sophistication in scaffold 
architecture and differentiation-cue presentation to ESCs.   
Scaffolds composed of biomimetic and natural polymers have been used in 
scaffold fabrication in order to present instructive microenvironments to pluripotent cells. 
ESCs cultured on the biomimetic material Cytomatrix formed 3D structures similar to 
EBs, but displayed enhanced ECM production as well as increased efficiency in 
differentiation to hematopoetic precursor cells[126]. Genes associated with ECM 
production as well as proliferation and differentiation were found to be enhanced relative 
to traditional EBs[127]. Incorporation of ESCs into porous alginate scaffolds resulted in 
efficient, homogeneous EB formation, with EBs spatially restricted within the pores. 
Agglomeration of EBs appeared to be inhibited, resulting in efficient cell proliferation 
and differentiation[56].  
Fibrin scaffolds have also been investigated for use in directed ESC 
differentiation to neural cell types[128]. Cells from both dissociated and intact EBs were 
seeded within fibrin scaffolds, and conditions including cell density and fibrinogen and 
thrombin concentration were optimized for cell proliferation and differentiation.  After 14 
days, successful differentiation of ESCs into neurons and astrocytes was observed. In an 
independent study, cells were seeded onto fibrin scaffolds as well as PEGylated fibrin 
scaffolds, and proliferation and differentiation were assessed relative to traditional EBs as 
well as EBs grown in semi-solid methylcellulose[46]. Proliferation in both types of fibrin 
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scaffolds was enhanced relative to EBs and methylcellulose EBs. Culture in non-
PEGylated fibrin resulted in differentiation similar to that observed in traditional EBs, 
with down-regulation of OCT4 and expression of VE-Cadherin, while ESCs growth in 
PEGylated fibrin were more similar to methylcellulose controls.  
Semi-interpenetrating polymer networks composed of the natural polymers 
collagen, fibronectin and laminin were examined as scaffolds for ESC differentiation[95]. 
Differentiation was found to be a function of both network composition and 
concentration, as high collagen concentration inhibited EB cavitation, fibronectin 
appeared to enhance endothelial differentiation, and laminin enhanced cardiomyogenesis. 
Use of the self-assembling nanofibrillar peptide scaffold PuraMatrix was investigated for 
osteogenic differentiation of ESCs[99].  EB-derived cells were seeded onto PuraMatrix 
scaffolds after 8 days of differentiation, and cells plated onto tissue culture polystyrene 
served as a 2-D control. Both PuraMatrix and 2-D substrates supported osteogenic 
differentiation, although maintenance of OCT4 positive cells was more prevalent in 3D. 
Scaffolds can be used to control physiochemical elements of the microenvironment, 
however, their use for large scale production of homogeneous cells may be limited due to 
diffusional limitations of nutrients in large constructs lacking vasculature.  
 
Encapsulation  
Encapsulation of stem cells into hydrogels represents a scalable way to present 
factors locally to cells. Unlike scaffolds, large numbers of capsules can be cultured in 
suspension culture. Encapsulation of stem cells can affect diffusion, control aggregate 
size and prevent agglomeration as well as provide an instructive environment depending 
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on the properties of the material chosen for encapsulation. From a bioprocessing 
perspective, encapsulation provides a method to grow anchorage dependent cells in 
suspension thereby increasing the surface area to volume ratio and scale up potential. 
MSCs are difficult to maintain as aggregates in suspension[129] and for this reason they 
are often studied using encapsulation. In addition to bioprocessing advantages, the 
creation of an artificial matrix aids in study of cellular response to specific elements of 
native ECM. Elements such as material stiffness or peptide density can be varied 
independent of other factors.   
Single cell suspensions or cell spheroids can be encapsulated several ways 
depending on the material properties. Thermosetting hydrogels such as agarose can be 
used to encapsulate cells by emulsifying a mixture of agarose, cells and oil. Agarose 
capsules containing EBs are formed in the oil phase after emulsification and can be gelled 
by lowering the temperature below the gelation point of agarose[26]. Materials such as 
alginate are useful for encapsulation because gelation occurs in the presence of Ca
2+
 ions 
and does not require oil phase emulsion or temperature change that can lower cell 
viability. Precisely sized droplets of alginate and cells can be created and gelled in CaCl2 
baths and cells can be retrieved at later time points after transfer to a medium without 
Ca
2+
[62, 130-132]. Artificial polymers such as poly(NiPAAm-co-AAC)[133], 
poly(ethylene glycol) (PEG)[134], and PEG derivatives such as PEG diacrylate[135, 136] 
and oligo(poly(ethylene glycol)) fumerate[137] have been utilized as well. 
Encapsulation also provides a method to investigate interactions between cells 
and specific signaling sequences in an artificial ECM environment in which the ligand 
density can be precisely controlled. For example, alginate can be modified to present 
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small peptide sequences such as arginine-glycine-aspartic acid (RGD) [132], found on 
ECM proteins such as fibronectin, fibrin and vitronectin. Increasing RGD density in 
alginate gels resulted in dose dependent decrease in encapsulated MSC response to TGF-
B1 and dexamethasone, components of chondrogenic media. It was hypothesized that 
integrin mediated signaling may be responsible for inhibition of chondrogenesis in the 
cells and control of integrin signaling may be a useful target for directed differentiation 
strategies. Mimicking ECM interactions using small peptide sequences can aid in 
understanding the mechanisms by which ECM components contribute to the cellular 
microenvironment.  
In regards to ESCs, encapsulation originated as a method to control the 
homogeneity of differentiation culture. ESCs express high levels of E-cadherin, a 
homotypic cell-cell adhesion molecule, which has been shown to be primarily responsible 
for EB formation in suspension culture[26, 55]. High levels of E-cadherin also can lead to 
agglomeration which is particularly problematic in static cultures. Agglomeration leads to 
heterogeneity in EB culture and is contributes to the heterogeneity of the resultant 
differentiated cell population. In addition, the size of the initial ESC aggregate has been 
implicated in the trajectory of subsequent differentiation, and therefore precise size 
control of EB formation is considered advantageous[48, 60, 61]. In addition, EBs formed 
using other methods can be later be encapsulated with one EB/capsule to prevent 
agglomeration and to shield EBs from shear forces experienced in a stirred bioreactor. 
ESCs can be encapsulated as a single-cell suspension and depending on the material used 
and the size of the capsule formed, the result can be single EBs or small individual 
clumps of cells.  
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ESCs can be encapsulated in natural polymers such as hyaluronic acid[47] or 
alginate[138] to maintain a pluripotent state useful for production of large amounts of 
cells. Cells can then either be retrieved from the gels or switched to differentiation 
conditions for further culture. Retrieval from hyaluronic acid encapsulation requires that 
the capsules be incubated in hyaluronidase, while alginate capsules can be depolymerized 
through the removal of divalent cations.  Encapsulation can be further used to promote 
differentiation into hepatocytes[62], chondrocytes[139], cardiomyocytes[140], and 
definitive endoderm[141]. In some cases, encapsulation is used as a method to support 
differentiation of ESCs, however, directed differentiation techniques, such as the addition 
of soluble factors, can also be combined with encapsulation to promote specific directed 
differentiation.  
Material design can be based on knowledge of biological processes which occur 
naturally to direct stem cell behavior, such as the presentation the RGD peptide to 
promote adhesion, however, another strategy is to screen biomaterials with different 
surface chemistries to discover new non-physiological interactions which can be useful in 
directing cell differentiation. Using this strategy, the gene expression of stem cells on 
different surfaces can be analyzed on an array set-up with high-throughput analysis and 
materials that promote the desired differentiation can be further analyzed in 3D culture. 
PEG hydrogels functionalized with small side functional groups of varying charge and 
hydrophilicity illicit different gene expression profiles of encapsulated hMSCs[142].  
 
Microcarriers 
Encapsulation of ESCs and other stem cell types is a method to introduce 
biomaterial control of differentiation cues; however, this method is an “outside-in” 
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strategy. Biomaterial interaction with the microenvironment is directly imparted on cells 
of the surface of encapsulated aggregates whereas interior cells are not directly affected. 
Alternative strategies have similarly focused on incorporating biomaterials with cells 
cultured in suspension; however, they rely either on culture of cells on microcarriers or 
the incorporation of microparticles within stem cell aggregates.  
Microcarriers are spherical beads, normally 150-500 microns in diameter, and can 
be made of a variety of materials such as polystyrene, dextran and glass. Cells can be 
grown on the surface of microcarriers to increase the available growing surface area per 
unit volume and have been used to scale up culture of anchorage dependent cells. 
Microcarriers have been reported to support maintenance culture of human ESCs[143-
145], mouse ESCs[55, 146, 147] and MSCs[148, 149] and importantly, population 
doubling times remain comparable to 2D culture standards. Dextran beads coated in 
collagen are most often used for ESC attachment. These cells can then be differentiated 
while adhered to the bead or they can be separated from the beads for use in other 
differentiation protocols. The choice of coating is important to the cell yield and in the 
case of polystyrene beads cells can adhere without a coating through electrostatic 
interactions. Cell collection from uncoated polystyrene is difficult and results in 
decreased cell viability, whereas with gelatin coated dextran, trypsin can digest the 
collagen layer and cells can be recovered with high yield. Matrigel has also been 
successfully used as a dextran bead coating as it is known that Matrigel will support 
undifferentiated growth of ESCs[143, 145].  
In contrast to scaffold-based approaches, the material properties of microcarriers 
have not been extensively studied in regards to directed differentiation or 
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microenvironmental control. Microcarrier materials are evaluated on their ability to 
expand large amounts of undifferentiated cells. This is in part due to the fact that 
microcarrier culture is analogous to 2D culture where media manipulation using growth 
factors or small molecules is a potent regulator of cell behavior. Limitations remain with 
microcarrier culture including agglomeration and low cell viability after collection 
procedures. Stirred suspension bioreactors are commonly utilized to agitate the culture 
and prevent agglomeration and a balance must be reached between shear forces 





Figure 2.3. Biomaterials can be incorporated within 3D stem cell 
microenvironments to direct cell behavior. Cells can be cultured on or within 
polymeric scaffolds (A) which provide physiochemical cues. Encapsulation of cell 
aggregates or single cells (B) can be used to increase the surface area to volume ratio for 
scalable culture and to provide an artificial matrix. “Inside-out” approaches to direct the 
microenvironment include culture of cells on microcarriers (C, Top) and the 
incorporation of microparticles within stem cell aggregates (C, Bottom). 
 
While microcarriers are used to scale up the culture monolayers of cells, smaller-
sized particles, ranging from 250 nm to 10 um in diameter, can be incorporated within 
larger cell spheroids to take advantage of increased cell-cell contacts and 3D ECM 
contact. The incorporation of materials within stem cell aggregates is a relatively new 
approach of “inside-out” engineering that can be used to place cells on the interior of the 
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aggregate in direct contact with the biomaterials. Biomaterial microparticles have been 
widely used in the field of drug delivery as vehicles for controlled release of encapsulated 
molecules, and their surface can be functionalized with cell specific adhesion ligands for 
cell-targeted delivery, especially useful in cancer therapies. In addition, microparticle 
surfaces can be modified to mimic cell-cell interactions, loaded with soluble morphogens 
for controlled release or can be used to introduce ECM proteins for control of matrix 
properties[150]. The surfaces of materials such as polystyrene and poly(2-hydroxyethel 
methacrylate) have previously been modified in 2D cultures to present LIF to prevent 
differentiation or Jagged-1 to mimic cell-cell signaling[108, 151]. Microparticles can be 
combined with other techniques discussed previously to add further control of soluble 
factor release. Microparticles incorporated in scaffolds[152, 153] can continually release 
encapsulated factors throughout the construct and this could similarly be used in capsules 
of encapsulated cells.  
Microparticles incorporated within progenitor cell spheroids was first used to 
improve post-transplantation cell viability of neural cells[154]. Fetal rat brain cells were 
mixed with poly(lactic-co-glycolic acid) (PLGA) microparticles which released nerve 
growth factor (NGF) to increase cell viability after transplantation. This concept has also 
been applied to synthetic microenvironments for ESCs for the purpose of directed 
differentiation[155, 156]. As introduced in the beginning of the chapter, ESC spheroids 
present barriers to diffusion and therefore cells in the interior are not completely 
accessible to molecules in the media as is the case with 2D culture. Cell-cell contacts and 
deposited ECM can limit the diffusion of even small molecules and the formation of 
gradients is likely to contribute to the heterogeneous nature of EB differentiation.  
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Incorporation of biomaterials within EBs circumvents the diffusion barriers to 
cells on the EB periphery and microparticles can act as point sources continuously 
releasing morphogen within the EB (Figure 2.4). In this way, gradients of molecules can 
be minimized to create a more homogeneous environment for the cells within EBs. An 
example of microparticle-mediated control of the EB microenvironment is the 
incorporation of PLGA microparticles within mouse EBs[155]. The microparticles were 
loaded with retinoic acid (RA), a small, hydrophobic morphogen, and were designed to 
continually release RA throughout EB culture. The resulting EBs upregulated gene 
expression of genes characteristic of epiblast stage embryos and uniform cavitation was 
observed in large populations of EBs. This effect could not be matched through any 
soluble addition of RA to the EB medium, suggesting that the controlled release of the 
RA by the particles inside the EBs was needed to provide the appropriate 
microenvironment for epiblast-like EB formation. Evidence that this effect was 
widespread throughout the entire culture indicates that this strategy could be used to 
direct differentiation of ESCs in a scalable manner. Controlled release of morphogens is 
also desired to conserve growth factor for large scale experiments. Biomaterials can 
preserve the bioactivity of encapsulated growth factor by maintaining the molecule in a 
bound state and preventing degradation. Soluble addition of growth factors must be 
replenished as determined by the half-life of the molecule in order to maintain the desired 





Figure 2.4. Biomaterial incorporation within EBs. Integrated biomaterials can be used 
to present ECM molecules, release soluble factors and mimic cell-cell interactions in a 
precisely controlled manner. A) Biomaterial microparticles integrated within the EB. 
Particles can be engineered with immobilized cell adhesion mediating receptors, ECM 
and incorporated soluble factor for delivery within the EB. B,C) Confocal microscopy 
demonstrates fluorescently-labeled microparticles (CellTracker™ Red) are distributed 
throughout the interior of the EBs. EBs were also counter-stained with CellTracker™ 
Green, which only labeled the cells on the exterior of the EBs, demonstrating the 
diffusive limitation of small molecules into 3D EBs. Separate optical sections (denoted 












Pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and 
induced pluripotent cells, provide a powerful model system for the study of morphogenic 
differentiation and represent a potent cell source for regenerative medicine therapies.  
Maintenance of pluripotency or differentiation of PSCs is dependent on extracellular cues 
such as autocrine and paracrine signaling, cell-cell and extracellular matrix 
interactions[157].  Appropriate culture conditions have been developed for the derivation 
and maintenance of pluripotent mouse[3] and human cells[7] and likewise, manipulation 
of the stem cell microenvironment can be used to promote lineage specific 
differentiation[150].  Although simple addition of soluble factors to cell culture medium 
is a commonly used method for directed differentiation protocols, it represents only a 
portion of the complex extracellular milieu which directs morphogenesis in the 
developing embryo. 
In order to enhance the efficiency of many differentiation protocols, biomaterials 
are increasingly being used to engineer the biochemical and biophysical properties of the 
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stem cell microenvironment[158].  Relevant properties of biomaterials such as 
degradation kinetics, molecular compatibility, porosity, etc., can be engineered to enable 
spatial-temporal control of extracellular cues presented to stem cells, thereby allowing for 
the customization needed for the differentiation to a variety of cell types.  Studies of 
biomaterial-stem cell interactions have demonstrated that materials may influence stem 
cell differentiation even in the absence of delivered biomolecules.  Though the exact 
mechanisms remain the subject of ongoing studies, material properties such as surface 
chemistry[142, 159] and elasticity[96] have been reported to promote lineage specific 
differentiation of stem cells.  For the most part, stem cell-biomaterial interactions have 
been examined by introducing stem cells into artificial environments, such as 2D cell 
culture on biomaterial surfaces[159, 160], encapsulation of cell suspensions within 
hydrogel materials[26, 142], or cell seeding on 3D polymeric scaffolds[124].  In contrast, 
incorporation of materials directly within 3D stem cell environments, such as cell 
spheroids, permits control over the amount and spatial presentation of materials enabling 
systematic examination of the effects of biomaterials on stem cell differentiation and 
morphogenesis. 
Recent studies have demonstrated the efficacy of morphogen delivery within stem 
cell spheroids via incorporated biomaterials[155, 156, 161].  ESCs mixed with 
poly(lactic-co-glycolic) acid (PLGA) MPs loaded with retinoic acid (RA) resulted in the 
homogeneous and organized differentiation of ESC-derived spheroids, referred to as 
embryoid bodies (EBs)[155].  The observed biological response could not be duplicated 
by simple soluble application of RA suggesting the importance of spatial presentation of 
morphogens in the context of EB differentiation.  PLGA MPs are well suited for the 
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encapsulation and release of small, hydrophobic molecules, such as RA; however, 
organic solvents used in fabrication of MPs can adversely affect the bioactivity and 
efficiency of encapsulation of larger biomolecules such as growth factors[162, 163].  As 
an alternative, growth factors can be loaded into hydrogel materials, such as agarose[164] 
or gelatin[165, 166], under aqueous conditions without substantially compromising 
subsequent bioactivity.  Stem cell differentiation protocols utilize a wide variety of 
molecules delivered with distinct temporal profiles, accordingly, it is advantageous for 
biomaterials-based strategies to be compatible with a variety of materials so the 
appropriate molecular compatibility and release kinetics can be engineered for the desired 
application.  As previous studies have been limited to PLGA, the aims of this study were 
first to develop a method for robust incorporation of various biomaterials within PSC 
aggregates, and second to characterize the effects of biomaterial incorporation on stem 
cell differentiation. 
Here we examined the incorporation of equal-sized microparticles (MPs) 
fabricated from different materials (agarose, PLGA and gelatin) within aggregates of 
PSCs.  A forced aggregation technique, previously developed for formation of 
populations of homogeneously sized EBs[49], was used to coalesce MPs and cells and 
compared to simple mixing during formation under dynamic culture.  The quantities of 
MPs incorporated within cell aggregates were assessed as a function of the seed ratio of 
MPs to cells used to form the biomaterial/cell hybrid constructs.  The morphology, gene 
and protein expression patterns of aggregates with different types of incorporated MPs 
were evaluated to determine the effects of the materials on PSC differentiation.  Overall, 
the controlled incorporation of microparticles within stem cell aggregates represents a 
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new approach to systematically investigate the effects of biomaterials on stem cell 
phenotypes in 3D. 
 
Methods 
ESC culture and aggregate formation 
Undifferentiated D3 ESCs were maintained on gelatin-coated tissue culture dishes 
in DMEM media supplemented with 15% fetal bovine serum and 10
3
 U/ml leukemia 
inhibitory factor (LIF) (Millipore, Billerica, MA).  ESCs were trypsinized into a single 
cell suspension and aggregates were formed by forced aggregation in AggreWell
TM
 400 
inserts (Stem Cell Technologies, Vancouver, CA)[49] or by rotary orbital culture[167].  
Briefly, 1.2 x 10
6
 cells in 0.5 mL of medium were inoculated into AggreWell
TM
 inserts, 
containing approximately 1200 wells per insert, and centrifuged at 200 x g for 5 minutes 
to cluster cells in the wells.  After 24 hours of culture, cell aggregates were removed from 
the wells using a wide-bore pipette and transferred to suspension culture on a rotary 
orbital shaker (40 RPM) to maintain the homogeneity of the population.  In order to 
investigate material incorporation, a second centrifugation of 200 µL of a MP solution at 
200 x g for 5 minutes was performed immediately after cell centrifugation.  Rotary 
orbital culture was used for aggregate formation with and without MPs by modifying a 
method previously described[155].  Uncoated MPs and cells were mixed together in a 
suspension-culture Petri dish and cultured on a rotary orbital shaker at 40 RPM.  
Following initial formation, cultures were re-fed with fresh differentiation media (without 




Microparticle fabrication and size characterization  
Agarose MPs were fabricated using a water-in-oil single emulsion similar to 
previously described methods[168].  A 3% w/w solution (2 mL) of Ultra-low melt 
SeaPrep Agarose (Lonza, Rockland, ME) was prepared in deionized (dI) water at 60°C 
and added drop-wise to 60 mL of corn oil (Sigma Aldrich St.  Louis, MO) containing 1 
mL Tween 20 (Sigma Aldrich, St. Louis, MO).  An emulsion was created by 
homogenizing at 5000 RPM for 5 minutes using a PT3100 (Kinematica, Switzerland).  
The emulsion was cooled at 4°C for 20 minutes, agarose MPs were retrieved through 
centrifugation at 200 x g and rinsed a minimum of 3 times with 25 mL of dI H2O to 
remove residual oil.  Agarose MPs were conjugated to AlexaFluor 488-labeled bovine 
serum albumin (BSA) using the hetero-bifunctional, photochemical crosslinker Sulfo-
Sanpah, N-Sulfosuccinimidyl-6-(4'-azido-2'-nitrophenylamino) hexanoate (Pierce 
Biotechnology, Rockford, IL), using a modification of a previously described 
method[169].  A Sulfo-SANPAH solution, 6 mg in  24 µL dimethyl sulfoxide, was mixed 
into 2 mL 3% w/w agarose solution.  The solution was treated with 365nm longwave UV 
light using a Blak-Ray B-100AP light source (UVP, Upland, CA) for 30 minutes, at a 
distance of 10 cm, to conjugate the Sulfo-Sanpah to the agarose.  Subsequently, a 50 
mg/mL solution of AlexaFluor 488 succinimidyl ester (Invitrogen, Carlsbad, CA) labeled 
BSA was added to the agarose solution and allowed to react overnight.  The agarose MPs 
were rinsed 3 times in 20 mL of dI H2O to remove unbound BSA. 
Gelatin MPs were fabricated using a modification of a previously published 
protocol[165].  Briefly, 2 mL of a 10% w/w solution of gelatin B (Sigma Aldrich) in dI 
H2O was heated to 55°C, added drop-wise to 60 mL of corn oil, and homogenized at 
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5000 RPM for 5 minutes to create a water-in-oil emulsion.  The emulsion was cooled at 
4°C for 10 minutes without mixing, before adding 35 mL of cold acetone to the solution 
and sonicating the emulsion continuously at 12 W for 1 minute (Sonicator 3000, Misonix, 
Inc, Farmingdale, NY).  The solution was cooled at 4°C for 10 minutes and the MPs were 
retrieved through centrifugation at 200 x g followed by 3 washes in 25 mL of acetone.  
The MPs were then crosslinked at room temperature with a 5 mM glutaraldehyde, 0.1% 
w/w Tween 20 solution in dI H2O under stirred conditions.  After 15 hours of 
crosslinking, the MPs were retrieved by centrifugation and treated with 25mL of 25 mM 
glycine in dI H2O to block residual aldehyde groups.  MPs were washed 3 times in 25 mL 
dI H2O and labeled either with AlexaFluor 488 or 546 succinimidyl ester in a 0.1 M 
sodium bicarbonate solution at a pH of 8.3 for 1 hour at room temperature.  Fluorescently 
labeled MPs were washed 3 times in 25 mL of diH2O to remove un-conjugated dye. 
PLGA (50:50, Absorbable Polymers International) MPs were fabricated using an 
oil-in-water single emulsion[155].  PLGA was dissolved in dichloromethane (DCM) 
(20mg/mL), added to 0.3% PVA, and homogenized at 3000 RPM.  The DCM was 
evaporated for 4 hours at room temperature in a fume hood and MPs were collected by 
centrifugation at 200 x g.  Prior to homogenization, PLGA MPs were fluorescently 
labeled by adding 50 mg of CellTracker
TM
 Red (Molecular Probes, Invitrogen, Carlsbad, 
CA) to the DCM solution.  For all materials, MPs were suspended in a small volume of 
diH2O and frozen at -80°C before lyophilization and storage. 
The average size of the MP populations was assayed using a Multisizer 3 Coulter 
Counter (Beckman Coulter, Fullerton, CA) equipped with a 100 µm aperture with a lower 
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detection limit of 2 µm.  MPs were suspended in Isoton II diluent (Beckman Coulter) at a 
dilution which resulted in the counting of at least 2000 events in a sample size of 0.5 mL.  
 
Scanning electron microscopy 
Samples were dehydrated in graded acetone dilutions and critically point dried 
using a Polaron E3000 critical point dryer (Quorum Technologies Inc., Guelph, ON, 
Canada).  MPs were sputter coated for 120 seconds at 2.2 kV using a Polaron SC7640 
sputter coater and imaged using a Hitachi S-800 scanning electron microscope (Hitachi 
High Technologies, Pleasanton, CA). 
 
Microparticle incorporation analysis 
After 24 hours of formation, aggregates were removed from the microwells and 
washed several times in media to separate unincorporated MPs.  In order to quantify MP 
incorporation, volumes chosen to contain on the order of 40-60 aggregates from each 
experimental condition were sampled and the precise number of aggregates were counted 
prior to lysing the cells in a 5% SDS solution.  MPs were then retrieved from the lysate 
and quantified using a hemocytometer and normalized to the number of lysed aggregates.  
Incorporation levels of MPs were assayed in triplicate over 3 separate experiments (n = 9 
total for each ratio and condition examined). 
The spatial location of fluorescently-labeled MPs within spheroids was analyzed 
using a LSM 510 microscope (Carl Zeiss, Inc).  Cells were labeled with Hoechst dye 
(1:100) for 15 minutes followed by 3 washes in PBS prior to imaging.  Images were 
obtained at a minimum depth of 30 µm (significantly greater than microparticle 
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diameters) into spheroids for each experimental condition in order to examine the 
distribution of particles throughout the cell aggregates. 
 
Cell viability 
PSC spheroids were formed as described above, and after 2 and 10 days of 
differentiation, cell viability was assessed using LIVE/DEAD staining (Invitrogen).  
Samples were incubated in serum-free, phenol red-free medium containing 1 µM calcein 
AM and 2 µM ethidium homodimer I at room temperature for 30 minutes.  Spheroids 
were then washed three times with PBS and immediately imaged using confocal 
microscopy. 
 
Gene expression analysis 
RNA was extracted from spheroids at various time points for up to 14 days of 
differentiation with the RNeasy Mini kit (Qiagen Inc, Valencia, CA).  Samples analyzed 
using the Mouse Embryonic Stem Cell array (PAMM-081, SA Biosciences, Frederick, 
MD) were converted to complimentary DNA using the RT
2
 First Strand Kit (Qiagen Inc), 
loaded in the pre-fabricated 96-well array plates and analyzed using real time PCR 
(MyIQ cycler, BioRad).  Genesis software version 1.7.5 
(http://genome.tugraz.at/genesisclient/genesisclient_ download.shtml) was used to 
construct a heat map of log2 transformed PCR array data[170].  Hierarchical clustering 
was performed using Euclidean distance and average linkage clustering. 
For all other gene expression analysis, RNA was converted to complimentary 
DNA using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) and analyzed using 
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real time PCR (MyIQ cycler, BioRad).  Forward and reverse primers for Oct-4, MLC-2V, 
Pax6, AFP, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were designed 
with Beacon Designer software (sequences and conditions are given in Table 1) and 
purchased from Invitrogen.  Oct-4 gene expression was calculated with respect to 
undifferentiated ESC expression levels using the Pfaffl method[171].  Pax6, MLC-2V, 
and AFP expression in treated samples were normalized to GAPDH expression levels and 
compared to untreated spheroid expression.  
 
Histology and immunostaining  
PSC spheroids were collected, fixed in 10% formalin, embedded in Histogel 
(Thermo Scientific), processed and paraffin embedded.  Sections of 5 µm in thickness 
were deparaffinized before staining with hematoxylin and eosin (H&E).  Histological 
samples were imaged using a Nikon 80i upright microscope and a SPOT Flex camera 
(15.2 64MP Shifting Pixel, Diagnostic Instruments).  For whole-mount 
immunofluorescent staining, spheroids were permeabilized in a 1.5% Triton X-100 BSA 
solution for 30 minutes, incubated with primary antibody in 2% BSA solution overnight 
at 4°C, rinsed with PBS and incubated with a secondary antibody for 4 hours.  Antibodies 
and concentrations used were: mouse monoclonal, anti-α-sarcomeric actin (5c5, Sigma, 
St.  Louis, MO) (1:500) with an AlexaFluor 488 conjugated, goat–anti-mouse secondary 
(Invitrogen) (1:200), and rabbit polyclonal anti-human alpha-fetoprotein (AFP) (Dako, 
Glostrup, Denmark) (1:200) with a goat–anti-rabbit, FITC-conjugated secondary 
(Invitrogen) (1:200).  Spheroids were counterstained with Hoechst (1:100), washed 3 




Experimental values are reported as mean ± standard deviation (n>3).  Statistical 
analysis was determined using one or two way ANOVA coupled with Tukey‟s post hoc 






SEM micrographs indicated that MPs from each of the materials exhibited similar 
round shapes and smooth topological surface morphologies.  The hydrogel MPs are likely 
to appear smaller when analyzed by SEM due to the necessary dehydration of the 
samples, prior to imaging, thus the diameter of the different MPs was analyzed using a 
Coulter Counter in an aqueous buffer in order to obtain more accurate size measurements.  
The average diameters of the PLGA, agarose and gelatin MPs were determined to be 5.2 





Figure 3.1. MP characterization.  PLGA, agarose and gelatin MPs were fabricated 
using a single oil-in-water or water-in-oil emulsion to create similarly sized MPs.  MPs 
were generally round with smooth surfaces as indicated by scanning electron microscope 
images. Coulter counter size analysis of MPs in aqueous conditions revealed average 




Microparticle incorporation using forced aggregation 
Simple mixing of MPs and PSCs did not result in efficient incorporation of the 
various materials assayed; therefore forced aggregation of MPs and PSCs in microwells 
was investigated as an alternative means to incorporate materials within aggregates.   
 
Material incorporation using rotary orbital culture 
Rotary spheroid formation has been used previously by our lab as a method to 
control the incorporation of ECM-coated PLGA MPs within EBs[155, 161], and was 
therefore tested initially as a method to incorporate various uncoated MPs within the 
aggregates.  However, simple mixing of ESCs with uncoated PLGA or agarose MPs 
using rotary culture resulted in limited incorporation of the materials within aggregates 
(Figure 3.2).  Out of nearly 150 aggregates analyzed, 57% did not contain any PLGA 
MPs, 42% contained 1 to 5 PLGA MPs, and only a single aggregate contained more than 
5 PLGA MPs.  Agarose MP incorporation within aggregates was even lower, with no 
aggregates containing more than one MP and <5% containing a single agarose MP.  In 
contrast, rotary orbital mixing of ESCs with gelatin MPs resulted in 100% of the 
aggregates examined containing 10+ gelatin MPs each; however, the extent of 
incorporation was rather heterogeneous and large (~1mm diameter) gelatin MP-cell 





Figure 3.2. Rotary culture results in variable MP incorporation within EBs.  
Fluorescently labeled MPs (CellTracker
TM
 Red incorporated or AlexaFluor
®
 488 
succinimidyl ester conjugated) were mixed with ESCs at a ratio of 2:1 and cultured on a 
rotary orbital shaker at 40 rpm for 48 hours to promote aggregate formation.  Non-
adhesive materials (PLGA and agarose) were not efficiently incorporated as 
demonstrated by a lack of punctuate fluorescent particles.  Gelatin, an adhesive material, 
was incorporated efficiently within the aggregates, however, the formation of large 
masses of MPs and cells (arrow) were observed along with smaller sized aggregates.  





Figure 3.3. Rotary and forced aggregation incorporation of gelatin microparticles.  
Gelatin microparticles were incorporated within ESC spheroids either through rotary 
mixing at 40 RPM or by forced aggregation.  In each case, microparticles were added to 
ESCs at a 2:1 MP:cell ratio.  Forced aggregation resulted in ~10 fold higher incorporation 





Figure 3.4. Forced aggregation of PSCs and MPs results in uniform material 
incorporation within spheroids.  ESCs centrifuged alone (A), or with fluorescently 
labeled MPs (B-D) in microwells formed spheroids after 24 hours of culture.  Spheroids 
were removed from the wells and thereafter maintained in rotary orbital suspension 
culture at 40 rpm (bottom row).  Uniform incorporation of materials within populations 
of PSC aggregates was observed (E-H).  Scale bar = 200 µm. 
 
Using the same 2:1 ratio of MPs to cells as used in rotary formation, increased 
incorporation of each material in homogeneously sized aggregates was observed when 
the materials were either centrifuged with the cells (1 spin) or centrifuged on top of the 
cells (2 Spins) (Figure 3.3).  Two centrifugations, however, were observed to be 
necessary for materials which do not contain integrin binding sequences such as agarose.  
Agarose MPs were only observed to be incorporated when centrifuged on top of the cell 
layer.  
Analysis of the fluorescent signal within aggregates indicated that gelatin MP-
treated aggregates contained the most incorporated MPs and agarose MP-treated 
aggregates contained the fewest MPs per aggregate.  In contrast to rotary culture, all 
aggregates formed through forced aggregation contained more than one MP for each 
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material investigated.  Because the efficiency of incorporation was noticeably different 
across material groups, the average number of MPs incorporated per aggregate was 
analyzed as a function of the seed ratio of MPs to cells for a range of MP values with a 
fixed number of 1.2 x 10
6
 cells/insert (1000 ESCs/microwell) (Figure 3.4A).  The 
incorporation of non-adhesive materials (PLGA and agarose) was characterized by a 
gradual increase allowing for incorporation of up to approximately 125 MPs per 
aggregate over the range of seed ratios examined, whereas gelatin MPs were incorporated 
with much greater efficiency.  In order to determine if incorporation was dependent on 
the adhesivity of the material surface, the incorporation of gelatin-coated PLGA MPs was 
also analyzed.  The profile of gelatin-coated PLGA MP incorporation resembled that of 
gelatin MPs and was greater than uncoated PLGA MPs.  Optical sectioning of aggregates 
indicated that MPs were incorporated throughout the aggregate and not simply localized 
to the surface of the aggregates (Figure 3.4B). In PLGA and gelatin-treated samples, 
some aggregation of MPs was observed within spheroids, whereas aggregation of 
incorporated agarose MPs was not observed.  In order to test the method with other cell 
types, gelatin MPs were incorporated within another mouse ESC line, R1, and also within 
a human induced pluripotent stem cell line derived from IMR-90 fibroblasts (Figure 3.5).  
Together these results indicate that forced aggregation can be used to control the extent of 





Figure 3.5 Forced aggregation can be used to incorporate biomaterial 
microparticles in various stem cell lines.  In order to demonstrate the applicability of 
forced aggregation to incorporate biomaterial MPs within pluripotent stem cell lines, 
another mouse line, R1, and also a human induced pluripotent stem cell line were used to 
incorporate gelatin MPs.  MPs were labeled with AlexaFluor 488 (R1s) or with 




Gelatin microparticle degradation within EBs. 
 The gelatin MPs are essentially denatured collagen, cross-linked to provide 
stability in aqueous solutions.  As the gelatin MPs were fluorescently labeled to visualize 
incorporation the degradation of the particles could also be tracked by fluorescence 
microscopy (Figure 3.6).  Punctate fluorescence was observed at early time points (day 4- 
10) indicative of intact particles. As culture time increased, the fluorescence became 
more diffuse, indicative of degradation.  At the higher loading ratio, intact particles were 
still observed after 14 days of EB culture.   
 
Figure 3.6 Degradation of gelatin MPs within mouse EBs.  Gelatin MPs were 
fluorescently labeled and incorporated within D3 EBs using forced aggregation at 
seeding ratios of 1:3 and 2:1 (MPs : cells).  Fluorescence is punctuate at early time points 
indicative of intact MPs and diffuse at later time points indicative of MP degradation. In 
both cases the number of punctuate particles decreases; however, with higher MP loading 
individual MPs are still observed at day 14 of culture.  
 
Microparticle effects on viability and differentiation 
The effects of MP incorporation on PSC viability and differentiation were 





Figure 3.7. MP incorporation is controlled in a dose-dependent manner.  
Incorporation was analyzed as a function of MP to cell seed ratio (A).  Adhesive 
materials (gelatin and gelatin-coated PLGA) were incorporated more efficiently than non-
adhesive materials (agarose and PLGA).  The presence of fluorescently labeled particles 
throughout the spheroids was confirmed by confocal microscopy (shown at a depth of 30 




MPs.  Formation conditions which resulted in ~125 MPs per spheroid (1 MP for every 8 
cells) were chosen for subsequent studies and corresponded to the following MP to cell 
seed ratios: agarose 4:1, PLGA 4:1, and gelatin 1:4 (as indicated in Figure 3.7).  In 
addition, in order to investigate the effects of increased MP incorporation, the increased 
dynamic range of gelatin incorporation was exploited to include a fourth MP 
experimental group of 2:1 gelatin, which resulted in an average incorporation of ~800 
MPs per spheroid (4 MP for every 5 cells). 
PSC aggregates cultured with materials were collected at days 2 and 10 of 
differentiation and stained for live and dead cells (Figure 3.8).  At both time points, 
spheroids contained few dead cells and no differences were observed across any of the 
experimental conditions suggesting that the presence of materials did not negatively 




Figure 3.8. Cell viability is not adversely affected by MP incorporation.  Cell 
viability was assayed after 2 (top row) and 10 (bottom row) days of differentiation using 
LIVE/DEAD
®
 stain.  Live cells were labeled with calcein AM (green) and dead cells 
were labeled with ethidium homodimer (red).  Few dead cells were observed in any of the 
groups at either of the time points examined. 
 
Gene expression analysis of PSC aggregates after 10 days of suspension culture 
was performed for 84 distinct genes initially using PCR SuperArrays (Figure 3.9A).  
Overall, relatively modest differences were observed for the majority of genes examined 
within any of the experimental groups compared to spheroids that lacked MP 
incorporation.  Interestingly, hierarchical clustering of the resulting data indicated that 
each of the replicate samples grouped most closely together, reflecting a common gene 
expression profile among spheroids treated with the same type of material.  Significant 
differences (p ≤ 0.05) in the expression of 34 of the genes assayed (40%) were noted in at 
least one of the MP-treated groups compared to untreated spheroids; this level of 
significance corresponds to a probability of no more than 2 falsely identified genes.  The 
majority of the genes affected by incorporation of different MPs were associated with 
endoderm (AFP, Gata-6, Serpina1a, Glucagon, and Ptf1a) or mesoderm (Hemoglobin Y, 
57 
 
VE-Cadherin, CD34 antigen, Hemoglobin X) differentiation, whereas few differences in 
pluripotent or ectoderm lineage markers were observed.  Thus, the gene expression 
profile of PSC aggregates is sensitive to the incorporation of different materials even 
after normalization of MP size and number are taken into account. 
Temporal gene expression analysis of the pluripotent marker Oct-4 (Figure 3.9B), 
as well as several germ lineage markers (AFP, Myosin light-chain 2 ventricle (MLC-2V), 
Pax6, Figure 3.9C) was performed using qRT-PCR over 14 days of culture.  In all of the 
conditions examined, Oct-4 expression decreased significantly after 4 days of 
differentiation and no significant differences were observed between any of the 
experimental groups.  Pax-6 expression was not affected by the presence of materials; 
however, consistent with PCR array data, significant differences in mesoderm and 
endoderm marker expression were detected.  MLC-2V expression was significantly (p < 
0.05) increased by 4.5 fold in gelatin 2:1 spheroids at day 14 compared to untreated 
spheroids.  Agarose and PLGA spheroids expressed 1.7 and 3.2 fold less AFP at day 10, 
respectively, while gelatin 2:1 spheroids expressed AFP at a 1.6 fold higher level than 





Figure 3.9. Gene expression is modulated by the presence of different materials.  
SuperArray analysis (A) at day 10 of differentiation demonstrated that the presence of 
different materials within PSC aggregates significantly (p<.05) modulated the gene 
expression of 40% (34/84) of the genes examined.  Magnified view of heat map (B) 
results displayed the top 15 genes with the greatest fold changes relative to aggregates 
that lacked MPs.  Oct-4 gene expression (C) was not significantly different between any 
of the experimental groups at any of the time points examined (days 4, 7 and 10).  Pax-6 
gene expression was not significantly altered, whereas AFP (E) and myosin light chain 2-
ventricle (MLC-2V) (F) were modulated by the presence of different materials at days 10 




Incorporation of MPs did not appear to have any gross effects on aggregate 
formation or morphology through 14 days of differentiation in suspension culture.  
Immunostaining of the spatial distribution of phenotypic markers was assessed within the 
aggregates to further characterize differentiation as hematoxylin and eosin staining of 
cross-sections of spheroids revealed no observable differences in morphology (Figure 
3.10, day 7 shown).  Whole-mount immunofluorescent staining was performed on alpha-
sarcomeric actin (cardiac mesoderm) and AFP since gene expression differences were 
almost exclusively found in mesoderm and endoderm markers.  The observed spatial 
distributions of mesoderm-like and endoderm-like phenotypes were altered within the 
different treated groups.  In untreated spheroids, positive expression of alpha-sarcomeric 
actin, a cardiac muscle actin, was localized to small, concentrated regions on the spheroid 
exterior, and similar expression patterns were observed in spheroids with agarose MPs.  
In contrast, alpha-sarcomeric actin staining was not observed in PLGA and gelatin 2:1 
spheroids at the same time point (14 days), whereas gelatin 1:4 spheroids displayed 
positive expression in larger sections including the interior sections.  In day 14 spheroids, 
AFP expression was localized to the outer layer of cells for most of the experimental 
groups, in agreement with previous literature reports that endoderm differentiation is 
primarily localized to the periphery of EBs by this stage of differentiation[29, 30].  
However, in gelatin 2:1 spheroids, more homogeneous AFP expression was observed 
throughout and was not limited to the cells at the periphery.  Altogether the gene and 
phenotypic marker expression data demonstrate that materials incorporated within PSC 





Figure 3.10.  Spatial distribution of cell phenotypes is altered by the presence of 
materials.  Hematoxylin and eosin staining of day 7 PSC spheroids with or without 
different MPs did not exhibit gross differences in morphology (top row).  At day 14 of 
differentiation, the spatial distribution of α-sarcomeric actin and AFP within EBs was 
assessed.  α-sarcomeric actin expression in gelatin (1:4) aggregates was observed 
throughout, while positive expression was localized to the periphery in untreated and 
agarose-treated spheroids and no positive expression was observed in PLGA- and gelatin 
2:1-treated spheroids.  AFP expression was localized to the periphery of all experimental 
groups with the exception of gelatin 2:1 spheroids, where expression was detected 





 In this study, the effects of PLGA, agarose and gelatin MPs (of equal size) 
incorporated within pluripotent stem cell aggregates were directly examined and 
compared.  Rotary aggregate formation, previously used to incorporate gelatin-coated 
PLGA MPs, was not sufficient to homogeneously incorporate the three materials equally 
and therefore we developed a forced aggregation technique that enabled dose-dependent 
control of MP incorporation for each of the materials.  The incorporation efficiency of the 
materials varied according to their relative adhesivity and therefore, the appropriate 
aggregate formation conditions for each material were determined empirically in order to 
normalize for equivalent numbers of MPs/spheroid to make fair evaluations of material 
effects.  No differences were observed in the formation of aggregates or cell viability in 
any of the experimental groups compared to cell aggregates alone, although gene and 
protein expression of phenotypic markers indicated that even at low incorporation levels 
(~1 MP/8 cells) the differentiation of PSCs to mesoderm and endoderm lineages was 
affected.  Interestingly, none of the genes assayed were uniformly up-regulated or down-
regulated by MP-treated spheroids, suggesting that the differences in gene expression 
were related to specific material characteristics and not simply the presence of foreign 
particles.  While the gross morphology of the MP-treated aggregates was not 
distinguishable from untreated aggregates, the spatial distribution of certain differentiated 
phenotypes was altered, suggesting that the biomaterials themselves influence the 
extracellular microenvironment.  The adhesive and elastic properties of the biomaterials 
examined, both of which have been linked to stem cell fate determination[96, 172], vary 
widely between PLGA, agarose and gelatin.  Overall, the results of this study indicate 
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that PSC differentiation within spheroids is sensitive to various types of biomaterials and 
that forced aggregation can be used as a platform for direct study of stem cell-biomaterial 
interactions in 3D culture. 
 Previous studies of stem cell-biomaterial interactions have been performed using 
monolayer culture or cell encapsulation[142, 159].  Stem cells cultured on spotted 
biomaterial arrays can be used for high-throughput screening of various surfaces and in 
this manner materials may be identified for further study in more complex 3D systems.  
Monolayer culture has been used previously to identify polymer combinations which 
supported the growth and differentiation of human ESCs[159].  Encapsulation of cells 
within biomaterials is low-throughput in comparison to monolayer arrays, but allows for 
study of the biomaterial effects on stem cell differentiation in a 3D suspension-culture.  
Mesenchymal stem cell differentiation, for example, can be influenced by the chemical 
moiety presented in the hydrogel in which they are encapsulated[142].  Encapsulation 
works particularly well with single cell suspensions, where each cell is surrounded by the 
biomaterial, however; with respect to spheroid culture, encapsulation presents the 
material surface only to the cells on the aggregate exterior.  The distinction of MP-based 
strategies is that the material can be incorporated in a controlled manner throughout cell 
spheroids allowing for the study of biomaterials directly within a 3D stem cell aggregate 
environment.  Although the forced aggregation approach detailed in this study was 
originally developed for the production of homogeneous EBs, it has recently been 
successfully applied to form spheroids of mesenchymal stem cells (MSCs) as well[173].  
Thus, the method of controlled incorporation of biomaterials within cell aggregates 
described herein could be applied to other cell types cultured as spheroids, such as MSCs, 
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neural stem cells or tumor cells[174], for studies of directed differentiation or the 
influence of microenvironment on cell fate. 
The materials examined in this study were chosen to represent different classes of 
biomaterials that have been used in conjunction with stem cells either as molecular or 
cellular delivery vehicles.  PLGA is a hydrolytically-degradable, synthetic copolymer, 
commonly used for controlled release of small, hydrophobic molecules.  Agarose is a 
polysaccharide thermo-sensitive hydrogel material that is largely considered non-
adhesive and is not degraded by mammalian cells, however it can be functionalized in a 
variety of manners for controlled presentation of biomolecules, such as growth 
factors[175, 176] and short peptide sequences[177].  Gelatin is an enzymatically 
degradable hydrogel material formulated from denatured collagen that is dually capable 
of growth factor delivery and direct binding to cells via integrin receptor ligation.  The 
three materials can be used alone or in combination to deliver a variety of morphogens or 
growth factors with different kinetics, yet it is notable that even in the absence of loading 
with exogenous molecules, the results presented within this study indicate that naïve 
materials themselves can influence the relative differentiation of PSC aggregates. 
PLGA is composed of acidic monomers, consequently, the hydrolytic degradation 
of the polymer can result in acidification of the local environment[178].  Although the 
effects of pH on ESC differentiation have not been extensively studied, it has been 
reported that below pH 7.0, mouse ESC proliferation is decreased and at a pH of 6.7 Oct-
4 expression is reduced[179].  PLGA MP treatment at the levels studied here did not 
result in any differences in cell viability nor in relative changes to Oct-4 expression 
(Figure 6B), suggesting that the local pH levels may not be decreased significantly within 
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the spheroids during the culture period examined.  This is supported by previous studies 
of the degradation kinetics of 50:50 PLGA, which have reported that degradation is 
limited to between 10 and 15% of the original mass during the first 2 weeks of 
degradation[180, 181].  Longer-term studies using PLGA for stem cell cultures may need 
to take into account acidification of the stem cell microenvironment. 
Integrins are known to play critical roles in cellular differentiation, migration and 
proliferation[182].  Likewise, growth of ESCs on extracellular matrix proteins such as 
laminin has been used to direct neural differentiation of human ESCs mediated through 
ɑ6β1 integrin signaling[183].  In addition to integrin signaling effects, it is possible that 
the addition of adhesive materials within the spheroids can affect the mobility of cells.  
Time lapse microscopy and cell tracking have demonstrated that cells are very mobile 
within early stage embryos[184] as well as EBs[185], a characteristic which may be 
modulated by the presence of adhesive MPs within PSC aggregates.  Tracking of 
Disabled-2 (Dab2) positive, primitive endoderm cells suggests that endoderm 
differentiation may occur throughout aggregates during the earliest stages of 
differentiation and as cells are passively migrating throughout the spheroid, Dab2 
mediated polarization enables primitive endoderm cells to create a non-adherent apical 
interface and remain preferentially at the exterior surface of EBs throughout 
differentiation[185].  We observed endoderm, identified as AFP
+
, cells on the exterior of 
untreated, PLGA and agarose-treated spheroids.  However, in aggregates containing an 
increased concentration of gelatin MPs, positive AFP expression was observed 
throughout.  In aggregates with a high adhesive MP to cell ratio, more cells are exposed 
to adhesive biomaterial surface within the spheroid and it is possible that cell adhesion to 
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the biomaterial could restrict movement and disrupt the normal migration patterns of 
PSCs undergoing differentiation.  In future studies, incorporation of adhesive ECM-
derived MPs within PSC aggregates could be used to specifically examine the effects of 
cell movement on early differentiation events, such as endoderm formation, primitive 




We have developed a forced aggregation technique to control the incorporation of 
biomaterials within PSC aggregates, without the need for surface modification of the 
materials.  This advance allows for direct study of stem cell-biomaterial interactions in a 
3D model system of PSC differentiation.  The results of this study demonstrate that PSC 
differentiation is sensitive to the presence of biomaterials in the extracellular 
microenvironment, suggesting that biomaterials incorporated within stem cell spheroids 
can be used in conjunction with other methods (i.e. soluble molecule delivery, 
mechanical forces) to direct the differentiation of stem cells for tissue engineering and 





HEPARIN-MODIFIED GELATIN MICROPARTICLE 
INCORPORATION WITHIN EMBRYOID BODIES 
 
Introduction 
The fate of embryonic stem cells (ESCs) is influenced by microenvironmental 
factors including soluble factors, extracellular matrix composition and cell-cell 
interactions[150, 157].  In 3D culture, the effects of cell-cell interactions and extracellular 
matrix interactions can be investigated through the use of genetically engineered cells or 
biomimetic materials engineered to present integrin binding sequences or cell-adhesion 
molecules.  Supplementation of soluble factors to the culture medium; however, remains 
the most heavily utilized method for directed cell differentiation due to ease of use and 
efficacy.  Additionally, ESCs can also be cultured in conditioned media (CM) as growth 
factors secreted by somatic cell types can provide instructive cues for differentiation, 
though more current research has favored defined, xeno-free media for maintenance of 
pluripotency and differentiation.   
Stem cells are also known to secrete their own factors into their surroundings in 
vitro and when transplanted in vivo[186, 187].  Study of the secretome of both 
mesenchymal stem cells (MSCs) and ESCs has increased recently as it is believed that 
that benefits observed after transplantation of stem cells in models of disease and wound 
healing are due to the release of paracrine factors by the transplanted cells rather than 
engraftment and subsequent stem cell differentiation, as was first hypothesized to be the 
case[187, 188].  Not surprisingly, the profile of secreted molecules is dynamic and 
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depends on the state of cell differentiation[189], [Ngangan and Nair et al., Unpublished 
data].  Research from our lab and others has aimed to collect factors secreted from stem 
cells in vitro in biomaterials which could then be used in cell-free application of stem 
cell-produced molecules for regenerative medicine[190-193]. It is notable that many of 
the molecules identified in secretome studies are also molecules, such as bone 
morphogenetic protein-4 (BMP-4) and vascular endothelial growth factor (VEGF), that 
are added to ESCs for directed differentiation protocols[194-196]. For example, BMP-4 
has been shown to induce and mesoderm differentiation in ESCs[195, 197, 198], VEGF 
promotes angiogenesis during early embryonic development[197, 199], and insulin-like 
growth factor 2 (IGF-2) promotes growth in mouse embryos[200].  It is likely that what is 
generally referred to as “spontaneous” differentiation observed within EBs is due in some 
part to the secreted molecules from neighboring cells.  One possible hypothesis for why 
incorporation of unloaded MPs within EBs modulated differentiation[201] is that the 
materials themselves are capable of interacting with secreted molecules and can alter 
growth factor concentration or availability for cell signaling.   
Recent reports have utilized heparin-modified materials or materials containing 
heparin binding peptides, to direct cellular interaction with endogenous growth 
factors[202, 203]. The aim of this study was to utilize this strategy within 3D stem cell 
aggregates by incorporating hydrogel microparticles capable of interacting with secreted 
growth factors within EBs and then to investigate growth factor secretion and 






ESC culture and aggregate formation 
Undifferentiated D3 ESCs were maintained on gelatin-coated tissue culture dishes 
in DMEM media supplemented with 15% fetal bovine serum and 10
3
 U/ml leukemia 
inhibitory factor (LIF) (Millipore, Billerica, MA).  ESCs were trypsinized into a single 
cell suspension and aggregates were formed by forced aggregation in AggreWell
TM
 400 
inserts (Stem Cell Technologies, Vancouver, CA)[49].  Briefly, 1.2 x 10
6
 cells in 0.5 mL 
of medium were inoculated into AggreWell
TM
 inserts, containing approximately 1200 
wells per insert, and centrifuged at 200 x g for 5 minutes to cluster cells in the wells.  For 
EB culture, the media was switched to ESGRO complete basal media (Millipore) 
supplemented only with penicillin and antimycotic.  After 24 hours of culture, cell 
aggregates were removed from the wells using a wide-bore pipette and transferred to 
suspension culture on a rotary orbital shaker (40 RPM) to maintain the homogeneity of 
the population.  In order to investigate material incorporation, a second centrifugation of 
200 µL of a MP solution at 200 x g for 5 minutes was performed immediately after cell 
centrifugation. 
 
Fabrication of gelatin microparticles 
Gelatin MPs were fabricated using a modification of a previously published 
protocol[165].  Briefly, 2 mL of a 10% w/w solution of gelatin B (Sigma Aldrich) in dI 
H2O was heated to 55°C, added drop-wise to 60 mL of corn oil, and homogenized at 
5000 RPM for 5 minutes to create a water-in-oil emulsion.  The emulsion was cooled at 
4°C for 10 minutes without mixing, before adding 35 mL of cold acetone to the solution 
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and sonicating the emulsion continuously at 12 W for 1 minute (Sonicator 3000, Misonix, 
Inc, Farmingdale, NY).  The solution was cooled at 4°C for 10 minutes and the MPs were 
retrieved through centrifugation at 200 x g followed by 3 washes in 25 mL of acetone.  
The MPs were then crosslinked at room temperature with a 5 mM glutaraldehyde, 0.1% 
w/w Tween 20 solution in dI H2O under stirred conditions.  After 15 hours of 
crosslinking, the MPs were retrieved by centrifugation and treated with 25mL of 25 mM 
glycine in dI H2O to block residual aldehyde groups.  MPs were washed 3 times in 25 mL 
dI H2O and labeled either with AlexaFluor 488 or 546 succinimidyl ester in a 0.1 M 
sodium bicarbonate solution at a pH of 8.3 for 1 hour at room temperature.  Fluorescently 
labeled MPs were washed 3 times in 25 mL of diH2O to remove un-conjugated dye. 
 
Heparin modification of gelatin MPs 
Heparin was conjugated to the gelatin microparticles using 1-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC) and Sulfo-N-hydroxysuccinimide (S-NHS) 
chemistry. Heparin was first activated using a 1:10 molar ratio of Heparin to EDC and 
combined with 2:5 ratio of EDC to S-NHS in a 0.1M MES, 0.5M NaCl buffer for 15 
minutes at 37°C with agitation. The reaction was quenched by addition of 20mM 2-
mercaptoethanol solution. The solution was then added at desired molar ratio (1:10, 1:1, 
5:1, or 10:1) of heparin to gelatin microparticles and allowed to react for 4 hours on a 
tube shaker at 37°C.  
Following conjugation of heparin to the gelatin MPs, free heparin was removed 
by washing the MPs 3x in ddH2O with 30 minutes of rotation between each wash. The 
amount of heparin per mg of microparticles was then determined using a toluidine blue 
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assay. Toluidine blue forms a color-shifted crystal when reacted with heparin. Free 
toluidine can then be removed by centrifugation and the precipitant can be solubilized 
measured using a spectrophotometer.  Toluidine blue (500 µL of 0.4mg/ml toluidine blue 
and 4 mg/ml sodium chloride in 0.1M Hydrochloric Acid) was added to approximately 3 
mg of gelatin MPs and heparin-gelatin MPs in 300 µl of ddH20 and agitated on a tube 
shaker at 2000 RPM for 4 hours. Free dye was removed by washing the MPs 3x after 
centrifugation at 6000 RPM for 10 minutes. The precipitant was then dissolved in 1 mL 
dissolving buffer (1:4 solution of 1 M sodium hydroxide to 95% ethanol) and the 
resulting solution was read on a spectrophotometer at 595 nm and compared to a set of 
standards of known heparin concentration.  
 
Collection and analysis of spent media 
 After formation in AggreWells
TM
, (Stem Cell Technologies, Vancouver, CA) the 
EBs were transferred to 100 mm suspension culture dishes and further cultured on a 
rotary orbital shaker at 40 RPM[54].  Every 48 hours following transfer to rotary culture, 
the EBs were transferred to 15 mL conical tubes and allowed to sediment to the bottom of 
the tube.  The media was then removed and stored for analysis of growth factor content 
and fresh medium was added to the EBs and then the solution was transferred back to the 
culture dish for further culture. At each collection point the EBs were cultured in the 
media for 48 hours. The spent media was then analyzed using ELISA (R&D Systems, 
Minneapolis, MN) based assays to determine growth factor concentration. For all 
samples, ESGRO media supplemented only with penicillin and antimycotic was used 
both for culture and for standard dilution in the ELISA.  
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Growth factor binding capacity of MPs from spent media 
 The growth factor binding capacity of the MPs was determined for the following 
growth factors: BMP-4, IGF-II, and VEGF.  Lyophilized microparticles (1 mg) were 
suspended in 0.5 mL of day 9 spent media from untreated EBs.  The solution was then 
allowed to equilibrate with gentle agitation 24 hours at 4°C. After 24 hours the sample 
was centrifuged at 4000 x g for 5 minutes and the supernatant was sampled for growth 
factor content analysis using the appropriate ELISA (R&D Systems) for each respective 
growth factor.  A sample of spent media with no MPs was handled in parallel with MP 
treated samples and was used as the reference point to determine the starting 
concentration of growth factor.   
 
Gene expression analysis 
RNA was extracted from spheroids at various time points for up to 11 days of 
differentiation with the RNeasy Mini kit (Qiagen Inc, Valencia, CA).  Samples to be 
analyzed using a custom designed PCR array (SA Biosciences, Frederick, MD) were 
converted to complimentary DNA using the RT
2
 First Strand Kit (Qiagen Inc), loaded in 
the pre-fabricated 96-well array plates and analyzed using real time PCR (MyIQ cycler, 
BioRad).   
For all other gene expression analysis, RNA was converted to complimentary 
DNA using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) and analyzed using 
real time PCR (MyIQ cycler, BioRad).  Forward and reverse primers for Oct-4, MLC-2V, 
Pax6, AFP, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were designed 
with Beacon Designer software and purchased from Invitrogen.  Oct-4 gene expression 
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was calculated with respect to undifferentiated ESC expression levels using the Pfaffl 
method[171].  Pax6, MLC-2V, and AFP expression in treated samples were normalized 
to GAPDH expression levels and compared to untreated spheroid expression.  
 
Histology analysis and immunostaining 
Spheroids were collected, fixed in 10% formalin, embedded in Histogel (Thermo 
Scientific), processed and paraffin embedded.  Sections of 5 µm in thickness were 
deparaffinized before staining with hematoxylin and eosin (H&E).  Histological samples 
were imaged using a Nikon 80i upright microscope and a SPOT Flex camera (15.2 64MP 
Shifting Pixel, Diagnostic Instruments).  For whole-mount immunofluorescent staining, 
spheroids were permeabilized in a 1.5% Triton X-100 BSA solution for 30 minutes, 
incubated with primary antibody in 2% BSA solution overnight at 4°C, rinsed with PBS 
and incubated with a secondary antibody for 4 hours.  Antibodies and concentrations used 
were: mouse monoclonal, anti-α-sarcomeric actin (5c5, Sigma, St.  Louis, MO) (1:500) 
with an AlexaFluor 488 conjugated, goat–anti-mouse secondary (Invitrogen) (1:200), and 
rabbit polyclonal anti-human alpha-fetoprotein (AFP) (Dako, Glostrup, Denmark) (1:200) 
with a goat–anti-rabbit, FITC-conjugated secondary (Invitrogen) (1:200).  Spheroids 
were counterstained with Hoechst (1:100), washed 3 times in PBS and imaged using a 
Zeiss LSM 510 confocal microscope (Carl Zeiss Inc.).  Sections of 5 μm were stained 
using Safranin-O (Sigma-Aldrich) for GAG detection, Fast Green (Sigma-Aldrich) for 
cytoplasm, and Weigert‟s hematoxylin (Sigma-Aldrich) for cell nuclei and imaged using 





Microparticle fabrication and heparin modification 
Heparin was conjugated to gelatin MPs using EDC / S-NHS chemistry at a range 
of molar ratios (heparin : gelatin) from 1:10 to 10:1.  Agitation at high speeds (>1500 
RPM) was required to prevent aggregation of the MPs during the heparin conjugation 
phase presumably because the EDC / S-NHS can also crosslink MPs to other MPs.  The 
amount of heparin that was conjugated to the gelatin MPs was then assayed using a 
toluidine blue stain, which is a commonly used histological stain to identify GAGs 
(Figure 4.1A).  Heparin content increased with increasing heparin:gelatin ratio from 1:10 
(no increase from unmodified gelatin) to 5:1 (5.53 ± 1.3 µg / mg MP).  Conjugation 
performed at a 10:1 ratio of heparin:gelatin did not result in significantly (p < 0.05) more 
heparin present (7.48 ± 1.32 µg / mg MP) compared to 5:1, and therefore a 5:1 
conjugation ratio was used for all further analysis. In addition to heparin quantification, 
the toluidine stain could be visualized using a phase microscope (Figure 4.1B,C).  
Heparin-gelatin MPs were stained with toluidine blue, while unmodified gelatin MPs 
treated with toluidine blue demonstrated some low-level background staining on phase 
images, which necessitated subtracting baseline values of unmodified gelatin MPs from 
heparin-gelatin values for more accurate heparin quantification analysis in the plate 





Figure 4.1. Gelatin MPs can be modified with varying amounts of heparin.  The 
molar ratio of heparin to gelatin was varied in the conjugation phase in order to 
characterize total amount of heparin which could be conjugated to the gelatin MPs (A).  
Molar ratios of 5:1 and 10:1 (heparin:gelatin) resulted in significantly higher heparin 
content (p < 0.05) compared to both 1:1 and 1:10 molar ratios (n = 3).  The heparin 
content between the 5:1 and 10:1 ratios were not significantly different suggesting 5:1 
could be used to obtain heparin content of approximately 4-7 µg heparin per mg of 
gelatin MPs. The conjugated heparin was evenly distributed across the population of 
MPs.  Both gelatin (B) and heparin-gelatin (C) MPs were treated with toluidine blue in 
liquid form which forms purple crystals upon reaction with heparin. Gross examination 
demonstrated a small baseline of color in unmodified gelatin MPs but a noticeably darker 






Incorporation of MPs within EBs 
 Both gelatin and heparin-gelatin MPs were incorporated within EBs using forced 
aggregation.  In order to visualize the MPs within the aggregates using fluorescent 
microscopy, amine-reactive AlexaFluor 546
TM
 was conjugated to both groups of MPs.  
EBs formed within 24 hours in the microwells as reported in chapter 3.  After transfer to 
suspension culture, EBs appeared as previously described and no gross differences were 
observed in phase images of EBs with gelatin or heparin-gelatin MPs (Figure 4.2).  One 
noted change in the EB culture was that the EBs from all groups grew to a much larger 
size (~0.5-1mm) in the defined medium compared to medium supplemented with 15% 
fetal bovine serum. 
 
Analysis of spent media and growth factor binding capacity 
 EBs are known to secrete BMP-4, IGF-II and VEGF into the surrounding medium 
as differentiation progresses, therefore the concentration of these three growth factors 
was assayed in spent medium at days 5, 7, and 9 of culture to begin to assess material 
effects (Figure 4.3).  The detected levels of IGF-II decreased as differentiation progressed 
in control EBs, while both MP-treated EB conditions remained relatively constant except 
for heparin-gelatin MP EBs which contained significantly (p < 0.05) lower amounts of 
IGF-II in the medium at day 9.  In contrast to IGF-II levels, VEGF was present in 
increasing levels as differentiation progressed in all samples and was significantly higher 
in heparin-gelatin MPs compared to untreated EBs at all days assayed.  The only 
significant difference in BMP-4 samples was observed in day 9 spent medium, where 
levels were below the detectable range (15 pg/mL) 
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As differences were observed between treatment groups in the amount of secreted 
protein, it was necessary to confirm the ability of the MPs to sequester the individual 
growth factors from a complex media.  Spent medium was chosen over pure preparations 
of recombinant factors to characterize the ability of both MP formulations to bind and 
sequester growth factors for more relevant analysis of binding capacity in presence of 
other molecules capable of competing for binding (Figure 4.4).  Interestingly, though 
IGF-II levels were decreased in heparin-gelatin MP EB groups, the heparin modified 
MPs did not sequester any detectable amount of IGF-II,; however, unmodified particles 
captured approximately 50 pg IGF-II per mg MPs.  The amount of VEGF captured from 
heparin-gelatin MPs was not different compared to unmodified particles.  The affinity of 
BMP-4 for heparin is highest among the growth factors tested, therefore it was expected 
that heparin modification would result in increased capture of BMP-4 from the spent 
media compared to unmodified particles.  In fact, capture of BMP-4 by heparin-gelatin 







Figure 4.2. Fluorescently labeled MPs are incorporated within EBs using forced 
aggregation.  EBs were formed with 1000 cells per well and MPs were seeded at a ratio 
of 1:3 cell:MPs.  No differences were observed across groups during formation (top row, 
24 hours of culture) or after immediately after transfer to suspension culture (bottom 




Figure 4.3 Growth factor concentration in spent media.  IGF-II concentration 
decreased with differentiation in all groups and for days 5 and 7, both microparticle 
groups demonstrated significantly (p < 0.05) lower levels than untreated control. On day 
9, levels of IGF-II were undetectable in the heparin-gelatin MP group, which was 
significantly lower than gelatin MP EBs and untreated EBs. BMP4 and VEGF levels 
increased with differentiation time and heparin-gelatin MPs had higher levels than the 
other groups.  *= Significant difference compared to No MP (p<0.05) †=significant 
difference compared to gelatin MPs (p<0.05) 
 
Figure 4.4 Analysis of growth factor content in the medium before and after MP 
addition.  Gelatin MPs were able to sequester ~50 pg/mg IGF-II per mg MPs while the 
heparin-gelatin MPs did not sequester any detectable amount.  The opposite was true with 
BMP-4, where the heparin-gelatin MPs were able to sequester significantly more growth 
factor compared to unmodified gelatin.  VEGF was captured at similar levels by both 




Effects of MP incorporation on EB differentiation 
 Having demonstrated that the gelatin and gelatin-heparin particles are capable of 
sequestering growth factors produced by EBs and that growth factors are secreted in 
different concentrations into the surrounding media, the particular effects of MP 
incorporation on differentiation were first analyzed using a custom PCR array containing 
24 genes of interest including markers for pluripotency and for each of the three germ 
layers (Figures 4.5 and 4.6).  Expression of 20 out of the 24 markers was down regulated 
in both microparticle groups on day 7 of culture.  Of the remaining 4 markers, 
Brachyury-T, Pax6, Flt1 and Sox4, only expression of Pax6 was significantly different (p 
< 0.05) from No MP expression levels.  Of the genes significantly decreased, Gata4 
(endoderm, -4.94 fold), Nkx 2.5 (cardiac mesoderm, -5.47 fold) and desmin (mesoderm, -





Figure 4.5. Gene expression analysis of day 7 EBs with gelatin and heparin-gelatin 
MPs normalized to untreated EB expression levels.  20 out of 24 genes analyzed were 






Figure 4.6 Gene expression analysis of day 11 EBs with gelatin and heparin-gelatin 
MPs normalized to untreated EB expression levels.  For heparin-gelatin MP EBs, all 
but 4 of the 24 genes assayed were significantly altered.  Unmodified gelatin MPs had 
less of an effect both in the magnitude of gene shifts and also the number of significantly 




 Day 11 gene expression data demonstrated increased differences between the 
treated groups (Figure 4.6).  As with day 7 gene expression, a majority of the genes were 
down regulated in the presence of both types of MPs, and similarly, heparin MP 
treatment resulted in larger changes compared to unmodified gelatin MP treatment. 
Pluripotent marker expression was significantly down-regulated in the presence of 
heparin MPs (Nanog down 265 fold, Oct4 down 183 fold and sox2 down 4 fold).  Several 
markers showed up-regulation in the presence of heparin including both Flk1 and Flt1, 
both encoding for receptors of VEGF.  This is notable because the amount of VEGF in 
the medium of heparin-gelatin EBs was also increased, suggesting that the cells were 
responding to the increased presence of VEGF even though VEGF was down-regulated 
by almost 5 fold at the gene level in heparin-gelatin MP EBs.  Also of interest are genes 
that were up-regulated in the presence of one type of particle and down-regulated in the 
presence of the other particle and vice versa.  Genes up-regulated in heparin-gelatin MP 
EBs but not gelatin MP EBs include the VEGF receptors, Gata4, Cdh5 and Sox17.  
Similarly, genes up-regulated in gelatin MP EBs but not heparin-gelatin MP EBs were 
Gata2, Sox4, Nestin, VEGFA and Brachyury-T.   
 
EB morphology and safranin-O staining 
 EB morphology was next examined in paraffin processed 5 µm sections.  
Morphological differences were observed in Day 11 EBs containing gelatin or heparin-
gelatin MPs. (Figure 4.7).  For example, the cross-sectional area of EBs with MPs 
appeared to be larger even though large amounts of MPs were not visible in any single 
section of a particular EB.  The appearance of organized, oval-shaped cell organization, 
83 
 
morphologically similar to gut-like structures identified in teratoma assays[204], (Figure 
4.7, arrows) was noted in each of the conditions.  Untreated EBs contained 1-2 of the gut-
like areas, whereas gelatin MP EBs contained 3-5 and heparin-gelatin MP EBs contained 
5-15 per EB.  The presence of these structures was transient as they were not observed at 
later time points.  Safrinin-O staining was performed to identify areas of proteoglycans 
and glycosaminoglycans.  It was hypothesized that Safranin-O stain would identify 
regions of heparin; however, areas of positive stain were observed in all groups possibly 
indicative of heparan sulfate which is expressed on the cell surface. 
 
 
Figure 4.7.  MP incorporation results in distinct morphological differences in EB 
structure.  H&E staining of day 11 EBs revealed the presence of organized structures 
resembling the formation of gut like structures identified in teratoma assays[204].  The 
oval-shaped structures (indicated by arrows in 10x images) contained an outer cell layer 





Figure 4.8.  Safranin-O stain of day 7 and 11 EBs.  Safranin-O stain was performed to 
identify areas of proteoglycans and glycosaminoglycans.  It was hypothesized that 
Safranin-O stain would identify regions of heparin; however, areas of positive stain were 
observed in all groups possibly indicative of heparan sulfate which is expressed on the 
cell surface. 
 
VE-Cadherin Localization  
 Immunostaining of vascular endothelial cadherin (VE-cadherin) was next 
performed to investigate the effects of MPs on spatial patterning of differentiation.  VE-
cadherin is expressed on the surface of endothelial cells at an early stage of 
differentiation[205] and is encoded by the cadherin-5 (cdh5) gene which was 
significantly up-regulated at day 11 (2 fold) compared to untreated EBs at day 11 of 
differentiation.  Additionally, because VEGF is used as a supplement in endothelial 
differentiation protocols and both VEGF receptor gene expression and VEGF content in 
spent media were increased in heparin-gelatin MP samples, VE-cadherin expression was 
investigated.  Positive VE-cadherin staining was observed in all three groups at days 7 
and 11 of culture.  In day 7 samples, both heparin-gelatin MP EBs and EBs without MPs 
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displayed greater amounts of positive VE-cadherin expression than EBs with gelatin 
MPs.  Interestingly, VE-cadherin expression was observed in the area directly adjacent to 
the heparin-gelatin MPs (Figure 4.9).  This phenomenon was not observed in the EBs 
containing unmodified gelatin MPs or in heparin-gelatin MPs at day 11 (Figure 4.10), 
indicating that the positive stain was not an artifact due to antibody interaction with the 
gelatin or with the heparin.  Immunostaining of day 11 revealed that the organization of 
positive staining was no longer related to the MPs, even in the case of the heparin-gelatin 
MPs.  This may suggest that the heparin specific effects have been attenuated by day 11 
possibly due to degradation of the particles or redistribution or degradation of the 





Figure 4.9 VE-Cadherin immunostaining of day 7 EBs.  Immunostaining for VE-
cadherin was performed on day 7 EBs.  Positive expression was observed in each of the 
samples analyzed. Differences in the samples were noted in the special localization of 
VE-cadherin signaling in that almost uniformly, positive signal was immediately adjacent 





Figure 4.10 VE-Cadherin immunostaining of day 11 EBs.  Positive expression was 
observed in each of the samples analyzed. Though the spatial patterning observed in day 
7 samples was not observed in day 11 samples, positive expression was increased 





The data presented here demonstrate that incorporation of heparin-modified 
gelatin MPs alters growth factor production and patterns of differentiation within EBs.  
Previous studies investigating the effect of microparticle incorporation within EBs used a 
medium supplemented with 15% fetal bovine serum[155, 161, 201].  The study in this 
chapter was the first to use a defined medium with no serum to incorporate biomaterials 
within EBs.  Serum is an undefined mixture of proteins and growth factors but is known 
to contain BMPs which can promote mesoderm and endoderm differentiation and inhibit 
ectoderm differentiation.  This was confirmed at the gene level where EBs cultured in 
defined medium expressed higher levels of Pax-6, a marker for ectoderm, compared to 
EBs in serum which never expressed Pax-6 at levels higher than ESCs, suggesting 
ectoderm differentiation was inhibited[201].  The basal media is designed to allow 
spontaneous differentiation to occur with a minimal level of signals which could 
influence differentiation. A low baseline of environment may be a better suited for 
investigation of material specific effects, which otherwise could be overwhelmed by 
soluble signals from serum.  The addition of basic fibroblast growth factor (bFGF) to 
ESC media can be used to direct ESCs towards an ectoderm phenotype[15, 42, 67, 75].  
Spent media in this study were analyzed for bFGF secretion, but no significant levels 
were detected (data not shown).  It is still possible that heparin-gelatin MPs are capturing, 
concentrating or enhancing the local signaling of even small amounts of bFGF that are 
secreted due to the known ability of heparin to bind bFGF[206]  Concentration of growth 
factor signaling may even be enhanced in part because the EBs were cultured under 
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hydrodynamic conditions where factors otherwise washed away into the surrounding 
medium could be locally retained by their affinity to the heparin on the gelatin MPs.   
Changes in growth factor concentration in spent media do not necessarily indicate 
that the MPs were able to capture growth factor within the EB.  Other factors can affect 
secreted growth factor content such as the state of differentiation of the cells as indicated 
by changes in the growth factor secretion profile with differentiation time in EBs which 
do not contain MPs.  Analysis of the amount of growth factor within EBs would be 
helpful in combination with growth factor content in the spent media.  Western blot 
analysis is required of EB lysates to determine the amount of growth factor retained.  
Gene expression profiling of EBs cultured with or without incorporated MPs 
revealed that MP incorporation decreased a wide variety of genes associated with early 
lineage differentiation.  Taken alone, the low expression levels of differentiated markers 
could suggest that the presence of particles inhibits differentiation; however, out of all the 
genes analyzed, the ones most decreased were Nanog, Sox2 and Oct4, genes expressed in 
undifferentiated cells. Additionally, the increased secretion of VEGF along with 
decreased secretion of IGF-2 as culture time progressed is consistent with what has been 
observed in differentiating EBs cultured in serum media [Ngangan et al. unpublished 
data].  Therefore, it is likely that the kinetics of differentiation are not suppressed, but 
altered in the presence of materials, especially with heparin-gelatin MPs.  Further 
characterization of global gene expression by EBs with and without MPs would likely 
yield insights to the overall profile of differentiation.   
Overall, the data presented for IGF-II may seem contradictory.  IGF-II levels in 
the spent media of heparin-gelatin MP EBs was below the assay detection limits, yet 
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heparin-gelatin MPs did not demonstrate the ability to sequester any significant amount 
of IGF-II from spent media in the absence of EBs.  Unmodified gelatin MPs were able to 
capture measurable amounts of IGF-II suggesting that the  heparin conjugation not only 
does not promote capture of IGF-II from spent media, but may prevent passive absorption 
observed in the unmodified MPs.  Altered levels of IGF-II secretion could be attributed 
either to altered differentiation in which cells responsible for IGF-II secretion were absent 
when treated with heparin-gel MPs, or the heparin on the MPs is not directly interacting 
with IGF-II, but instead with IGF binding proteins (IGFBPs)[207].  IGFBP-3,5,6 are 
known to contain a heparin binding sequence (B-B-B-X-X-B, where B is a basic 
residue[208]) and serve to regulate IGF protein interactions both with the extracellular 
matrix and with heparin-sulfate molecules on the cell surface.  Indirect interactions of the 
heparin with proteins responsible for regulating growth factor signaling should also be 
considered in a holistic model of MP microenvironemental effects.  
The spatial localization of VE-cadherin at day 7 indicated that the heparin-gelatin 
MPs can have local effects on the microenvironment which promote endothelial 
differentiation.  Because gene expression is a population based assay, localized effects of 
the particles could be diluted out by the cells not in the local vicinity of the MPs.  Further 
characterization of the phenotype of cells in direct contact with heparin-gelatin MPs may 
further elucidate the effects of heparin incorporation on differentiation.  The spatial 
patterning of VE-cadherin was transient and not observed in day 11 samples.  Analysis of 
the degradation of fluorescently-labeled gelatin MPs in chapter 3 demonstrated that the 
particles are degraded and are not detected after 14 days of culture in the case of 1:3 
cell:MP seeding ratio, the same ratio used in this study.  As the particles are degraded and 
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remodeled, the spatial organization of the heparin will also be degraded which could 
explain the loss of spatial organization at later time points.  Maintenance of spatial 
control could be possible if the heparin molecule were instead conjugated to the surface 
of a non-degradable material such as agarose. 
 
Conclusions 
 Molecular engineering of the MP surface can be performed by heparin 
conjugation to modulate interactions between the MPs and the microenvironment.  
Heparin modification resulted in differences in  the amount of growth factors secreted by 
EBs into the surrounding medium and also altered the ability of the gelatin MPs to 
capture growth factors from EB spent medium.  Gene expression analysis as well as VE-
cadherin staining indicated that the addition of heparin to the gelatin MPs increased 
modulation of differentiation observed with unmodified gelatin MPs.  Interestingly, VE-
cadherin expression was localized to the area in the immediate vicinity of the heparin 
MPs suggesting alterations in the local microenvironment cause by heparin addition.  The 
results of this study suggest that MPs can be used to introduce engineered extracelullar 
matrices to direct endogenous growth factor signaling.  MPs capable of controlled 
interactions with endogenous growth factors could be used to locally direct 
differentiation within EBs or possibly to remove the need for exogenous delivery of 










 Pluripotent stem cells are a unique in their ability to differentiate to any cell type 
in the body.  This plasticity, along with their theoretically infinite capacity for self-
renewal, makes them an ideal source for therapeutic cell types.  Their plasticity is also the 
major impediment to their use because efficient differentiation towards homogeneous 
populations of mature cell types is difficult.  The difficulty is due, in part, to the 
sensitivity of the cells to their microenvironment where small perturbations in soluble 
signals along with cell-cell and cell-extracellular matrix interactions can provide cues for 
differentiation.  This is especially relevant to the differentiation of ESCs as embryoid 
bodies (EBs) which are aggregates grown in suspension.  The microenvironment of cells 
in the EB is complex and constantly changing as cells differentiate and produce autocrine 
and paracrine factors.   
 Soluble factors are commonly added to the surrounding medium of EBs in an 
attempt to promote lineage specific differentiation[150].  This method is limited by 
barriers to free diffusion of molecules which exist in EBs.  These barriers are intensified 
with culture time as cell-cell contacts mature with outer-layer endoderm formation and 
also as cell produce their own ECM[78, 155].  Recently, incorporation of biomaterial 
microparticles (MPs) has been reported as a possible method to circumvent barriers to 
access of the interior microenvironment[150, 155, 156, 161, 201].  Poly(lactic-co-
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glycolic acid) (PLGA) MPs loaded with growth factors or with retinoic acid have been 
used in an attempt to direct differentiation within EBs.  Retinoic acid delivery from 
PLGA MPs in mouse EBs resulted in the formation of an epiblast-like aggregate which 
was comprised of two layers of well-organized cells, with OCT-4 positive cells found on 
the inner layer and FoxA2 positive cells lining the outside of the structure[155].  The 
effects could not be reproduced by soluble addition of retinoic acid at any of a wide range 
of concentrations, suggesting that the spatio-temporal control of morphogen delivery 
using MPs incorporated within the extracellular space may yield yet unknown insights to 
stem cell biology and may be useful for directed differentiation and tissue engineering 
applications. 
 Disadvantages exist to the use of PLGA MPs for growth factor encapsulation 
including low incorporation efficiency, batch to batch variability and decreased 
bioactivity[162, 163].  Therefore, a forced aggregation method of EB formation was 
adapted to allow for controlled incorporation of hydrogel MPs within EBs.  Hydrogels 
are advantageous for growth factor delivery in part because bioactivity can be preserved 
during the loading phase by soaking of lyophilized MPs within a concentrated growth 
factor solution[209].  Gelatin has been used for growth factor delivery of molecules such 
as basic fibroblast growth factor (bFGF), bone morphogenetic proteins (BMPs) and 
vascular endothelial growth factor (VEGF)[165, 209] 
Gelatin can be manufactured with differing properties depending on the method in 
which it is isolated.  Type A gelatin is produced using acid curing of connective tissue 
which results in a gelatin material which has an isoelectric point between 7 and 9 with a 
net positive charge, whereas gelatin type B is produced from lime cured tissue and has an 
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isoelectric point ~5.6 making it net negatively charged.  The isoelectric point of the 
protein to be delivered and the effects of polyion complexation should be taken into 
consideration when choosing the type of gelatin for MP fabrication[210]. 
Previously the effects of unloaded MPs on ESC differentiation were investigated 
and the goal of this study was to utilize gelatin MPs for delivery of BMP4, a growth 
factor known to induce mesoderm differentiation in ESCs[195, 197] and a BMP4 agonist, 
Noggin[211].  Growth factor release profiles were first characterized from gelatin MPs.  
Then the differentiation effects of incorporation of growth factor loaded MPs within EBs 
were investigated by gene expression and morphological analysis of adherent and 
suspension cultured EBs. 
 
Materials and methods  
Cell culture 
Brachyury-GFP cells (E14.1, 129/Ola)[212] were maintained on 0.5 % gelatin 
coated flasks in a humidified 5 % CO2 atmosphere, using the modified serum-free 
maintenance media and base differentiation media previously described[199].  
Undifferentiated D3 ESCs were maintained on gelatin-coated tissue culture dishes in 
DMEM media supplemented with 15% fetal bovine serum and 10
3
 U/ml leukemia 
inhibitory factor (LIF) (Millipore, Billerica, MA). 
 
Aggregate formation 
ESCs were trypsinized into a single cell suspension and aggregates were formed 
by forced aggregation in AggreWell
TM
 400 inserts (Stem Cell Technologies, Vancouver, 
95 
 
CA)[49].  Briefly, 1.2 x 10
6
 cells in 0.5 mL of medium were inoculated into 
AggreWell
TM
 inserts, containing approximately 1200 wells per insert, and centrifuged at 
200 x g for 5 minutes to cluster cells in the wells.  For EB culture, the media was 
switched to ESGRO complete basal media (Millipore) supplemented only with penicillin 
and antimycotic.  After 24 hours of culture, cell aggregates were removed from the wells 
using a wide-bore pipette and transferred to suspension culture on a rotary orbital shaker 
(40 RPM) to maintain the homogeneity of the population.  In order to investigate material 
incorporation, a second centrifugation of 200 µL of a MP solution at 200 x g for 5 
minutes was performed immediately after cell centrifugation.  In all cases the MP:cell 
seed ratio used was 1:3. 
 
Fabrication and loading of gelatin microparticles 
 Microparticles of type A (G1890) or B (G9391, Sigma) gelatin were generated 
using a water-in-oil emulsion method and fluorescently labeled as previously 
described[201].  Expected electrostatic interactions between the gelatin types and 
proteins were examined using ExPASy's Compute pI/MWprogram 
(www.phosphosite.org/psrSearchAction.do)[213, 214].  Heparin sodium salt 
(CalBiochem, San Diego, CA) was conjugated to gelatin type A MPs after MP 
formulation in the following manner.  EDC and S-NHS (Thermo Scientific, Waltham, 
MA) were added to heparin at 10:1 and 25:1 molar ratios respectively, relative to heparin 
dissolved in 800 µL activation buffer (0.1M MES, 0.5M NaCl, pH 6.0) and reacted for 
15 min at room temperature to modify the carboxyl groups of heparin to amine reactive 
S-NHS esters.  The EDC/NHS reaction was quenched with 20 mM 2-mercaptoethanol 
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and the activated heparin was added to 400 µL of particles in PBS at a 5:1 molar ratio of 
heparin to gelatin and allowed to react with agitation for 4 hours at 37 C.  Prior to cell 
culture, MPs were treated in 70 % ethanol for a minimum of 30 min before washing 3x 
with ddH2O.  Each MP batch was lyophilized and stored at -20 C.  Growth factors were 
added to MPs at 5 µL/mg and kept overnight at 4 C,  MPs were resuspended in 
differentiation media (≤ 500 L) and counted on a hemocytometer to estimate the 
concentration (ng/MP). 
 
Human BMP4 ELISA 
A quantitative sandwich enzyme immunoassay technique was used to determine 
BMP4 concentration after release from MPs suspended in PBS, based on the 
manufacturer‟s protocol (R&D, DBP400).  Briefly, 2-5 mg of MPs were suspended in 
750 L of a 0.1% solution of BSA in PBS at 37°C with rotation; at each sample time 
point 300 L was removed following centrifugation of the microparticles and replaced 
with an equivalent volume.  
 
Gene expression analysis 
RNA was extracted from spheroids after 4 days of differentiation with the RNeasy 
Mini kit (Qiagen Inc, Valencia, CA).  RNA was converted to complimentary DNA using 
the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) and analyzed using real time 
PCR (MyIQ cycler, BioRad).  Forward and reverse primers for Oct-4, Brachyury-T, 
Pax6, Flk1, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were designed 
with Beacon Designer software and purchased from Invitrogen.  Gene expression was 
97 
 
calculated with respect to expression levels of EBs without MPs using the Pfaffl 
method[171].   
 
Statistical Analysis 
Unless otherwise indicated, data are reported as mean ± standard deviation of the 
mean.  Statistical significance was assessed using one-way ANOVA with Tukey‟s post 
hoc analysis or student‟s t-test.  P-values of less than 0.05 were considered significant 
(n ≥ 3). 
 
Results 
Growth factor release from gelatin-based microparticles 
 Growth factor release kinetics from gelatin MPs were analyzed for VEGF (Figure 
5.1).  The release of VEGF displayed a burst phase in the first 24 hours where the 
majority of the VEGF was released from gelatin type B MPs.  Gelatin type B was chosen 
for VEGF because the isoelectric point of VEGF is 9.22 indicating that VEGF has a net 
positive charge. Because VEGF has known affinity for heparin, heparin-modified gelatin 
type B MPs were also tested for release of VEGF in an attempt to limit burst release.  The 
amount of VEGF released by the heparin-gelatin MPs was decreased in the burst phase; 




Figure 5.1 VEGF release from gelatin and heparin-gelatin MPs. VEGF release 
profiles appeared similar from both type of MP except unmodified gelatin MPs released a 
higher percentage of VEGF and released stopped after 24 hours compared to heparin-
gelatin MPs which continued to release VEGF for several days.  
 
BMP-4 release kinetics 
 BMP-4 release kinetics were next investigated from both gelatin type A and B. 
BMP-4 has a lower isoelectric point (8.97) compared to VEGF; therefore the positive 
formulation of gelatin (type A) was included.  Release results from type A gelatin MPs 
revealed that almost 100% of the loaded BMP-4 is released by the particles after 24 
hours.  This is explained by the fact that gelatin type A and BMP-4 are both positively 
charged, meaning they lack electrostatic interactions to slow the release from the 
particles.  Type A MPs were then modified with heparin in an attempt to increase the 
affinity of the MPs for BMP-4 and slow release.  BMP-4 release from heparin-type A 
gelatin MPs was then analyzed along with release from unmodified gelatin type B MPs 
under various growth factor loading conditions.  Heparin modification of gelatin type A 
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MPs resulted in decreased release of the BMP-4 molecule, whereas nearly all was 
released by type A MPs, only 40-70% of the incorporated BMP-4 was released by 
heparin-modified type A and gelatin type B MPs.  Release from heparin-type A MPs and 
type B gelatin MPs was similar and individual replicates overlapped between groups.  It 
was observed that a greater percentage of the loaded BMP-4 was released when more 
BMP-4 was loaded into the MPs.  This suggests that there is a threshold level of BMP-4 
which remains entrapped within the particle and that significant release of this portion of 
BMP-4 is not detected after 6 hours.  When excess BMP-4 is loaded beyond this 
threshold, the time period of release is extended as demonstrated in the group loaded with 







Figure 5.2 BMP-4 release from gelatin MPs.  Analysis of BMP-4 release from various 
formulations of gelatin including type A, type B and also type A with heparin 
modification demonstrated that BMP-4 release was dependent on both the concentration 
of growth factor used when loading the MPs and also the affinity of the MP material for 




Fluorescently labeled BSA release within EBs 
Bovine serum albumin was first fluorescently labeled with AlexaFluor 488 and 
then incorporated within gelatin type B MPs for the purposes of visualization of molecule 
release within EBs.  After EB formation the particles could be identified within the EBs 
using fluorescent microscopy.  As culture time progressed, the fluorescent signature 
became more diffuse indicating the tagged BSA was being released from the particles.  
Release occurred over a period of 4-6 days and by day 7 no areas of punctuate 
fluorescence were identified in EBs.  Fluorescent signal from the BSA could be 
distinguished from gelatin auto fluorescence by limiting exposure time to less than 30ms 





Figure 5.3. BSA release from gelatin microparticles. BSA fluorescently labeled with 
Alexa488 was incorporated within gelatin microparticles and then loaded within EBs. 
The fluorescence was punctuate at early time points (2-4 days) and gradually was 
replaced by a diffuse fluorescence indicating that BSA was released from the MPs within 




Brachyury-T expression  
R1 ESCs genetically engineered to express green fluorescent protein (GFP) on the 
Brachyury-T promoter were used to investigate induction of mesoderm differentiation 
either with BMP-4 delivered solubly to the media or delivered from MPs.  GFP signal 
peaked day 4 of differentiation in BMP4 treated samples. At day 4 EBs were fixed and 
counterstained with Hoechst, a nuclear dye, and then imaged using a confocal microscope 
(Figure 5.4).  Heparin-gelatin MPs were included in the experiment because it was 
hypothesized that affinity of BMP-4 for heparin would maintain a higher local 
concentration of BMP-4 immediately surrounding the MPs and therefore direct 
mesoderm differentiation only in the direct vicinity of the MPs.  The data did not support 
this hypothesis as no spatial patterns were observed in BMP-4 MP EBs.  BMP4 treated 
samples appeared similar but expression varied greatly from EB to EB.  Noggin treated 
EBs (soluble and both types of MPs) demonstrated a similar level of GFP expression. 
Brachyury-T expression was then quantified by flow cytometry measuring GFP 
positive cells in day 3 and 4 EBs.  On day 3, expression was limited to 5% in any of the 
groups, with the exception of the BMP MP group in which an average of 17% of cells 
were GFP positive (Figure 5.6A).  Day 4 expression increased in each of the groups, and 
it was revealed that Noggin treatment did not suppress Brachyury-T signaling compared 






Figure 5.4  Brachyury expression of EBs at day 4 of culture.  Brachyury-T expression 
was visualized by analysis of GFP signal.  Very few GFP positive cells were observed in 
control EBs (no treatment or unloaded MPs) or in Noggin treated samples.  The highest 
GFP signal was observed in EBs treated with soluble BMP-4; however, positive 




 It was hypothesized that local presentation of growth factor would be more 
efficient compared to bulk, soluble delivery in directing differentiation.  Because the 
relative levels of Brachyury-T positive cells were similar with MP delivery and soluble 
delivery, the total amount of growth factor used in each case is of interest.  In the case of 
soluble delivery, BMP4 was added to the medium at a concentration of 10 ng/mL first 
during EB formation in the microwells, then to the medium after 24 hours of culture 
when EBs were transferred to suspension and then again at day 3 prior to analysis of 
differentiation at day 4 of culture.  The total amount of BMP-4 added soluble was 
therefore 210 ng.  In the case of MP based delivery, 125 ng of BMP-4 was added to each 
mg of MPs during loading.  Each mg of MPs equates to approximately 3 million 
individual MPs.  For each well of EBs formed 400k MPs (0.133 mg) were added.  The 
amount of BMP4 originally loaded in this amount of MPs was 16.67ng.  Therefore, the 
amount of BMP-4 delivered via MPs was 12 fold lower than the amount delivered by 






Figure 5.5 Quantification of Brachyury-T positive cells in day 3 and 4 EBs.  Flow 
cytometry was performed on day 3 and 4 EBs and analyzed for GFP expression.  Day 3 
samples had low positive expression (<5%) except for BMP MP treated EB in which 
17% of the cells were positive. At day 4, expression increased in all groups, up to a 
baseline level of 20% in untreated and noggin treated samples and 40% and 55% in BMP 
soluble and MP groups, respectively.  
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Microparticle dose response 
 Growth factor loading experiments demonstrated that release kinetics and the total 
amount of growth factor released can be modulated by the concentration of growth factor 
used to load the MPs.  In order to identify whether or not this translated into dose 
responses in differentiation, gelatin MPs were loaded with 10 and 25 µg/mL solutions of 
BMP-4 and Noggin.  This corresponded to addition of 50 and 125 ng of growth factor per 
mg of MPs.  After loading, MPs were incorporated within EBs and differentiation was 
assessed using gene expression of Brachyury-T, Flk1 and Pax6 at day four of 
differentiation.  Samples containing BMP-4 loaded MPs up-regulated Brachyury T and 
Flk1 expression compared to untreated control EBs.  Brachyury-T and Flk1 are both 
mesoderm specific genes which are expressed very early in the onset of differentiation.  
Brachyury-T expression is sensitive to BMP4 and is useful for preliminary optimization 
of MP treatment.  Pax6, a marker for neural ectoderm, was down-regulated in BMP-4 MP 
samples.  The opposite trends were observed in EBs treated with Noggin loaded MPs.  
No significant differences were observed between Noggin loading conditions; however, 
BMP MPs loaded with the higher concentration of BMP-4 solution (25 µg/mL) were able 
to significantly alter gene expression of Brachyury-T and of Pax6.  Therefore, for further 
investigation of BMP-4 delivery from MPs, the higher loading concentration was used 







Figure 5.6  Gene expression analysis in response to growth factors delivered from 
gelatin MPs.  Gelatin MPs were loaded with a 10 (dark bars) or 25 (shaded bars) µg/mL 
solution of BMP-4 or Noggin. MPs were then incorporated within EBs and gene 
expression was analyzed at day 4 of culture.  EBs with BMP4 MPs demonstrated 
increased expression of mesoderm genes and decreased expression of Pax6, a 
neuroectoderm marker.  EBs with Noggin MPs demonstrated the opposite trend with no 
significant dose response. * = p < 0.05 compared to untreated EBs, ┼ = p < 0.05 
compared to 10 µg/mL BMP-4 MP. 
 
EB morphology  
 EBs cultured with growth factor loaded MPs or with soluble treatment through the 
first four days if differentiation were further cultured for 6 days in suspension or plated 
on gelatin coated dishes.  After 10 total days of differentiation, morphological differences 
were observed between groups (Figure 5.7).  BMP MP treated EBs developed translucent 
outgrowths, observed in suspension and in plated EBs. In contrast, Noggin MP treated 
EBs formed small protrusions visible in suspension and in plated EBs.  Differences in EB 
morphology observed after 10 days of differentiation suggested that MP based growth 
factor delivery had lasting effects on cell behavior.  By day 14 of differentiation small 
ring-like structures were commonly observed in BMP-4 treated samples (Figure 5.8).  
These structures were not observed in untreated or noggin treated samples but instead 
neurite outgrowths were observed.  This was consistent with early gene expression where 
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Pax6, a neuroectoderm marker, was up-regulated in Noggin samples and down-regulated 
in BMP-4 samples.    
 
Discussion 
 The data presented here demonstrates that BMP-4 loaded gelatin MPs are capable 
of inducing mesoderm differentiation at comparable levels to soluble delivery of BMP-4.  
Gene expression of mesoderm markers, Brachyury-T and Flk1 were increased in EBs 
treated with soluble BMP-4 or MPs loaded with BMP-4 and quantification of Brachyury-
T positive cells with flow cytometry confirmed mesoderm differentiation on a per cell 
basis.  The morphology of EBs also demonstrated differences between the groups even 
after 10 to 14 days of culture.  This suggests that cell fate can be influenced at an early 
stage of differentiation and that the effects will carry on after the differentiation cue is 
removed.  Noggin treatment did not demonstrate effective directed differentiation either 
delivered solubly or from MPs.  Noggin acts to prevent BMP4 signaling and because this 
study used a defined medium lacking BMP-4, it may be that Noggin treatment would be 
more effective at later time points of differentiation when cells begin to secrete 
endogenous BMP4.  Alternatively, Noggin delivery could be useful when delivered 
simultaneously with BMP4.  For example, Noggin would be beneficial in future studies 
utilizing dual growth factor release from multiple microparticle populations, spatially 
patterned to release BMP-4 and Noggin on opposite sides of a single EB.  Further 
analysis of the amount of BMP-4 used soluble vs. MP delivery demonstrated that MP 
delivery of BMP-4 required 12 fold less growth factor.  This is a significant savings in 
reagent and more importantly it suggests that factors presented via microparticle 
incorporation can more efficiently direct stem cell differentiation.   
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 The release of BMP-4 from MPs fabricated from gelatin types A and B confirmed 
the important role of polyion complexation between the growth factor and the MP base 
material.  BMP-4 was almost entirely released from type A particles after just 6 hours; 
however, heparin modification of type A particles resulted in delayed release kinetics 
which mirrored those of type B particles.  Growth factor release from MPs in a cell-free 
assay gives valuable information when comparing between material types; however, the 
environment within EBs is such that release kinetics in cell-free assays cannot be equated 
to the release kinetics of growth factor within EBs. For example, Figure 5.3 demonstrates 
that fluorescently labeled BSA is released from gelatin MPs within EBs over a period of 
4-6 days.  In cell free assays, BSA release is similar to BMP-4 and is exhausted over a 
period of 24-48 hours.  Characterization of release kinetics of growth factors from MPs 
within EBs would be useful for optimization of directed differentiation protocols.  A 
complicating variable is endogenous BMP-4 production from cells within the EB, 
requiring the use of radio- or fluorescently-labeled growth factor to distinguish between 
exogenous and endogenous growth factor.   
 MP-based delivery of growth factors could be used as an “inside-out” approach to 
deliver morphogens within the EB with the goal being to create a homogeneous 
concentration of growth factor within the EB thereby directing differentiation towards a 
more homogeneous population of differentiated cells. Another application could be to 
locally deliver morphogens to the cells in the direct vicinity of the MPs.  The goal could 
then be to create pockets of differentiated cells or to study growth factor gradients in a 






Figure 5.7 Phase images of BMP4 and Noggin MP treated EBs after 10 days of 
culture.  BMP MP treated EBs formed optically translucent, bubble shaped outgrowths 
(arrows) both in suspension (top row) and in plated EBs (bottom row).  Noggin MP 
treated EBs, however, were morphologically distinct with smaller protrusions (arrows) 
observed both in suspension (top row) or after plating (bottom row).  Scale bars = 500 






Figure 5.8 EBs plated for 14 days display differing morphology depending on 
treatment.  EBs treated either with soluble BMP-4 or with BMP MPs demonstrated 
strikingly different morphologies after 14 days of culture.  In both BMP-4 treated 
conditions, small, ring-like structures were frequently observed.  These structures were 
not observed in untreated or noggin treated samples, but instead neurite outgrowths were 






MICROPARTICLE INCORPOARTION WITHIN EBS FOR 





Mammalian tissues are comprised of individual cells assembled in a hierarchical 
manner to form multi-cellular units that span micron to millimeter scales in order to 
coordinately contribute to tissue function[101].  The engineering of tissues ex vivo seeks 
to emulate the complexity of native tissues and organs by generating 3D multi-cellular 
constructs capable of serving as models of healthy and diseased tissues for use as novel 
diagnostic and drug-screening platforms[218] and potentially for organ replacement or 
regenerative therapies[109].  Construction of 3D multi-cellular neo-tissues requires 
directed assembly of both homogeneous and heterogeneous populations of cells.  Current 
approaches to control the assembly and patterning of cells in 3D rely on intrinsic 
adhesive properties of the cells or engineering cellular interactions.  Intercellular 
adhesion is mitigated through natural cell-cell adhesion mechanisms, such as 
cadherins[219, 220], or can be engineered by chemically modifying cell surface 
molecules to promote and stabilize multi-cellular assembly[221-223].  In some instances, 
otherwise non-adhesive cell types can be induced to form homotypic cell aggregates; 
however, engineering of aggregates with multiple cell types requires a step-wise building 
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process which has thus far been limited to the formation of small aggregates comprised of 
at most 2-4 cell layers[221].  One particular concern associated with engineering cell 
surface adhesion properties of stem cells is the possibility of attenuating or inhibiting 
signaling pathways important to differentiation that rely upon dynamic transmembrane 
binding events, including cell-cell and cell-ECM interactions.  An alternative approach to 
controlling larger scale cell aggregation is to entrap cells within biomaterials, such as 
hydrogels, which can then be assembled by engineering the chemical and physical 
properties of the cell-laden material building blocks[224, 225].  Unlike modification of 
individual cells, cell encapsulation technologies can control the spatial assembly of multi-
cellular modules (100s of µm to mm in size) into composite structures.  However, cell 
encapsulation limits the interaction of cells in different modules and properties of 
hydrogel materials such as degradability, stiffness and ligand density can independently 
and cooperatively influence cell phenotype[226-228], thereby requiring that cell-specific 
design criteria potentially be considered for different stem and progenitor cell 
populations.  In either case, engineering cell membrane properties and cell entrapment 
both require a priori design of parameters including complementary cell adhesion 
mechanisms or design of material properties based on the cell type and desired construct 
geometry.  Thus, a robust method capable of geometrically controlled multi-scale 
assembly for a variety of cell types without the need for cell modification or a priori 
materials design would provide a novel and flexible route to study the biology of multi-
cellular structures in 3D. 
Magnetic forces can be broadly applied across multiple length scales to direct 
individual cells at the micro-scale (i.e. microtweezers[229] and microfluidics[230]) and 
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have long been used for larger scale applications including technologies for separation 
and sorting of cell populations[231, 232].  In general, approaches to magnetically label 
and direct cells have required surface modification of the magnetic particles and/or the 
cell plasma membranes in order to permit stable association between the materials and 
the cells[233].  Alternatively, the directed endocytosis of magnetic material can be 
utilized to induce magnetic sensitivity of individual cells[234]; however, endocytosis of 
sub-micron magnetic material can interfere with intracellular signaling and viability[235, 
236].  In contrast, magnetic manipulation of multi-cellular aggregates with larger (>1 µm 
diameter) paramagnetic material incorporated within the extracellular space does not 
require cellular modification or material internalization and remains an attractive route to 
control cell behavior because of the inherently flexible and spatiotemporally controlled 
manner in which magnetic fields can be applied.  Recently our lab has demonstrated that 
biomaterial microparticles (MPs) of varying sizes (1-20 µm) can be efficiently 
incorporated in a dose-dependent and homogeneous manner within the extracellular 
space of multi-cellular spheroids to engineer physicochemical properties of the 3D stem 
cell microenvironment[155, 161, 201].  However, to date, controlling the spatial 
incorporation and distribution of MPs or populations of different cells within multi-
cellular aggregate environments has proven difficult.  Thus, we aimed to incorporate 
magnetic microparticles (MPs) as a means to spatially control homogeneous and 
heterogeneous multi-cellular aggregates, without adversely impacting cell viability or 
phenotype. 
We report here that magnetic MPs (magMPs) can be efficiently and stably 
incorporated in a dose-dependent manner in the extracellular environment of 3D stem cell 
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aggregates without the need for biochemical modification of the cell membrane or 
material adhesive properties.  MagMP entrapment within multi-cellular aggregates 
enables the directed movement and assembly of spheroids in suspension culture with an 
externally applied magnetic field to yield complex organization of 3D constructs across 
broad length and time scales.  Therefore, this method can be used to address a variety of 
questions of relevance to stem cell and developmental biology, tissue engineering and 
cell bioprocessing. 
 
Materials and methods 
Spheroid formation and magMP incorporation 
D3 murine embryonic stem cells (ESCs) were propagated on 0.1% gelatin-coated 
tissue culture dishes in DMEM media containing 15% FBS and 10
3
 U/ml leukemia 
inhibitory factor (LIF; Millipore, Billerica, MA).  Embryoid bodies (EBs) were formed 
using a single-cell suspension by forced aggregation in AggreWell
TM
 400 inserts (Stem 
Cell Technologies, Vancouver, CA).  Briefly 1.2x10
6
 cells in 0.5 ml of medium were 
inoculated into AggreWell inserts, containing approximately 1,200 wells per insert, and 
centrifuged at 200 RCF for 5 minutes to pellet cells in the wells.  Magnetic, polystyrene 
microparticles with a diameter of 4µm (SpheroTech, Lake Forest, IL) were washed 3x 
with ddH2O, diluted in 0.1 mL DMEM media, and subsequently added at a 1:10, 1:3, 
1:1, and 3:1 microparticle-to-ESC ratio.  To pellet microparticles in the wells, either a 
second centrifugation was performed at 200 RCF for 5 minutes or a magnet (10 lb pull 
strength) was applied below the plate for 5 minutes.  All magnets used to create external 
magnetic fields were purchased from Gaussboys Super Magnets (Portland, OR).  After 24 
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hours of culture, aggregates were removed from the wells using gentle pipetting and 
transferred to a suspension culture on a rotary orbital shaker (45 RPM) to maintain the 
homogeneous populations of spheroids[54]. 
 
Quantification of magMP incorporation in EBs 
 After 24 hours of culture, EBs containing magnetic microparticles were collected 
and transferred to a 48 well plate where they were first counted and then lysed in a 5% 
SDS solution.  The magMPs remaining were counted using a Coulter Counter (Beckman 
Coulter, Brea, CA) using a collection window of 3.5-4.5 µm for each sample.  The 
resulting count was divided by the number of EBs lysed to calculate the average 
incorporation of magMPs per EB. 
 
Histological analysis and cell viability 
Spheroids cultured for 2 days were collected and rinsed in PBS, fixed in 10% 
formalin and embedded in Histogel (Thermo Scientific), processed and paraffin-
embedded.  Sections of 5 µm in thickness were deparaffinized before staining with Fast 
Green.  Histological samples were imaged using an 80i upright microscope (Nikon) and 
an SPOT Flex camera (15.2 64 MP Shifting Pixel, Diagnostic Instruments).  Cell viability 
was analyzed after 2 days of EB differentiation using LIVE/DEAD staining (Invitrogen, 
Carlsbad, CA).  Samples were incubated in serum-free, phenol red-free medium 
containing 1 mM calcein AM and 2 mM ethidium homodimer I at room temperature for 
30 minutes.  Spheroids were then washed three times with PBS and imaged using an 




Spheroids formed from 1:10 and 1:3 magMP:cell seed ratios were aligned linearly 
in a 100 mm suspension culture Petri dish using a bar magnet (65 lb pull strength) placed 
below the dish.  The magnet was removed from directly below the magMP laden 
spheroid population and placed under the dish at a distance of 4 mm away from the linear 
array of cell aggregates.  The movement of individual spheroids was recorded at 3 frames 




Adherent ESC monolayers were rinsed in PBS and incubated with a 5 ųM 
solution of CellTracker
TM
 (Blue, Red or Green, Invitrogen) in serum-free medium for 30 
minutes.  The CellTracker solution was aspirated and cells were incubated with serum 
containing medium for 30 minutes prior to trypsinization and spheroid formation. 
 
Magnetic manipulation  
4mm x 1mm nickel plated neodymium magnets were used to spatially confine the 
location of spheroids in rotary orbital suspension culture.  The desired configurations of 
magnets were created by magnets held in place on opposing sides of the culture lid.  The 
ability of the magnets to pattern the spheroids was dependent on the distance of the 
magnets to the level of culture medium, which could be adjusted by stacking magnets on 
top of each other to increase the thickness of the magnet layer.  After the magnets were 
configured, the dish was placed on a rotary orbital shaker at 40-50 RPM.  In order to 
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reversibly manipulate the translocation of individual spheroids between paramagnetic 
elements, iron rods were embedded in a PDMS gel approximately 4 mm in thickness 
such that the ends were spaced 2-3 mm apart and the opposite end of each iron element 
protruded at least 2 cm from the PDMS gel near the outside edge of the dish.  Individual 
rods were transiently magnetized by contacting the free end of each with a 10 lb pull 
force bar magnet in a sequential manner such that after removing the magnet, one of the 
other rods could be magnetized.  Individual spheroids were added in 1 ml of medium on 




Spheroids were first formed from ESC populations labeled with CellTracker 
fluorescent dyes.  For multi-aggregate assembly patterning, a 15mm x 2mm nickel plated 
neodymium magnet was applied underneath cell culture dishes to control spheroid 
location.  Populations of spheroids were then added to the dish in small volumes of 
medium (100-500 µL) in the order shown in Figure 4 A,D.  The EBs were then guided to 
a closely packed formation by swirling the magnet around the area occupied by the 
spheroids.  After a population of spheroids was closely packed, spheroids labeled with a 
different color were added to the culture.  For a stacked Venn diagram configuration, 
spheroids were sequentially added to the side of magnet each time, whereas for 




For merging of individual aggregates, single spheroids labeled green, red or blue 
were transferred from batch suspension culture to a 30 mm suspension culture Petri dish 
containing 500 µl of medium.  A 3mm x 9mm nickel plated neodymium cylindrical 
magnet positioned beneath a Petri dish was used to direct the spheroids to the desired 
position.  Merging of two spheroids was monitored at 37ºC via time lapse microscopy 
(Biostation IM, Nikon) with images taken every 3 minutes for a period of up to 15 hours.  
Merging of 3 and 4 spheroids composed of fluorescently labeled cells was performed 
similarly by adding different colored individual spheroids (one blue, red, green and no 
fluorescent label) sequentially to a culture dish.  Each spheroid was then magnetically 
guided to the desired position and allowed to sit for 10 minutes before other spheroids 
were added.  After spheroids were in contact with each other, the plate was placed in a 
cell culture incubator overnight and imaged using epifluorescent microscopy after 18-24 
hours.   
 
Statistical analysis 
Experimental values are reported as mean ± standard deviation (n = 6).  Statistical 
analysis was determined using one way ANOVA coupled with Tukey‟s post hoc analysis 







Magnetic microparticle incorporation in cell spheroids 
Mouse ESCs and magMPs (4 µm diameter) were sequentially seeded in PDMS 
microwells through successive centrifugation or a combination of centrifugation and 
magnetic pull-down (Figure 6.1A).  Immediately after centrifugation or magnetic pull-
down, magMPs were clearly observed on top of the cell layer (Figure 6.1Bi, arrows) and 
were primarily visible along the edges of the wells (Figure 6.1Bii, arrows). Within 18-24 
hours, multi-cellular aggregates formed within the wells (Figure 6.1Biii) with magMPs 
distributed throughout the entirety of the spheroids (Figure 6.1Biv).  Time-lapse 
microscopy analysis indicated that cell movement during spheroid formation 
corresponded with displacement of the magMPs, but no significant differences were 
observed in the kinetics of spheroid formation with or without the introduction of 
magMPs.   
 
Figure 6.1 Magnetic MPs are incorporated in a dose dependent manner. (a) MagMPs 
were incorporated within stem cell spheroids within PDMS microwells  (b) MagMPs 
(arrows) were observed after ESC and magMP centrifugation (i,ii) as well as throughout 
the spheroids that were formed after 18-24 hours of culture (iii,iv).  Scale bars, 100µm 




The number of magMPs incorporated within cell spheroids significantly (p < 
0.01) increased in a dose-dependent manner as a function of the microparticle-to-cell 
seed ratio (Figure 6.2).  At a seed ratio of 3:1 (MPs : cells) approximately 1500 MPs were 
counted on average for each spheroid. This represents an incorporation efficiency of 
41.6%. The upper limit of incorporation was not reached; however, it is likely that the 
probability of altering normal EB behavior (differentiation, cell viability, cell movement) 
increases with the number of incorporated MPs.  The goal of the experiment was not to 
find an upper limit of incorporation but to investigate a range of incorporation values so 
that EBs could be fabricated with various magnetic sensitivities.   
 
 
Figure 6.2 MagMP incorporation quantification.  Spheroids were formed using 
centrifugation or magnetic pull-down and the number of MPs incorporated per spheroid 
was determined after 24 hours of culture. * p < 0.05 Comparison of loading ratios, † p < 
0.05 comparison between pull-down and centrifugation.   
 
After transferring the multi-cellular aggregates from the microwells to suspension 
culture, the resulting spheroid populations exhibited comparable sizes and shapes, and the 
magMPs (observed as opaque regions) remained readily apparent in contrast to the 
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translucent cells (Figure 6.3).  EBs formed with a 1:10 and 1:3 seed ratio were 
sufficiently sensitive to magnetic manipulation; therefore, further analysis on the effects 
of magMP incorporation on EB morphology and cell viability were performed with these 
groups.  Additionally, it is worth noting that EBs became difficult to maintain in culture 
at the higher incorporation levels (1:1, 3:1) confirming the idea that when the number of 
MPs approaches the number of cells in the EB, behavior is likely to be altered.  Culture 
difficulty came from the fact that the EBs were prone to merging and were difficult to 







Figure 6.3 EBs formed with MagMPs.  EBs formed at cell seeding ratios of 1:10 (i), 
1:3 (ii), 1:1 (iii), 3:1 (iv) were of similar shape and size and dark regions of magMPs 





Figure 6.4 EB histology and viability.  Histological sections stained with Fast Green 
stain revealed that magMP incorporation did not disrupt cellular arrangement or 
morphology.  No differences in cell viability were observed for any of the groups 
(LIVE/DEAD assay, dead cells labeled red and live cells labeled green). Scale bar 100µm 




MagMPs in histological sections were visibly brown, due to their iron 
composition, and were clearly identifiable in the extracellular space of the cell spheroids 
in proportion to the respective seed ratio.  The addition of magMPs (1:10 or 1:3) did not 
alter the cellular organization within EBs or affect the morphology of the cells in direct 
contact with the magMPs (Figure 6.4).  Additionally, no difference in cell viability was 
observed between EBs with or without magMPs as assessed by LIVE/DEAD
®
 staining 
after 2 days of culture.   
Differentiation of EBs, with and without magMPs, was assessed by gene 
expression analysis of pluripotent and germ layer specific markers over seven days of 
culture in serum containing medium.  The expression of pluripotent markers, Nanog and 
OCT4, decreased with differentiation time and temporal expression patterns of markers 
from each of the three germ lineages (Pax6 – ectoderm, Brachyury-T – mesoderm, and 
Gata4 – endoderm) appeared as expected, with no significant differences between the 
experimental groups indicating that the presence of magMPs did not interfere with the 
normal differentiation process (Figure 6.5).   
MagMPs were also similarly incorporated within spheroids of human 
mesenchymal stem cells (Figure 6.6) and human induced pluripotent cells, indicating the 






Fig 6.5 EB differentiation is unchanged in the presence of magMPs. EBs cultured in 
serum containing media for 7 days were sampled and gene expression was analyzed 
using RT-PCR and normalized to ESC values.  Expression of pluripotent markers, Oct4 
and Nanog, decreased with culture time (a,b) indicating the magMPs did not disrupt the 
kinetics of differentiation.  Additionally, temporal expression patterns of germ layer 
differentiation markers, GATA4 – endoderm (c), Brachyury T – mesoderm (d), and 
PAX6 – ectoderm (e) appeared as expected, with no significant differences between the 





Figure 6.6 MagMP can be incorporated within human mesenchymal stem cell 
spheroids. Magnetic MPs, seeded in a 1:10 ratio, were incorporated within human 
mesenchymal stem cell spheroids using forced aggregation within microwells.  Dark 
regions, consistent with those observed in ESC aggregates, were observed in all spheroids 
(a-c) indicating the presence of magMPs. Scale bars 50µm (a), 100 µm (b) and 200 µm 
(c). 
 
Spatially directed translocation of EBs containing magMPs 
Having demonstrated robust incorporation of magMPs within stem cell spheroids, 
the ability to manipulate the spatial positioning and translation of stem cell spheroids was 
examined in static and dynamic culture systems using externally applied magnetic fields.  
Under static culture conditions, entire fields of individual spheroids could be 
concentrated, translated and rotated based upon the relative location, direction and 
manner in which external magnetic fields were applied.  As expected, spheroids 
containing a higher density of magMPs were more sensitive to applied magnetic fields 
(increased acceleration towards the magnet) compared to spheroids with a lower density 
of magMPs.  In order to demonstrate the quantitative relationship between magMP 
incorporation and magnetic field strength, the positions of individual spheroids were 
tracked over time as they moved towards a magnet placed at a lateral distance of 4 mm 
(Figure 6.7A, D).  Spheroids formed at a ratio of 1:3 (magMPs:cells) were translated 
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(Figure 6.7B) at an average speed of 451 ± 96 µm/s, whereas spheroids formed at a ratio 
of 1:10 moved at an average speed of 144 ± 80 µm/s in response to an identical magnetic 
field (500 Gauss).  Spheroids with a lower seed ratio (1:10) demonstrated increased 
variability in their response to the magnet, presumably a consequence of the greater 
variability of magMPs per spheroid with lower seeding ratios.  As expected, weaker or 
stronger magnets (10 – 65 lb pull strength) resulted in slower or faster translocation, 
respectively, of the same magMP-spheroid populations (data not shown).  It was notable 
that the velocities of the distinct spheroid populations did not overlap (Figure 6.7B, C), 
suggesting that complex mixtures of different types of spheroids could be sorted and 
organized rapidly based simply on the number of magMPs incorporated in distinct 





Figure 6.7 Spheroids with magMPs respond in a dose dependent fashion to magnetic 
fields. (a) Spheroids can be directed to move in a dish by an externally applied magnetic 
field.  (b,c) Spheroids formed with a higher ratio (1:3) of magMPs to cells move faster 
and more uniformly relative to spheroids formed with a 1:10 seed ratio.  (d) The distance 
moved between frames was tracked and suggests that the populations could be sorted 





Magnetic control of hydrodynamic suspension cultures 
Bioreactor culture is often utilized or envisioned in stem and progenitor cell 
culture as a means to produce high yields of cells thought to be required for large-scale 
biomanufacturing and clinical efficacy[64, 237].  The inability to control the spatial 
position of cells and aggregates under hydrodynamic conditions becomes problematic 
because shear forces, which can affect stem cell differentiation, vary as a function of 
position within individual mixed/stirred systems[55, 238].  As a simplified example, we 
examined the use of patterned magnetic fields to constrain spheroid location within rotary 
orbital culture.  Our lab and others have previously reported the use of rotary orbital 
shaker culture of ESCs to create and maintain homogeneous populations of EBs in 
suspension culture conditions[54, 239, 240].  In rotary culture, spheroids generally 
occupy a focused region of the dish (Figure 6.5A) and are subjected to a range of shear 
forces depending on their precise location, which changes slightly with each revolution of 
the culture.  By adhering magnets in a circular pattern on the lid of a Petri dish (Figure 
6.5B), we observed that the distance of the EBs to the center of the dish could be 
confined exclusively to the region below the magnetic pattern, which constrains the range 
of shear forces experienced by the cell spheroids.  Other patterns could also be imposed 
on dynamically cultured spheroids including discrete islands across the dish (Fig. 6.8Bii), 
a “four leaf clover” pattern (Figure 6.8Biii) or a straight line (Figure 6.8iv) by altering the 
configuration of the magnets on the lid of the Petri dish (shown in the insets of Figure 
6.8B).  Asymmetric geometries (Figure 6.8C) could also be formed and maintained by 
simply altering the externally applied magnetic field via the configuration of the magnets 
on the lid of the dish. 
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The transient application of magnetic fields was also investigated as a method to 
control the spatiotemporal localization and translocation of individual spheroids.  A 
triangular configuration was created with iron rods embedded in a thin layer of PDMS 
approximately 1 mm apart (Figure 6.8D) and individual spheroids containing magMPs 
were placed in the center of the configuration on top of the PDMS (Figure 6.8Di).  In the 
absence of an external magnetic field, a spheroid remained free-floating in the center of 
the configuration, but as soon as one of the iron rods was magnetized, the spheroid was 
immediately attracted by the magnetic field to the end of that particular rod.  By 
sequentially magnetizing other rods, the spheroid could be rapidly and specifically 
translocated from point-to-point, demonstrating the ability to direct multi-cellular 
movement and location in suspension culture purely by alternating magnetic fields of 





Figure 6.8 Spheroids location can be controlled in dynamic suspension culture.  (a) 
Without magnets, spheroids cultured on a rotary orbital shaker (45 RPM) cluster in the 
center of the dish.  Scale bar 20 mm.  (b) The placement magnets on the lid of the dish 
(configuration shown in insets) could be used to confine the spheroids to (i) a defined 
radius, (ii) distinct islands, (iii) a four-leaf clover, (iv) or a line configuration.  Scale bar 
20 mm.  (c). More complicated patterns, including the Georgia Tech logo, could be made 
at slower culture speeds.  Scale bar 20mm.  (d) In addition, the location of a single 
spheroid could be manipulated back and forth between iron pillars embedded in PDMS. 
The iron pillars were alternately magnetized (demonstrated by a “+” label), resulting in 




Multi-scale complex assembly of spheroid units 
The sequential assembly of bulk populations of magMP containing spheroids 
(hundreds to thousands of aggregates) was next examined using external magnetic fields 
in static culture environments.  A single population of fluorescently labeled spheroids, 
indicated with a “1” in Figures 6.9A,D, was added to a Petri dish and aggregated into a 
circle using a magnet 5 mm in diameter.  When subsequent populations, labeled “2”, “3” 
were added only on one side of the magnet, the spheroids aggregated into a stacked Venn 
diagram pattern (Figure 6.9B).  At the interfaces between the different spheroid 
populations little mixing was observed, demonstrating that geometry could be controlled 
with good pattern fidelity (Figure 6.9C).  When subsequent aggregate populations were 
added around the entire circumference of a fixed magnet, large numbers of spheroids 
could be arranged in a “bullseye” pattern of concentric circles (Figure 6.9E).  Again, 
higher magnification analysis revealed that the interface between different spheroid 






Figure 6.9 Macro manipulation of EB populations.  Large populations of magMP 
spheroids were manipulated to form macroscopic patterns including a “stacked Venn 
diagram” shape (a-c) or a “bullseye” pattern (d-f). Populations of CellTracker labeled 
EBs were added sequentially as shown in panels a and d and were aggregated using a 
magnet applied underneath the Petri dish.  Mixing between the layers was limited as 
demonstrated in panel c and f, magnified from the boxed areas in b and e.  Scale bars 




Spatial patterning of magnetically sensitive spheroids can be applied to various 
cell types which can be grown as aggregates but embryonic stem cell spheroids are prone 
to E-cadherin mediated agglomeration during early stages of differentiation[55].  In 
general, agglomeration increases the heterogeneity of culture and is avoided; however, 
controlled agglomeration may yield a platform for local control of the spheroid 
microenvironment. In order to test this hypothesis, individual spheroids, pre-labeled with 
CellTracker
TM
 Red, Blue or Green (or not labeled), were magnetically guided within 
close proximity of each other (Figure 6.10Ai) and monitored continuously thereafter with 
time-lapse microscopy.  After 5 hours of static culture, the individual spheroids remained 
in contact and began to merge along the interface adjoining adjacent aggregates (Figure 
6.10Aii).  After an additional 5 hours, the initially distinct spheroids continued to merge 
to form an oblong, oval structure (Figure 6.10Aiii) that eventually became a fully 
conjoined aggregate by ~15 hours (Figure 6.10Aiv). Interestingly, throughout the entirety 
of the merging process, the fluorescently labeled populations of cells remained largely in 
the same hemispheres corresponding to the initial relative location of their original 
respective spheroids.  Based on the ability to assemble spheroids that retained the relative 
position of the original sub-units, the same process was applied to the step-by-step 
construction of more complex multi-spheroid aggregates (Figure 6.10B).  Two spheroids 
were magnetically oriented adjacent to one another (Figure 6.10Bi-ii) before introducing 
a third (Figure 6.10Biii) and fourth spheroid (Figure 6.10Biv) on opposite sides.  Within 
18 hours the individual spheroids had merged to form a multi-quadrant aggregate, whose 
contributing multi-cellular units could be identified and distinguished by epifluorescent 





Figure 6.10 Merging of EBs can be spatially controlled on the single aggregate level.  
(a) The merging process of two spheroids was visualized over a period of 15 hours using 
time lapse microscopy. Fluorescently labeled stem cell spheroids were brought in contact 
with one and other using a magnetic probe (i) and began to merge after 5 hours of culture 
(ii). The spheroids continued to merge after 10 hours (iii) and became more rounded after 
15 hours (iv).  Scale bar 100µm.  (b) Merging of more than two spheroids could also be 
controlled by magnetic manipulation.  Spheroids were drawn together magnetically in a 
sequential manner (i-iv) which maintained the position of the spheroids relative to each 
other.  Scale bar 100µm.  (c) After 24 hours of culture 4 spheroids merged to create a 





In these studies, we have shown that magnetic manipulation of stem cells in 3D 
cultures provides a simple approach to control the aggregation and design of multi-
cellular geometries for neo-tissue constructs.  The method described herein relies upon 
high-throughput formation of magnetically sensitive stem cell spheroids, which differs 
significantly from other lower-throughput methods[234, 241], in part because it is not 
dependent on engineered cell or material properties.  Entrapment of magnetic 
microparticles can be conducted with various types of stem cells that are commonly 
grown as spheroids including embryonic[37], induced pluripotent[9], mesenchymal[242, 
243] and neural stem cells[244, 245].  Magnetizing cells or cell spheroids generally 
requires internalization of sub-micron material or conjugation to the cell surface which 
can impede cell motility and induce cell death[235].  By simply physically entrapping 
magMPs within the extracellular space of stem cell spheroids, magnetic fields can be 
applied to induce multi-cellular aggregates to rapidly assemble into higher order 
structures without directly perturbing intracellular machinery and signaling pathways.  In 
addition, the patterns that we report in these studies could all be created in static 
suspension culture using a relatively weak (10x weaker than a 3 tesla magnetic resonance 
imaging electromagnet) and transiently (1 min or less) applied magnetic field.  In such 
case where a continuous magnetic field may be necessary, the effects of magnetic field 
strength on stem cell differentiation could be assayed, though adverse effects on viability 
are not expected, based on prior reports of ESCs and neural stem cells cultured in the 
continuous presence of a magnetic field for 48-72 hours[246, 247]. 
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Patterning of spheroids in dynamic suspension culture systems, such as 
bioreactors, can be used for more uniform control of the extracellular environment and 
therefore offers advantages for stem cell bioprocessing.  Spheroids with incorporated 
magMPs could be strictly confined to specific locations within dynamic suspension 
culture suggesting a possible route to study confined regions of shear forces for 
individual EBs.  The distinct position of spheroids could also be controlled by 
magnetizing paramagnetic elements that could be physically integrated into the culture 
vessel design.  This method introduces the possibility of automating electromagnetic field 
patterning for precise control of spheroid locations within a bioreactor to better direct 
stem cell differentiation in batch culture processes. 
Another distinct advantage of incorporating magMPs within multi-cellular 
aggregates is the ability to manipulate their movement over multiple length scales, 
thereby providing new ways to study interactions of heterogeneous cell populations or 
homogeneous cells engineered within heterogeneous microenvironments.  Distinct types 
of cells or preformed spheroids can be conjoined with control over the ratios of different 
cells, as well as their spatial organization with respect to one another in order to create 
more complex 3D spatial patterns[248].  The sensitivity of the spheroids in this study to 
magnetic manipulation was dependent on the number of magMPs incorporated.  
Therefore the magnetic sensitivity can be determined during the formation of spheroids 
and populations can be self-sorted in a rapid and scalable manner to form complex, 
organized structures from mixed populations of different types of spheroids.  Magnetic 
field patterns could be specifically created with this purpose in mind to form hierarchical 
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tissue architectures with multiple cell types from a mixed population of multi-cellular 
aggregates. 
The magMPs incorporated within multi-cellular aggregates are currently used for 
magnetic control of the spheroids; however, recent work from our lab and others has 
shown that MPs can also be used to deliver morphogenic factors locally within cell 
spheroids[154-156, 249].  Dual incorporation of magMPs and morphogen-laden MPs 
within pluripotent stem cell aggregates could be used to engineer the types of gradients 
observed during embryonic morphogenesis, a novel and powerful approach to study 
fundamental principles of developmental biology in a more controlled and tractable 
manner.  This approach could also be complemented by encapsulation of individual 3D 
cell aggregates, like EBs, in engineered microgel niches to expose cells to patterned, 
heterogeneous environmental signals[250].  Specifically, a spheroid containing MPs 
loaded with a single morphogen could be merged together with three other spheroids 
each containing MPs loaded with complementary or antagonist molecules, as in Figure 
6.10C, to pattern pluripotent cells in a polarized manner similar to what is observed in 
pre-gastrulation stage embryos.  As such, spatiotemporal effects of controlled morphogen 
and inhibitor delivery could be studied to model aspects of human or mouse embryonic 
development and potentially be applied to the production of tissues from stem cells ex 
vivo.   
 
Conclusions 
The incorporation of magnetically sensitive microparticles within the extracellular 
environment of stem cell spheroids provides a facile means to control the subsequent 
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spatial location of spheroids in dynamic and suspension cultures using transiently applied 
magnetic fields.  The number of magMPs incorporated could be controlled during the 
aggregate formation stages and determined the magnitude of aggregate response to 
applied magnetic fields.  The method described herein was applied to single aggregates as 
well as large populations of spheroids without a priori design of materials or alterations 
to the cellular membrane.  This work is suited to the construction of neo-tissues 
comprised of aggregates made from different cell types in which the spatial orientation is 
important to tissue function.  In addition, combining magMPs with morphogen loaded 
MPs for localized delivery of multiple molecules within a single aggregate could be used 
for spatially controlled heterogeneous differentiation. Altogether, the incorporation of 
magMPs within stem cell spheroids represents an easily implemented method to further 
address significant questions of interest to the fields of stem cell biology, tissue 







The formation of EBs is a reliable and commonly used method to induce the 
differentiation of ESCs into various somatic cell types.  Hence, EB differentiation permits 
mechanistic studies of embryological development in vitro, including the examination of 
the effects of morphogenic cues on cell fate determination.  Previous efforts to engineer 
the EB microenvironment have focused primarily on the regulation of EB size and cell-
cell interactions, as well as addition of soluble factors, and ECM-molecules to EB 
cultures.  The inherent 3D organization of EBs limits the effectiveness of „outside-in‟ 
approaches which aim to affect differentiation of cells on the EB interior by controlling 
elements of the exterior EB environment.  An alternative strategy to improve the control 
of the EB microenvironment in order to better direct ESC differentiation may be to use an 
„inside-out‟ approach, such as integrating engineered biomaterials within the assembly of 
ESCs during EB formation.  Engineering the interior of the EB microenvironment via 
molecularly engineered biomaterials to enhance the directed differentiation of ESCs 
could facilitate the production of large numbers of homogeneous cell populations useful 
to the development of regenerative cellular therapies and diagnostic cell-based 
technologies. 
 The work herein demonstrates the method of forced aggregation can be used to 
incorporate a variety of materials in pluripotent stem cell spheroids.  Analysis of 
differentiation of EBs containing various types of unloaded MPs within aggregates 
demonstrated that the presence of materials themselves, in the absence of growth factors 
can modulate stem cell differentiation.  With this conclusion in mind, gelatin MPs were 
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modified with the objective of achieving control of material-microenvironment 
interactions, specifically by conjugating heparin, a molecule with known growth factor 
interactions, to gelatin MPs.  Incorporation of heparin-gelatin MPs within EBs resulted in 
increased changes in gene expression, growth factor secretion to the surrounding medium 
and localization of a marker for endothelial differentiation, VE-cadherin.   
 Gelatin MPs loaded with BMP-4 or Noggin and incorporated within EBs were 
investigated as a means to direct or inhibit mesoderm differentiation.  Analysis of EBs 
containing growth factor loaded MPs demonstrated that gelatin MPs can be used to 
deliver BMP-4 within EBs to direct mesoderm differentiation.  Analysis of growth factor 
release; however, demonstrated that gelatin MPs are not suitable for prolonged molecule 
release (longer than 24 hours) and other materials or methods of presentation may be 
necessary in protocols which require extended exposure to morphogens.  This platform is 
not suited for differentiation which requires different stages of soluble factors, as release 
from gelatin MPs cannot be externally controlled once they are incorporated within EBs.  
EBs containing BMP-4 loaded MPs expressed higher amounts of mesoderm genes 
(Brachyury-T and Flk-1) as well as lower amounts of an ectoderm gene (Pax6).  In 
addition to population based assays, formation of EBs using a Brachyury-T reporter ESC 
line demonstrated that the number of cells differentiated towards a mesoderm lineage was 
increased in BMP-4 gelatin MP treated EBs compared to solubly delivered BMP-4 and 
compared to untreated EBs.  Importantly, analysis of the amount of growth factor used in 
MP based delivery vs. soluble delivery revealed that MP based delivery required 12 fold 
less growth factor.  This finding is significant because the inefficiencies of currently used 
directed differentiation protocols combined with the large amount of cells needed for 
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development of clinically relevant therapies requires scalable processes for 
differentiation.  MP based control of morphogenic factors is scalable because forced 
aggregation can be used to form EBs at a high density. These EBs can then be transferred 
to suspension cultures, which have a much higher culture area to volume ratio compared 
to monolayer cultures.   
 Formation of magnetically sensitive spheroids was successfully performed 
through the incorporation of magnetic MPs.  Magnetic sensitivity was dependent on the 
number of MPs incorporated, a characteristic which could be useful in simple sorting of 
complex populations of EBs.  Furthermore, control of the location of individual spheroids 
or populations of spheroids in dynamic or static suspension culture could be controlled 
with magnetic fields.  This allowed for controlled agglomeration of single EBs or 
hundreds of EBs.  Controlled heterogeneity within aggregates is expected to yield 
insights in the fields of developmental biology and tissue engineering, fields where the 
organization of multiple heterogeneous cell populations with respect to each other are 






In general, most of the strategies attempted thus far to direct EB differentiation 
have relied on an „outside-in‟ approach to control aspects of the microenvironment.  
From the instant an aggregate of ESCs begins to form an EB, access to the interior 
intercellular environment and molecular composition of an EB becomes progressively 
restricted and „outside-in‟ manipulation of cell fate within an EB becomes limited in its 
ability to direct cell differentiation.  Although 2D differentiation of ESCs has been 
successfully used to spatially and temporally control the presentation of molecules for the 
differentiation of several cell phenotypes, the differentiation of some cells may require 
the synergistic effects of cell-cell and cell-ECM interactions provided within the context 
of EBs in 3D.  Therefore, in order to efficiently control the 3D microenvironment of 
differentiating ESCs within EBs, further development of engineering technologies 
capable of directly influencing cell fates within EBs are needed.   
 Engineering the microenvironment within EBs is difficult because variables are 
difficult to isolate and control.  Elements are constantly changing as the cells 
differentiate.  Cells move within the EB and autocrine and paracrine signaling occurs as 
cells secrete morphogenic factors which can in turn affect differentiation. Additionally, 
cell-cell contacts are dynamic as the profile of cell adhesion molecule expression on the 
surface of the cells changes with differentiation.  At later stages of EB differentiation, 
matrix production is an added variable.  Extracellular matrix (ECM) molecules can 
regulate growth factor signaling by controlling molecule diffusion, and growth factor 
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binding availability and ECM molecules can present integrin binding sequences thereby 
providing another microenvironmental cue for cell behavior.   
Work presented here demonstrates that forced aggregation is a flexible approach 
to incorporate various types of microparticles within stem cell spheroids and that the 
materials can present growth factors for directed differentiation.  While MPs loaded with 
growth factors were capable of inducing mesoderm differentiation, areas of this work 
require further study. 
 
2D vs. 3D differentiation 
One topic that is of interest with respect to terminally differentiated somatic cell 
types derived from embryonic stem cells is whether or not they are truly mature, 
functional cells.  Often cells derived from ESCs remain in an immature or embryonic-like 
state.  For example, ESC-derived cardiomyocytes differ from adult cardiomyocytes in 
that they express immature action potentials, a characteristic which may be detrimental to 
their use in clinical treatments[251, 252]. Another example is neuronal cells derived from 
ESCs fail to generate functional, synchronously oscillating neuronal networks as do 
primary neural isolates[253]. In vivo, the cells from the inner cell mass, where ESCs are 
derived, go on to differentiate into each of the over 200 adult somatic cell types.  
Therefore conditions exist which could be used to differentiate mature, fully functional 
adult cells but it is likely that current differentiation protocols fail to completely mimic 
the complex, spatially and temporally controlled microenvironment required for 
maturation and complete functionality of certain cell types.  The results presented in this 
work suggest that incorporation of biomaterials within stem cell aggregates may be a 
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method to better engineer the interior microenvironment.  An important area for future 
study is the comparison between mature cell types derived from ESCs in a monolayer 
format vs. a 3D format with incorporated MPs.  The hypothesis being that instructive 
cues provided by cell-cell and cell-ECM along with paracrine signaling from a 
heterogeneous population of cells will promote more mature differentiation of cell types. 
 
Cellular movement within 3D constructs 
 One observation that deserves further study is the impact of MP incorporation on 
cell movement within spheroids.  It was demonstrated that gelatin MP incorporation 
modulated phenotypic marker expression and this effect was dependent on the number of 
microparticles incorporated.  Possible mechanisms for altered differentiation in the 
presence of gelatin MPs include integrin mediated signaling, alteration in cell-cell 
contacts and the ability of gelatin to act as a depot for secreted growth factors, thereby 
altering the local concentration of signaling molecules either by increased retention 
within the spheroid or by depletion of these same factors.  One possible mechanism 
which may prove important even in the presence of morphogen delivery is the effect of 
adhesive materials on cellular migration during EB differentiation.  It is well known that 
cellular migration plays a vital role in the progression of morphogenesis and tissue 
formation.  For example, cell migration drives the process of gastrulation, critical for 
proper embryo development.  In time lapse videos of EB formation, extensive cell 
movement was observed in the x, y and z planes.  When microparticles were added to the 
cells, cellular movement appeared to decrease, dependent on the number of added MPs.  
Because EBs are often used as models of early mammalian development MP 
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incorporation could possibly be used to study the differentiation effects of stunted cell 
migration.  Additionally, MPs engineered to present specific cell adhesion molecules, 
such as cadherins, could be utilized to study cell movement or to localize the delivered 
signal to cells expressing the same cadherin.   
 Another application of the magMP constructs could be to study cell migration.  
Interestingly, when EBs formed from fluorescently labeled ESC populations merge over 
a period of 24-48 hours, the fluorescent signal remains localized within the quadrant of 
the original EB (Figure 6.10C) suggesting that cell movement is limited or else the 
fluorescent cells would be completely mixed.  Restricted cell movement is likely due to 
homotypic E-cadherin interactions between cells.  This could be studied experimentally 
by reducing the concentration of calcium ions in the media thereby disrupting homotypic 
e-cadherin interactions in which calcium ion dependent hydrogen bonding is 
necessary[254].  If under low calcium conditions, the cells were able to migrate further 
the fluorescence from each ESC population would be mixed across the aggregate and 
fluorescence from each of the original populations would be diffuse throughout the 
aggregate.  This same platform could be applied to study of developmental processes 
such as epithelial to mesenchymal transition (EMT) which occurs during gastrulation. 
During the EMT process, cells transition from an epithelial phenotype to migratory 
mesenchymal cells.  In this case the fluorescence in the construct would change from 
localized quadrants to diffuse fluorescence as the cells down-regulate e-cadherin and 
differentiate towards mesoderm lineages.  The EMT process is also implicated in a 
variety of diseases including tumor cell metastasis[255].  Because in vitro culture of 
explanted tumor cells are often cultured as spheroids, magMP incorporation could be 
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applied to study the process of metastasis within constructs composed of mixed 
populations of tumor cells and non-cancerous cell types.  These constructs could be used 
to study the effects of cell co-culture or small molecule libraries and their effects on 
tumor cell migration and viability in a 3D model.  High-throughput formation of cell 
constructs, as the one shown in Figure 6.10C would allow for screening of conditions 
promoting or inhibiting the EMT process.  Microfluidic platforms would be advantageous 
both as a method for high-throughput formation of heterogeneous constructs and also for 
high-throughput fluorescent analysis, analogous to identification of desired mutants in C. 
Elegans populations[256, 257].    
 
Next generation materials 
During mammalian organogenesis, the spatial-temporal presentation of molecules 
is tightly regulated and exquisitely synched with processes such as cell migration, 
differentiation and maturation to direct the combination of both terminally differentiated 
cells and progenitor cells to form functioning organs.  The work presented in this thesis 
focuses on the use of microparticles to deliver morphogens within 3D aggregates of 
pluripotent stem cells for directed differentiation.  A long-term goal of the technology is 
to form neo-tissues in vitro from a starting population of ESCs.  Two possible routes to 
this end include: either priming or “jumpstarting” differentiation towards cells of a 
specific lineage, such as mesoderm, thereby relying on the cells to produce their own 
autocrine and paracrine factors to produce mature cell types, or secondly, the materials 
could be engineered to deliver multiple morphogens with specific starting and stopping 
points.   
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A current limitation of gelatin, agarose and PLGA particles is that the materials 
are not stimuli responsive.  Loaded morphogens are released continuously based on 
polymer degradation rate (PLGA) or diffusive mechanisms regulated in some respect by 
affinity interactions between the morphogen and hydrogel base material.  Therefore, 
these materials are limited in their ability to temporally control morphogen delivery; 
delivery of loaded morphogens begins as soon as the materials come into contact with 
cells.  It may be that the cells in an undifferentiated state do not express receptors 
necessary to respond to these signals and therefore, the signal is wasted or minimally 
effective.  Equally important is the need to turn off signals or switch the delivered 
morphogen to guide the cell through various stages of differentiation.  Work presented 
here serves as the framework to incorporate various materials and even to pattern 
multiple spheroids using magnetic manipulation to spatially pattern multiple populations 
of microparticles within single, merged spheroids.  Likewise, proof-of-principle 
experiments have demonstrated that morphogens, such as BMP4, can be delivered from 
microparticles to direct stem cell differentiation.  Therefore, attention should be given to 
design materials which are capable of responding to either cell based signals or externally 
applied signals. 
An example of a cell-based trigger could be matrix metalloproteinase (MMP) 
sensitive linkers embedded in the microparticle material.  The morphogen of interest 
would be freed from covalent attachment to the biomaterial after cell triggered cleavage 
of the linker, but only when the cell has differentiated to point that it is able to express the 
selected MMP[258, 259].  The MMP profile of spontaneously differentiating embryonic 
stem cells is as of yet not fully known and would require characterization before this 
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method could be implemented.  Early treatment with soluble factors or with 
microparticles delivering a soluble cue-- Noggin, for example, can induce specific MMP 
expression in ESCs[260]-- could be used to induce MMP expression. 
As an alternative to cell-triggered responses, externally applied stimuli could be 
used to control the kinetics of morphogen release.  Several reviews are available which 
discuss a variety of stimuli responsive materials[261-263], including those sensitive to 
the acidity of the microenvironment, temperature, light, applied electric and magnetic 
fields or changes in ion concentration.  Of particular interest are methods which can be 
externally applied to microparticles incorporated in EBs.   
 
Induction of VEGF production 
The effects on differentiation of heparin-modified gelatin MPs, suggest that 
further study should be undertaken on what specific factors are interacting with the MPs.  
Several pieces of data led to the hypothesis that incorporation of heparin with the EB 
promoted endothelial cell differentiation, including increased secretion of VEGF and 
increased expression of VEGF receptors Flk-1 and Flk-1.  To further test this hypothesis 
endogenous VEGF production could be induced by culture of EBs in hypoxic 
environment.  Hypoxic conditions induce VEGF production through the hypoxia-
inducible factor-1 pathway[264].  Increased VEGF production by EBs with and without 
heparin-modified gelatin MPs would elucidate whether or not increased VEGF 
production in heparin-gelatin MP treated EBs is responsible for the localized expression 
of VE-cadherin expression observed at day 7.  Increased VEGF expression could also be 
used to test whether the binding VEGF binding capacity of the heparin-gelatin MPs is 
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exhausted under normoxic conditions or whether increased VEGF production would 
further magnify the effects of heparin incorporation on ESC differentiation. 
 
Paracrine capture 
Just as endogenous growth factors secreted by differentiating ESCs can be used to 
direct ESC differentiation, these factors could possibly be captured for use in wound 
healing models.  This would require retrieval of the MPs from the EBs after formation.  
Several possible routes to disrupt the spheroid for MP retrieval could be examined; with 
the requirement being that the treatment does not disrupt protein interactions with the 
heparin.  This would exclude trypsin treatment but mechanical dissociation could still be 
used.  Another hurdle is purification of the freed MPs from the disassociated cells, 
important because delivery of undifferentiated cells leads to teratoma formation.  The 
MPs are of a different density than the cells and centrifugation separation could be used; 
however, an approach with likely a higher efficiency of purification would be to form the 
gelatin MPs with nano-sized magnetic material thereby making the MPs magnetically 
sensitive for purification purposes.  Prior to MP formation, magnetic material could be 
mixed with the base polymer and physically entrapped within the MP during the 
emulsion stage and crosslinking stages.  As an alternate approach, the entire population 
of EBs containing the heparin-gelatin MPs could be acellularized using the method 
previously reported by the McDevitt lab.  The intent of acellularization is to create a 
biomaterial containing ECM and growth factors of an embryonic-like environment for 
wound healing or revascularization purposes.  Acellularization of EBs containing 
particles capable of sequestering growth factors and limiting secretion of these factors 
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into the medium where they are washed away, would likely enhance the benefits 
observed from EBs acellularized without MPs.  This idea could also be tested by first 
soaking the heparin-gelatin MPs in media conditioned from later time point EBs. The 
particles could then be delivered in a wound healing model as a preliminary test of 
growth factor capture. 
 
Glycosaminoglycan based microparticles 
It was demonstrated that heparin modification of gelatin MPs resulted in altered 
differentiation of EBs.  It is likely that with biomaterials fabricated from other 
glycosaminoglycans (GAGs), such as chrondroitin sulfate or hyaluronic acid, will have 
differing growth factor interaction profiles.  One recent study reported that 
methacrylation of chondroitin sulfate allowed for facile fabrication of microparticles 
composed entirely of chondroitin sulfate which could then be incorporated within stem 
cell aggregates[265].  A further application would be to combine methacrylated GAGs in 
various ratios, crosslinked together as MPs to create synthetic extracellular matrices for 
directed differentiation.  Use of these MPs should be investigated in spheroids of other 
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Pluripotent stem cells (PSC) provide insight into development and may underpin new cell 
therapies, yet controlling PSC differentiation to generate functional cells remains a 
significant challenge.  In this study we explored the concept that mimicking the local in 
vivo microenvironment during mesoderm specification could promote the emergence of 
hematopoietic progenitor cells from embryonic stem cells (ESCs).  First, we assessed 
early phenotypic markers of mesoderm differentiation (E-cadherin, brachyury, 
PDGFRFlk1; ETPF) and revealed that E-T+P+F+ cells have the highest capacity for 
hematopoiesis.  Second, we determined how initial aggregate size influenced the 
emergence of mesodermal phenotypes (E-T+P+F+, E-T-P+/-F+, and E-T-P+F-) and 
discovered that colony forming cell (CFC) output was maximal with ~100 cells per PSC 
aggregate.  Finally, we introduced these 100-cell PSC aggregates into a low oxygen 
environment (5 %; to upregulate endogenous VEGF secretion) and delivered two potent 
blood-inductive molecules, BMP4 and TPO (bone morphogenetic protein-4 and 
thrombopoietin), locally from microparticles to obtain a more robust differentiation 
response than soluble delivery methods alone.  Approximately 1.7-fold more CFCs were 
generated with localized delivery in comparison to exogenous delivery, while combined 
growth factor use was reduced ~14.2-fold.  By systematically engineering the complex 
and dynamic environmental signals associated with the in vivo blood developmental 
niche we demonstrate a significant role for inductive endogenous signaling and introduce 




Introduction   
Many developing cell therapies and tissue engineering approaches seek to mimic 
aspects of development to produce therapeutic cells or promote healing within specific 
microenvironmental contexts.  Pluripotent stem cells such as embryonic stem cells 
(ESCs) are a useful resource for elucidating mechanisms of development and offer 
tremendous potential for regenerative cell therapies.  Although progress has been made in 
generating many cell types from PSC, the challenge to develop appropriate and scalable 
inductive processes for targeted cell generation still remains.  Differentiation of 
pluripotent stem cells is commonly induced as 3D cell aggregates, termed  embryoid 
bodies (EBs); a multicellular complex capable of recapitulating various morphogenetic 
cues from gastrulation and responding to exogenous factors relevant to lineage 
specification.  EBs reproduce many of the temporal and spatial relationships found during 
normal embryogenesis[266], however, they lack critical developmental factors including 
biomechanical regulators[267], paracrine signals and the cellular migration that occurs 
within the murine yolk sac, embryo proper, and placenta[268, 269].  Herein we explore 
the prospective engineering of mesoderm and blood development inductive signals into 
differentiating aggregates of pluripotent cells, specifically focusing on environmental 
control of endogenous signaling and the local delivery of exogenous signaling factors.   
During mouse gastrulation, morphogenetic movements coupled with cell 
proliferation and differentiation convert an embryo from two layers (primitive ectoderm 
and primitive endoderm) to a trilayered structure[270].  The epiblast cells (embryonic 
ectoderm) undergo an epithelial-to-mesenchymal transition (EMT), mobilize and migrate 
through a transient structure called the primitive streak.  The primitive streak contains 
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nascent mesoderm that transiently expresses the T-box transcription factor, Brachyury 
(T) and acts as a specific site of cell ingression, as the three definitive germ layers, 
endoderm, mesoderm, and ectoderm form[271].  Undifferentiated ESCs express 
epithelial-cadherin (E-cad) which mediates initial EB formation, and is an indicator of 
pluripotency that is downregulated during differentiation and EMT events[272-274].  To 
measure the influence of diverse niche factors on mesodermal differentiation we first set 
out to determine an early mesoderm / CFC predictive phenotype associated with the 
primitive streak that could serve to accelerate our niche screening efforts.  We 
investigated the phenotypes generated by combining E-cad staining with the pan 
mesodermal marker brachyury (T)[35, 275], and two receptor tyrosine kinases: platelet 
derived growth factor receptor-PDGFR and vascular endothelial growth factor 
(VEGF) receptor-2 (Flk1), that are expressed by early mesodermal cell types[276] and 
have been associated with axial, paraxial and lateral plate mesoderm. 
We hypothesized that greater spatiotemporal control may allow quantitative 
contribution of normally convoluted niche parameters and provide insight into how to 
improve direct differentiation to desired lineages.  The physical size of EBs has been 
reported to influence the proportion of cells differentiating toward specific lineages[48, 
277] and impacts diffusion of soluble molecules[78].  We took advantage of recent 
advances to control EB size though forced centrifugation in micro-pyramidal wells[49] to 
influence endogenous interactions with the microenvironment.  Using a range of mouse 
ESC aggregate sizes we assessed the predictive value of the identified mesoderm 
phenotypes (based on E-cad, T-GFP, PDGFRFlk1 expression: +/-ETPF) with respect 
to blood progenitor (CFC) output.  We replaced exogenous soluble factors with local 
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delivery within the cell aggregate from microscale biomaterials to mimic factors 
normally delivered in a more systemic fashion[150, 157].  This approach has been used in 
hESC and mESC aggregates to control the release of small molecules and proteins within 
the local 3D microenvironment[154, 155, 161, 278].  These systems employed a variety 
of biomaterials, including poly (lactide-co-glycolide) (PLGA) or gelatin microparticles 
(MPs) capable of sustained release of molecules in a bioactive form.  However, none of 
the previous systems used small aggregates of ESCs (more closely mimicking the 
developing embryo) or specifically induced cells towards the hematopoietic lineage.   
 
Materials and Methods  
Cell culture 
Brachyury-GFP cells (E14.1, 129/Ola)[212] were maintained on 0.5 % gelatin 
coated flasks in a humidified 5 % CO2 atmosphere, using the modified serum-free 
maintenance media and base differentiation media previously described[199].  
Differentiation was initiated with 5 ng/mL BMP4, 25 ng/mL VEGF (Sigma-Aldrich, 
St.Louis, MO), and 50 ng/mL TPO (R&D Systems, Inc. Minneapolis, MN) in normoxia 
(20% O2) from d0-2/4; only BMP4 and TPO were used in hypoxia (5% O2).   
 
Size controlled aggregation 
Full or partial microwell inserts[49] were attached to 6- or 24-well plates using 
polydimethylsiloxane, and allowed to cure overnight at 37ºC.  Plates were sterilized with 
UV and 70 % ethanol prior to coating with 5 % (w/v) Pluronic F-127 (Sigma).  Wells 
were washed twice with PBS, and allowed to stand in media for a minimum of 30 min at 
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37ºC prior to seeding.  Full-well inserts were seeded with a single cell suspension in 
differentiation medium (3.0 mL) at the desired number of cells/microwell and centrifuged 
for 5 min at 200g.  Partial-well inserts were similarly seeded, however cells were 
suspended in 4-6 mL DMEM (Invitrogen) to minimize the effect of the uneven surface 
area of the well bottom.  Cells not captured within the micropatterned square-pyramidal 
wells were carefully removed by aspiration and 3.0 mL of growth media was added.  
200x200 m wells were used to aggregate 1-20 cells (24000 agg/6-w insert), and 
400x400 m wells for 50-200 cells (6000 agg/6-w; 1200 agg/24-w). 
 
Encapsulation process  
To encapsulate 100 cell aggregates, 0.12 x 10
6
 cells were seeded/well in a 24-well 
plate in a final volume of 1-1.5 mL differentiation media.  Approximately 40 hours later, 
for each test condition triplicate wells were collected and settled to 100 µL.  
Encapsulation and washing was completed as previously described[199], except a lower 
vortex speed (7.25, Vortex-Genie2®, Scientific Industries Inc. Bohemia, NY ) and 
centrifuge setting (350 g) was used.  Aggregates were counted pre-and post-encapsulation 
in a gridded 35 mm petri dish or 24-well plate.  Following encapsulation, the sBVT 
condition was split into one culture without factors and another with sBVT in normoxia 
or sBT in 5% O2 for a further two days (d2-4) as indicated.  Aggregates with MPs were 





Fluorescent automated cell sorting (FACS)  
Flow cytometric analysis expression and cell sorting was carried out as 
described[279].  Staining of more than 5 samples was completed in a V-bottom 96 well 
plate with 20 µL of sample or control cells.  Primary antibodies, E-cadherin (R&D) and 
PDGFRα-biotin (eBioscience Inc. San Diego, CA) were added at 1:100 for 25 min on ice 
before washing twice with HF (2% FBS in Hank‟s Buffered Salt Solution).  Secondary or 
conjugated antibodies (BD, Franklin Lakes, NJ) were added at 1:200 for 35 min on ice: 
goat anti-mouse PECy7 (Santa Cruz Biotechnology Inc., Santa Cruz, CA), Stv-APC-Cy7, 
Flk1-APC or isotype rat IgG2 before washing twice and resuspending in 1μg/mL 
7-amino-actinomycin D (7AAD, Molecular Probes® Invitrogen).  Occasionally, 
PDGFRα-APC, Flk1-PE and their corresponding isotypes were used.  Cells were 
analyzed on a BD FACSCanto (Firmware version 1.14), using BD FACSDiva software 
(Version 5.0.1) with positive staining defined as fluorescence emission > 99.1 % of 
negative control cells from the same starting population or undifferentiated cells.  Cells 
were sorted on a BD FACSAria and collected in IMDM supplemented with 10 % serum, 
washed and resuspended in serum-free medium without growth factors.   
 
Hematopoietic cell assays 
EBs were dissociated with 0.25 % trypsin-EDTA (3 min, 37 °C, Sigma) before 
seeding the myeloid-erythroid colony forming cell assay (ME-CFC) at 100 000 c/mL in 
35 mm duplicate plates (M3434, Stem Cell Technologies, Vancouver, BC) or at 
60-100 000 c/mL in 24-well plates (0.5 mL duplicate wells).  Previously sorted cells were 
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also seeded in 24-well plates, but at variable densities below 20 000 c/mL (2-3 wells with 
0.3 mL).  Colonies were enumerated 7-10 days after seeding as previously detailed[280]. 
 
Manufacturing and loading gelatin microparticles 
 Microparticles of type A (G1890) or B (G9391, Sigma) gelatin were generated 
using a water-in-oil emulsion method and fluorescently labeled as previously 
described[201].  Expected electrostatic interactions between the gelatin types and 
proteins were examined using ExPASy's Compute pI/MW program 
(www.phosphosite.org/psrSearchAction.do)[213, 281].  Heparin sodium salt 
(CalBiochem, San Diego, CA) was conjugated to gelatin type A MPs after MP 
formulation in the following manner.  EDC and S-NHS (Thermo Scientific, Waltham, 
MA) were added to heparin at 10:1 and 25:1 molar ratios respectively, relative to heparin 
dissolved in 800 µL activation buffer (0.1M MES, 0.5M NaCl, pH 6.0) and reacted for 
15 min at room temperature to modify the carboxyl groups of heparin to amine reactive 
S-NHS esters.  The EDC/NHS reaction was quenched with 20 mM 2-mercaptoethanol 
and the activated heparin was added to 400 µL of particles in PBS at a 5:1 molar ratio of 
heparin to gelatin and allowed to react with agitation for 4 hours at 37ºC.  Prior to cell 
culture, MPs were treated in 70 % ethanol for a minimum of 30 min before washing 3x 
with ddH2O.  Each MP batch was lyophilized and stored at -20 C.  Growth factors were 
added to MPs at 5-5.5 µL/mg and kept overnight at 4 C, MPs were resuspended in 
differentiation media (≤ 500 L) and counted on a hemocytometer to estimate the 
concentration (ng/MP).  For use with cells, BMP-MPs were loaded using 10-50 µg/mL 
stock solutions, and TPO-MPs were loaded with a 50 µg/mL stock. 
162 
 
Generating mixed aggregates: microparticles and cells 
A single cell suspension was generated from undifferentiated T-GFP ESC and 
centrifuged into the microwells as described above; 200g for 5 min.  Resuspended 
microparticles were added to the wells to obtain the desired factor concentration before 
centrifuging a second time at 200g for 5 min.  This method of aggregate and MP 
formation has also been achieved with D3 ESC[201].  Aggregates were maintained with 
full media exchange in the microwells (daily or daily starting at 48h) prior to removal of 
soluble growth factors and transfer to Petri dishes on day 4.  Alternatively, aggregates 
were removed 38-42 h after formation for encapsulation in agarose and/or dilution into 
60-100 mm Petri dishes at approximately 300 aggregates/mL.    
 
Human BMP4 ELISA 
A quantitative sandwich enzyme immunoassay technique was used to determine 
BMP4 concentration after release from MPs suspended in PBS, based on the 
manufacturer‟s protocol (R & D, DBP400).  Briefly, 2-5 mg of MPs were suspended in 
750 L of a 0.1% solution of BSA in PBS at 37ºC with rotation; at each sample time 
point 300 L was removed following centrifugation of the microparticles and replaced 
with an equivalent volume.  
 
Statistical analysis 
Unless indicated, data are reported as mean ± standard deviation of the mean.  
Statistical significance was assessed using one-way ANOVA with Tukey‟s post hoc 
analysis, student‟s t-test, or nonparametric Mann-Whitney test (Minitab 15/16, State 
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College PA and OriginPro7.5 Northampton, MA).  P-values of less than 0.05 were 
considered significant (n ≥ 3). 
 
RESULTS  
Cell population phenotypes  
We previously demonstrated that in serum-free conditions the addition of a trio of 
mesoderm inducing cytokines, BMP4, VEGF, and TPO (BVT) resulted in an induction of 
myeloid-erythroid colony forming cells (ME-CFC)[197].  In order to quantitatively 
measure the impact of our niche engineering efforts on hemogenic mesoderm generation 
we sought to develop a set of predictive phenotypic markers.  Multiple cell lines respond 
to this differentiation strategy, however, to trace the dynamic process of mesodermal 
specification in greater detail we employed the Brachyury (T)-GFP line[212].  We 
postulated that the dynamic upregulation of brachyury and downregulation of E-cadherin, 
that appear to signal the upregulation of two mesodermal receptors (Flk1 and PDGFR, 
could be used in combination to identify the putative hemogenic population for tracking 
purposes.   
Monitoring the expression of E-cadherin, brachyury, PDGFR, and Flk1 during 
differentiation distinguishes 16 possible phenotypes (Figure1 A).  Once differentiation 
was initiated with BVT, E-cadherin expressing cells (E+T-P-F-) progressively 
downregulated that adhesive molecule while brachyury and both surface receptors were 
upregulated (Figure 1B).  The presence of either one or both of the tracked receptors in 
the absence of brachyury was only observed after the initial peak of E-T+P+F+/- cells 
and may correspond to more differentiated cells (day 5, Figure 1B).  Due to the rarity of 
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many of the phenotypic populations it is likely that they represent transient expression 
states during lineage specification. 
We grouped the expression patterns into populations that could broadly be 
classified as having mesendoderm (ME), mesoderm (M), endoderm (E), or unknown 
potential, and differences in their gene expression profiles demonstrate this.  We sorted 
the most abundant day 3.75 phenotypes associated with hemogenic mesoderm and 
assessed their colony forming capacity after 3 more days of suspension culture (the 
standard time to assess CFC).  We found that the E-T+P+F+ population had the greatest 
hemogenic capacity, and was significantly enriched compared to the unsorted population 
and all other fractions (Figure 1C).  The total number of colonies generated from the 
unsorted population was equivalent to the sum produced by the individual sorted 
fractions once the initial frequency of these phenotypes was taken into account.  This 
analysis defined the starting population necessary to further track and optimize 
parameters of hemogenic mesoderm differentiation.  
 
Aggregate size and mesodermal phenotype  
Endogenous signals can impact differentiation[34] and it has been established 
with both 2 and 3D systems[282, 283] that the number of neighboring cells impacts 
autocrine and paracrine factors within the immediate media surrounding the cells[284, 
285].  Thus, we examined how the initial number of cells per aggregate influenced 
mesoderm differentiation due to the interplay of endogenous stimulatory or inhibitory 
signals and exogenous factors (Figure 2A) utilizing a centrifugal forced-aggregation 
strategy[49] and assessing the resultant phenotypes and functional cell types.  Total cell 
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density was controlled by seeding different cell numbers into 200 or 400 micron square-
pyramidal well inserts that covered an eighth-, quarter-, half-, or full-well within 6-well 
plates (Figure 2B) to normalize the levels of nutrients and growth factors in the bulk 
media.  The conditioning effect that occurs with larger cell aggregates during microwell 
differentiation was demonstrated by exchanging media between 10- and 100-cell 
aggregates.  Media conditioned for two days by 100-cell aggregates boosted the CFC 
output of the smaller aggregates while no striking effect was observed with the reverse 
media exchange. 
Mesoderm phenotypes associated with CFC potential were modestly enhanced 
with increasing aggregate size (Figure 2C).  To insure that similar differentiation kinetics 
occurred across the different aggregate sizes we evaluated the CFC output of day 7-9 
EBs; the greatest output occurred on day 7 for each size (Figure 2D).  The hemogenic 
capacity of aggregates mirrored the trends of the combined phenotypic response and was 
maximal with 100-cell aggregates (1 in 145 ± 8 d7 cells).  Uniformly sized aggregates 
initially seeded at 50-200 cells produced significantly more CFC (p < 0.05) than non-
uniform LSC aggregates. Without inductive factors (BVT), spontaneous differentiation 
accounts for less than 0.5% of the CFC produced (data not shown).  Thus, the addition of 
soluble factors is necessary to initiate hemogenic induction within the 100-cell 






Microparticle growth factor delivery 
Pluripotent populations demonstrate heterogeneity and plasticity in vitro and these 
properties can be modulated by extrinsic signaling[286], thus we sought to provide 
exogenous factors locally using growth factor delivery vehicles incorporated within the 
cell aggregates.  Local delivery within multicellular aggregates may enhance the 
efficiency of differentiation by increasing the effective growth factor concentration and 
limiting the formation of gradients.  We first confirmed that the physical incorporation of 
gelatin microparticles (MPs) within the extracellular space of 100 cell aggregates (Figure 
3Ai) did not adversely influence aggregate formation, brachyury expression, or CD45 
output.  By varying the seed ratio of MP to cells, we noted that 1 MP to 3 or more cells 
produced stable aggregates with incorporated particles distributed throughout the volume 
of the 3D spheroids (Figure 3B, S4C).  
The electrostatic affinity between charged biomolecules and gelatin species has 
been the impetus behind its use as a matrix for the controlled-release of bioactive 
molecules (reviewed in[287]).  The characteristic isoelectric point (pI) of gelatin depends 
on the manufacturing conditions and it is expected that protein retention would be 
enhanced in gelatin of the opposite charge (Figure 3Aii).  We tested the bioactivity of 
growth factor release from gelatin A or B MPs with 100-cell aggregates by seeding 
different amounts of BMP4-loaded MPs (B-MP, Figure 3B).  To examine the inductive 
effect and release kinetics of BMP4, cells were grown in the wells until T-GFP was 
measured on day 4.5 with media exchange (ME) occurring daily or daily after an initial 
48 hours of culture (d2ME).  Brachyury expressing cells reached a plateau of ~70% with 
2-15 ng/mL soluble BMP4 (sB) treatment in the presence of either gelatin A or B 
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unloaded MPs (U-MP, Figure 3B).  Brachyury induction from both type A and B MPs 
was equivalent to soluble delivery if media was left standing for 2 days, however, with 
daily media exchange T-GFP and hence BMP4 release was significantly reduced (* p < 
0.05).  However, this robust response was only seen if media exchange began 48 hours 
after seeding, suggesting that BMP4 release kinetics were not optimal.  Compared to 
continuous delivery, 24h soluble BMP4 reduced the percent of brachyury positive cells 
by ~10% (** p < 0.05), and a similar proportion of T-GFP cells was observed with 
gelatin A MPs (Figure 3B).  BMP4 release from type A gelatin induced similar levels of 
T-GFP as 24h delivery of soluble BMP4, in contrast, type B gelatin was unable to induce 
Brachyury with daily media exchange, and T-GFP expression was significantly lower 
compared to both type A MPs with daily exchange and 24h († p < 0.05, Figure 3B), 
suggesting that not enough BMP4 was released due to stronger electrostatic interactions 
with the negatively charged gelatin.  These dose responses indicate that MP delivery 
induced mesoderm differentiation similarly to bulk delivery.  We next explored the 
capacity to increase cellular responses by tuning the release kinetics of our growth factor 
delivery vehicle through molecular engineering.  
 
Growth factor release  
To further investigate the interaction of BMP4 with gelatin A or B MPs we varied 
the stock concentration from 5-25 g/mL and determined the characteristic release 
profiles by ELISA.  Very rapid and full release from gelatin A MPs occurred within 24h 
when loaded with a 5 g/mL BMP4 stock solution (Figure 3C).  In contrast, only 35% 
BMP4 was released over the same time from gelatin B MPs.  Neither of these release 
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kinetic profiles would be capable of sustained-release on the order of 4 days and allow 
the cell aggregates to be transferred to bulk conditions for extended culture.  Doubling 
the stock concentration of BMP4 doubled its release from gelatin B, however, using a 25 
g/mL stock resulted in a more variable and intermediate extent of release (~50%) 
(Figure 3C).  The heparin binding domain of BMP4 has recently been identified[288], 
thus, we conjugated heparin to type A gelatin MPs to take advantage of the total release 
by enhancing the loading capacity via high affinity binding sites.  We found that 35% less 
BMP4 was detected in solution with heparinized type A gelatin MPs than untreated 
gelatin A MPs and this was on the same order of release as gelatin B MPs (Figure 3C).  
We hypothesized that using the heparinized type A MPs loaded with BMP4 from stocks 
 10 g/mL would enhance the overall delivery and bioactivity of the heparin-bound 
presentation of the morphogenic factor.   
We successfully replaced soluble BMP4 with local delivery or presentation of 
affinity-bound BMP4 using the heparinized gelatin A MPs in combination with sVT.  
The MPs were seeded with 100 cells to form aggregates that were transferred to bulk 
suspension culture on day two (Figure 3D).  We next sought to integrate local factor 
delivery with other cell inductive parameters in a manner that would lead to robust blood 
cell development.  
 
Low oxygen environment with growth factor delivery 
We and others have shown that low oxygen tension (5 % O2) is beneficial in 
generating hemogenic mesoderm[289, 290] via a mechanism that dynamically tunes 
VEGF signaling.  We combined 5% oxygen tension with local factor delivery to enhance 
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blood development in the absence of exogenous VEGF.  Gelatin microparticles were 
incorporated in 100-cell aggregates to support mesoderm development either loaded with 
BMP4 or TPO (previously shown to enhance CFC production), or as unloaded controls 
(Figure 4Ai).  Cells were allowed to form stable aggregates for 32-42 hours before they 
were removed from the microwells and encapsulated in agarose to allow our engineered 
niche to be incorporated into suspension culture processes (Figure 4Aii).  Brachyury 
induction was apparent after 3 days (Figure 4Aiii) and in addition to the soluble growth 
factor controls (BMP4, TPO), 25 ng/mL VEGF was provided for 4 days in normoxia 
(20% O2) in order to match the CFC induction due to VEGF upregulation in 5% O2. 
Although thrombopoietin (pI 9.4) has a slightly higher pI than BMP4, we 
hypothesized that it would interact with the heparinized gelatin MPs in a similar fashion.  
We found that increasing the dose of BMP4 delivered by the MPs, while holding the dose 
of TPO relatively constant (range 9-15 ng), yielded an increasing number of CFCs 
(Figure 4B).  The cells were split between normoxic and hypoxic conditions following 
encapsulation and similar trends were observed in both the phenotypic induction and 
CFC output in response to the B-MP and TPO-MP delivery regardless of oxygen tension, 
indicating that cells in low oxygen effectively upregulated endogenous VEGF to replace 
the exogenous delivery in normoxia.   
In normoxic conditions 2-5 ng/well B-MP with TPO-MP delivery generated an 
increasing trend in CFC output but did not significantly differ from the soluble BVT 
(d0-2) control.  Providing 8 ng/well B-MP provided a significant improvement over two 
days of soluble factors and was similar to the sBVT (d0-4) control.  The highest CFC 
output occured with 12 ng/well of B-MP delivery.  This indicates that depending on the 
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dose provided the factors were active following encapsulation (i.e. 8 ng, d0-4 and 12 ng, 
> 4 days).  The early mesodermal phenotypes observed at day 4 (E-T+P+F+ and 
E-T-P+/-F+) correlated to the CFC producing cells present at day 7 (Figure 4C).  
Representative erythroid, myeloid and mixed colonies are shown from the 5 ng/well 
B-MP normoxic condition (Figure 4D).  Altering the presentation of the growth factors, 
either from MP delivery or 5% O2 induction, did not significantly alter the proportion of 
colony types produced by the majority of the different treatment conditions. 
Seeding 8 or 12 ng BMP4 and ~12 ng TPO within the spatial context of 100-cell 
aggregates (1200 total) appears to induce comparable, if not greater, mesoderm 
differentiation than 5 ng/mL exogenous BMP4 and 50 ng/mL TPO.  When the total 
growth factor loaded into the MPs and the additional media required for the soluble 
control following encapsulation (300 agg/mL) are accounted for, roughly 14x less BMP4 
and TPO was required for local MP delivery/presentation than for bulk delivery.   
In all, we have demonstrated that tracking the emergence of E-T+P+F+, E-T-P+/-
F+, and E-T-P+F- phenotypes can predict the general capacity of a culture to produce 
CFC when seeded 3 days later, and aid in understanding the various microenvironmental 
factors capable of impacting CFC production.  Aggregate size can be used to enhance 
CFC with soluble factors and manipulating the microenvironmental niche through 
controlled aggregation with microparticles that deliver BMP4 and TPO can generate 
greater numbers of CFCs than soluble delivery (~1.7x) of factors in both low oxygen 
(sBT) or normoxic (sBVT) environments.  These results demonstrate that local delivery 





Modulating cell-cell interactions and the effects of autocrine, paracrine, and 
exogenous factors through initial aggregate size, oxygen tension, and local growth factor 
delivery, has provided insights into directed differentiation by monitoring both cellular 
phenotypes and functional responses.  We first explored the differential expression of 
mesodermal cell phenotypes and the functional CFC response to exogenous growth 
factors in a serum-free media.  We used a serum-free culture system that maintains the 
self-renewal of undifferentiated ESCs[197, 291] and the embryoid body system to model 
blood development as it induces differentiation similar to embryonic gastrulation.  In an 
aim to better define and characterize subsets of nascent mesodermal cells for tracking and 
culture optimization purposes we monitored E-cadherin, brachyury, PDGFRα and Flk1.   
Flk1 positive cells have been associated with hematopoiesis and 
vasculogenesis[212, 292, 293], as well as other mesodermal cell types[294-296].  Two-
marker cell sorting strategies have demonstrated that P+F- cells have substantial muscle 




cells demonstrate enhanced cardiac potential[298, 
299], and P-F+ cells retain hematopoietic potential[299].  Monitoring E-cadherin and 
T-GFP[212] expression provided an indication that mesodermal differentiation was 
proceeding in our cultures and we combined these markers with PDGFRα and Flk1 
expression to delineate potential hematopoietic progenitors.  For the first time, we 
demonstrated that cells co-expressing brachyury, Flk1, and PDGFRα had the highest 
frequency of CFC formation when they did not express E-cadherin.  Presumably the CFC 
output represents the cell autonomous capacity of the sorted phenotypes, as the cells were 
allowed to mature for an additional three days without the addition of exogenous growth 
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factors.  Furthermore, the close link between the cardiac potential (P+F+) and 
hematopoietic potential (E-T+P+F+) raises the question whether a bi-potent cell 
population remains at the time we sorted.  Insight from these phenotypes can be used to 
aid future developments in cell generation processes. 
Focusing on parameters that may easily be incorporated into engineered systems 
to enhance hematopoietic specification, we next investigated the influence of local cell 
density.  Examining the initial developmental stages leading up to the assessment of 
phenotypic expression, we showed an increasing proportion of hemogenic cells with 
increasing aggregate size (1-200 cells), with a maximum at 100-cell aggregates (Figure 
2B).  Aggregates seeded with 5-200 cells with or without growth factors continued to 
expand at similar growth rates, such that there were no significant differences in 
population doublings between the conditions.  As the rate of aggregate growth was not 
strongly influenced by initial cell numbers, controlling both aggregate size and the total 
aggregates per well assured similar numbers of the bioactive molecules (BMP4, VEGF, 
or TPO) were available on a per cell basis in the bulk media or macroenvironment.     
Taking advantage of the capacity for microenvironmental control from within the 
aggregate itself we incorporated gelatin MPs as a delivery vehicle to locally present 
BMP4[288]and TPO[300], which have known and presumed heparin binding domains 
and hemogenic induction capacity.  Heparin has previously been used with scaffolds to 
sustain the release/presentation of heparin binding growth factors (HBGF)[301] and its 
use with particulate systems for controlled delivery of HBGF is an emerging area in 
tissue engineering[302].  In addition, although the specific heparin binding consensus 
sequence to various hematopoietic cytokines have not been established, cytokine-
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immobilization using low molecular weight heparin was comparable for TPO, SCF and 
Flt-3 (both basic and acidic proteins) and ~32% remained after 6 days[300], suggesting 
that heparinized gelatin MPs are able to deliver a variety of morphogenic factors in a 
similar manner.   
Finally, we established a system incorporating heparinized microparticle delivery 
of two factors, BMP4 and TPO, into 100-cell aggregates, which supports the generation 
of hematopoietic progenitors equivalently, if not to a greater extent (~1.7-fold more 
CFCs) than bulk exogenous delivery.  Similar cell numbers were generated with or 
without the provision of growth factors and in the presence or absence of microparticles, 
thus differences in colony numbers and enhanced CFC output represent better process 
yields from the initial ESC input.  In all, integration of a microparticle approach for 
bioactive molecule delivery within EBs provides the opportunity to deconvolute the 
complex biological signals which cells receive during blood development.  
In the future, time-lapse imaging studies may be used to investigate the 
localization of the developing mesoderm with enriched CFC activity or the relation 
between the hemogenic and non-hemogenic endothelium produced by the mesodermal 
precursors.  Furthermore with the establishment of this system, studies may now be 
designed to explore asymmetrical signals within the aggregate (by providing 
hemispherical delivery) and further mimic embryonic development or polar axis 
definitions.  Overall, this approach based on engineered combinations of physical and 
biochemical signaling serves as a model to guide differentiation of pluripotent stem cells 
to specific mesoderm phenotypes, such as blood, as well as to quantitatively investigate 
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the contribution of normally convoluted niche parameters on pluripotent cell 
developmental fate decisions.  
 
CONCLUSION 
We have provided a model system that used mesodermal phenotype 
characterization with a forced aggregation technique to control aggregate size and to 
embed MPs to serve as local delivery vehicles.  Under serum-free conditions, heparinized 
MPs incorporated prior to aggregate encapsulation were able to induce differentiation to 
levels that were similar or exceeded bulk delivery methods. 
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Figure 1. Monitoring mesodermal specification.  (A):  Four-colour FACS 
employing a T-GFP cell line sheds light onto pan mesoderm development by tracking the 
surface expression of E-cadherin, PDGFRα and Flk1.  (B): Comparison of 
undifferentiated cells to cells after 3.75 or 5 days in serum free differentiation media with 
or without BVT highlights the dynamic progression of these lineage markers and 
demonstrates that not all phenotypic combinations occur.  (C):  Populations were sorted 








 cells (no. of colonies/no. of seeded cells x 100) was significantly (*) higher than 








 n=2; ANOVA with Tukey‟s post hoc 





Figure 2.  Controlling initial cell aggregate size influences mesodermal specification.  
(A): The overall effect of endogenously produced factors would depend on the balance of 
stimulatory or inhibitory regulators that are secreted by the mixture of cell types.  A 
higher local cell density would condition the microenvironment with more endogenous 
factors than lower density conditions.  (B): Two sizes of micropatterned square-
pyramidal wells and partial coverage allows similar overall cell densitites with constant 
volume to be compared.  Initial 10-or 100-cell aggregates are shown in 200 and 400 µm 
inserts respectively, immediately after spinning down the cells and following four days of 
growth.  (C): The mesodermal phenotypes associated most closely with CFC, are shown 
as a stacked percentage of expression for aggregates that were initially 1-200 cells or 
non-uniform aggregates, formed from liquid suspension culture (LSC).  (D): The 
phenotypic expression increased with larger aggregate sizes, however, CFC are maximal 
with 100 cell aggregates.  The average number of CFC ± standard error of the mean are 
shown.  Means that do not share a letter are significantly different (n=6-8; ANOVA with 





Figure 3.  Gelatin microparticles do not interfere with cell aggregation and exogenous 
factors can be delivered locally.  (Ai):  A schematic of the aggregate formation process with 
BMP4 loaded gelatin MPs.  (Aii):  Both type A and type B gelatin MPs with characteristic pI 
were tested within the cell aggregates as it was expected BMP4 would have different inductive 
capacities depending on the electrostatic interaction between the gelatin and protein.  (B):  A 
range of BMP4 concentrations were tested by calculating the theoretical amount of BMP4 
contained/MP.  Brachyury (T-GFP) was assessed on day 4.5 (n=3; one-way ANOVA with 
Tukey‟s post hoc analysis,  = 0.05).  Open symbols: daily media exchange.  Abbreviations: MP, 
microparticle; B-MP, BMP4-MP; U-MP, unloaded MP; sB, soluble BMP4; d2ME, daily media 
exchange from day two.  P < 0.05 for comparison of:  *daily exchange (open diamond) to sB 
(filled square) or d2ME of type A/B (filled diamond) gelatin respectively; **24h sB (filled grey 
circle) to continuous BMP4 (filled square/ diamond); †daily exchange type B (open diamond) 
to both type A MPs with daily exchange and 24h sBMP4 (filled grey circle).  The MP:cell ratio 
used to deliver 1-20 ng BMP4 are shown below the axis; representative fluorescent images were 
taken 24h after seeding.  (C):  BMP4 was loaded into type A (square), typeB (triangle), and 
heparinized type A (open square) MPs from 5, 10 or 25 µg/mL stock solutions as indicated and 
its release into PBS was monitored by ELISA (n=3).  (D):  Delivery of 5 ng/well BMP4 with 
heparinized MPs was as effective as soluble delivery for 100 cell aggregates (n=4, student‟s t-




Figure 4.  Combining local growth factor delivery with low oxygen supports 
mesodermal development.  (Ai):  Aggregates formed with blue and red microparticles  
can be removed and (Aii): encapsulated for further culture.  (Aiii):  The aggregates 
respond to media nutrients and soluble factors as this control aggregate seeded with 
unloaded MPs differentiated with BVT and expressed brachyury (T-GFP).  The agarose 
shell is hightlighted with a dashed white ring.  (B):  BMP4 and TPO were delivered 
locally within 100 cell aggregates using heparinized type A gelatin MPs, while VEGF 
was provided in solution (d0-2) in normoxia.  Means that do not share a letter are 
significantly different (n=4-8; one-way ANOVA with Tukey‟s post hoc analysis 
 = 0.05).  ND- not detected.  (C):  Assessing the phenotypes of the developing 
mesoderm at d3.75 as described earlier (ETPF), accurately predicts the general trend in 
CFC output from day seven cells in both 20% O2 (black bars) and 5% O2 conditions (grey 
bars).  (D):  Representative myeloid and erythroid colonies from dual BMP4 and TPO 
microparticle delivery are shown.  Suppl. Figure 5 shows the distribution of colony types 
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